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Abstract 
The National Health Service in the UK, spends over £1 bn every year treating dermatolog-
ical conditions such as chronic wounds. These wounds exhibit poor vascularisation prone to 
polymicrobial infections where slow or non-healing are,typical, and spend prolonged periods in 
the inflammatory stage. Chronic wounds sl~ch as leg and foot ulcers develop in patients with 
illnesses such as diabetes, where circulation is compromised and regular treatment and mon-
itoring are essential. r\'lany management strategies and new therapies have been introduced 
to combat chronic wounds and include growth factor therapy and skin substitutes. Although 
one of the greatest concerns is preventing an acute wound becoming chronic, and retrieving 
the normal healing before amputations are needed. Other dermatological conditions such as 
psoriasis affects 2-3% of the UK's population and shares some common traits with the wound 
, 
healing phenomena, however mathematical models in this area arc scarce. 
The thesis proposes a number of new mathematical models, to describe dermatological skin 
growth and recovery in both .the epidermal and dermal membranes. The resulting models 
consist of nonlinear highly coupled system of pl;lrtial differential equations (PDEs) studied 
using analytical and numerical methods. There are two broad themes (1) epidermal'growth 
and recovery and (2) dermal and epidermal healing bet\ .... een the proliferative and repaired 
states. 
The epidermal inodel based on the keratinisatioll process studied the interaction of cell be-
haviour, cell binding and a generic signal in superficial wounds. The model predicted epithelial 
recovery and the reformation of the well defined live and dead cell regions, regulated by grow.th 
factors and cell-cell binding properties. A simple extension of the model included the inflam-
matory response to describe psoriasis, and highlights abnormalities in cell maturation leading 
to hyperproliferation. Potential treatments based on manipulating the growth factors IGF 
and JGFBP-3 are investigated. 
The dermal model captures the entire healing process by considering the interaction of ker-
atinocytes, fibroblasts, signals and nutrients tha.t work collectively to ensure skin homeostasis. 
This allows the recovery of the damaged dermis and replaces the \\'Olllld medium with granula-
tion tissue. ~'lanipulating the key parameters responsible for vasculature sufficiency, clotting 
ability, infiltration of bacteria into the wound and loss of dermal tissue provided distinct 
wound scenarios. They demonstrated the transition from normal to delayed/abnormal heal-
ing profiles, where comparisons between the two states were possible. Prospective intervention 
methods based on treatments available were considered to study their effectiveness on com-
promised healing. The additional supply of nutrients, signals and fibroblasts led to Illany 
interesting outcomes particularly in the presence of bacteria. The growth factor treatment 
applied to the densely infected wound case given in our model was unsuccessful, as hypergran-
ulation prevents keratinocyte migration and stalls wound coveragej this can only be retrieved 
ii 
with fibroblast treatment resembling skin substitutes such as dermagraft. 
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Glossary 
• Actin: Protein found in muscle tissue. 
• ChenlOtaxis: Characteristic movement. or orientation of a organism or cell along a 
chemical concentration gradient either towards or a\vay from the chemical stimulus. 
• Connective tissue: Also known as fascia, it is a framework of fibres that provide 
support to body tissues and organs. 
• Cytokines: Regulatory proteins released by cells of the immune system. 
• Cytotoxic: Extent to which a subst,ance is toxic to living cells. 
• Desquamation: Cell shedding at the skin's surface. 
• Endotoxin: 1bxins excreted by micro-organisms e.g. bacteria. 
• Eschar: Necrotic tissue mass at the wound site. 
• Exotoxin: Toxins that appear in the presence of particular microbes. 
• Granulation tissue: Perfused connective tissue that replaces the fibrin clot in a wound. 
• Growth factors: Chemical proteins made by the body that functions to regulate cell 
division and proliferation. 
• Hyperoxia: Excess oxygen in organs or tissues. 
• Hypoxia: Deficient oxygen supply 
• ROS: Includes oxygen ions, free radicals and peroxides which are generated by macrophages 
and neutrophils to terminate bacteria that they engulf. 
• Signal Transduction: Signal movement from outside t? inside the cell. 
• Sloughing: The skin's natural renewal process of skin shedding. 
• Toxin: Harmful substance produced by living cells or organisms. 
• Quorum Sensing: The ability of bacteria to communicate and co-ordinate behaviour 
via signalling molecules. 
xix 
Chapter 1 
Introduction: Skin 
1.1 Brief History 
It has taken many centuries to appreciate and recognise the importance, functionality and 
role in terms of structure and complexity of the skirl. .Many early civilisations believed that 
the primary role of the skin was to cover the body and prevent it from violation from external 
,...agents. They looked unfavourably at cutting OpCll a human body, and even now many societies 
consider it a.<; a taboo. This continuous belief impeded the study of human anatomy in both 
the classical world and in Christian Europe [17, 139J. Embalming was practised by the Ancient 
Egyptians indicating proficiency of activity inside the body, however the individual responsible 
for the incisions was ostracised from society. They believed in protecting the skin even after 
death as the skin provided the soul's integrity [92, 17]. The skin was idealised in classical 
Greek culture and considered to prot.ect the body's solidarity, and also strongly believed in 
the non-violation theory. Aristotle described skin formation by referring to the loss of moist.ure 
and desensitised actions [17] 
"by the drying of the flesh, like scum upon boiled substances; it is so formed not only because 
it is on the outside, but also because whllt is glutinous, being unable to evaporate, remains 
OIl the surface." 
References are made in Hippocratic texts emphasising the skin's functional role of removing 
impurities from the body and t.he pores show great physicality. This initiated models demoll-
strating fluid transport from various parts of the body to another and fluid secretion. The 
Greek and Romans have adopted a variety of names to describe the different forms and aspects 
of skin which we still use today,' as listed below [17] . 
• Derma (Dip/to): Greek word for hide . 
• Cutis: Latin term describes the living skin and the skin that protects. 
It was conjured from Aristotle's theory that the skin was the last organ to form, which was 
widely accepted by early followers and has taken lJIany centuries to dislodge. The science and 
study of the skin is collectively termed dermatology, although in the earlier hospitals they 
used the term "cutaneous" disease. There was leniency towards dismembering of corpses in 
the third century BC, as the study of human anatomy progressed in medical schools. Although 
research was conducted to gain insight into structural details of the human body, they ignored 
the importance of examining the skin itself 117, 92j. 
Galen provided the doctrine on how to study the human body, based on knowledge obtained 
by examining animals. Students were instructed to consider the bones first as they form the 
shape of the body, then the muscles and the veins, arteries and nerves. He wa." not atten-
tive to the remaining bodily components. This form of studying human anatomy went on 
for centuries after, and the skin was not studied in detail until the 16th century by Vesalius 
(using early microscopes), who defined the cuticle (epidermis), the derma (dermis), and the 
fat (hypodermis) and also described the flesh membrane separating skin froIll bodily con-
stituents which he referred to as "panniculus carnosus". He contested Aristotle's statement 
of the skin being senseless, as examination highlighted nerves extending frolll the skin to the 
body, insinuating the skin's involvement in sensations such as touch. This helped develop the 
knowledge and appreciation of the skin's role in anatomy, prompting researchers to consider 
the organ both structurally and physically. Towards the end of the 18th cent.ury, when the 
microscopes were more refined and commonly used amongst scientists the skin was considered 
more and more as an organ and a perllleable membrane. It was no longer considered as just 
an integument, where thermoregulation wa." believed to accompany its excremcntal propcrties 
[17,921· 
IVlany books dedicated to the skin followed, which discussed the structure and function, but 
also began to classify skin diseases. Joseph Plenck, a military surgeon treated lllallY skin dis-
eases and identified 114 of them, based on their anatolllicallocation and characteristic lesions. 
This was then shortlisted to only 10 (scurf, scale, sc~b, stigma, papula, rash, macula, tubercle, 
vesicle and pustule) by Robert \Villan who wrote the book On Cutaneous Diseases, helping him 
name and define a range of skin conditions; and his work was continued even after his death 
by his student Thomas Bateman who introduced the first atlas .of skin conditions. It should 
be highlighted that the skin was considered independently, and conditions/diseases identified 
were based on how they surfaced ignoring the underlying pathological cause [17]. 
In this introductory chapter we will discuss the skin anatomy and review details regarding the 
healing process and skin diseases that may occur. 
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1.2 Skin Anatomy 
The skin is a multilayered organ with intricate stnlcture and physiology with the ability 
to continuously self repair. This complex produces various distinctive derivative appendages 
including hair follicles, sweat glands and sebaceous glands each consisting of miscellaneous cell 
types and extracellular components as presented in Figure 1.1: It acts ll."> a physical barrier of 
protection by separating the external environment from our internal constituents and accounts 
for 16% of the body's mass. The non-uniform appearance and thickness implies that the skin 
depth, composition and density of appendages will vary in accordance to anatomical sites, the 
sole of Ollr feet is much thicker (6mm) when compared to the eyelids (lmm) for example. The 
skin distinguishes itself from other epithelial tissue 8..'" it prevents fluid loss and the ingress of 
noxious chemicals and micro-organisms [34, 40j. 
The three functional layers (of the skin) are the epidermis. dermis and hypodermis which all 
arc unique in their cellular, structural and functional composition as shown Figure 1.1. Such 
layers interact and work collectivcly, to help develop and maintain homeostasis, although each 
mcmbrane will be discussed independently in more detail [56, 139]. 
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Figure 1.1: The skin alld its functional membranes [l.o9J 
The skin has numerous functions and the main ones are Ill, 40, 171. 
• Thermoregulation. 
• Structural integrity to the body. 
• Mechanical protection. 
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Figure 1.1: Tbe skin and its functional membranes {lOg} 
The skin has numerous fnnctions and the main ones are Ill, 40, 171. 
• Thermoregulation. 
• Structural integrity to the body. 
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• Removing waste products of metabolism. 
The remainder of this chapter will explore the skin and related topics to provide information 
relevant to the biological ideas and mathematical modelling that will form the background of 
the work presented Ul this thesis. 
1.2.1 Epidermis 
The epidermis is a stratified multilayered protective medium ranging from 0.07-1.5mm in 
thickness, providing an initial interface hetween the body and its e.'Cternal environment, char-
acterised by both regenerative and djfferentiable properties and the first membrane affected 
by injury, damage or loss to Skill [11, 15[ . 
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Figure 1.2: Keratinisation process in the epidermis {40j. 
There are many types of cells that reside in the epidermal membrane, of which 80-95% consist 
of keratinocytes " Other key cells include melanocytes and Langerbans cells which are also 
important in terms of protection and homeostasis. This superficial membrane comprises of 
five sublayers, which are described below and presented in Figure 1.2 (starting with the layer 
ITbe epidermal cells in particular keratinocytes become proliferative and differentiable, allowing the for-
mation and renewal of this membrane. 
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nearest to the basement membra".) [15,46, 128). 
• Basal layer (stratum basale): This is the only sublayer wbere keratinocytes can mi-
totically divide, they appear columnal/cuboidal and rigid in appearance. One daughtcr 
cell produced from every mitotic division is forced to move upwards (see Figme 1.3), 
which results from tbe growth pressure created and the presence of actin'. 
• Prickle layer (stratum spinosum): The epidermal cells present in this layer ap-
pea.l' more polyhedral. Keratin synthesis produces keratin filaments, which are resilient 
btmdles/cables that anchor cell-ceU attachments namely desmoacmes' allowing equal 
distribution of tensility over the entire tissue. 
• Granular layer (stratum granulosum): The epidermal cells morph into diamond 
structures and acquire granules/keratohyalin, which continue to differentiate. Although 
enzymes contained in this sublayer begin to dehydrate cytoplasmic organeUes (such as 
the nuclei) and they are filled with keratin fila.ments to form a more dense intracellular 
framework. 
• Clear layer (stratum lucidUln): The epidermal cells become more elongated, and 
cens begin to disintegra.te as they come nearer to the skin's surface releasing sphin-
golipids; whlch arc oily droplets that occupy the int racellular space. 
• H orny layer (stratum cOrneUD'l): The epidermal cells are elongated further and 
appear flat in appearance although still polygonal. In this layer the cells are com-
pletely lifeless 8,nd are referred to as corneocytes, forming a protective barrier against 
pathogens and water. Corneocytes are removed from the skin's surface through desqua.-
mat,ion/sloughing. 
§B..0IlS LAYER 
TA TA 
o o o o o o BASAL LAYER 
BASEMENT MEMBRANE 
Figure 1.3: The bebavioUl' and relevance of stem cells (SC). SC divide asymmetrically pr(}-
dllcing two daughter cells, one wWch will be retained in the basal layer .,hilst tbe other will 
become a tmnsit amplifyiug (TA) cell, to enhance its progeny. It is tbe post mitotic dif-
ferentiating ceJJs (PMD) that detach from tlle basal layer and move into suprabasaJ Jayers 
/11, 40}. 
2KeratinocyteS contain actin, ena.bling comfortable motility in tiSsue and active migration upwards. 
3The desm060mes connecting cells appear as "prickles" hence the name (15J. 
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The upper layers are characterised by the production and accumulation of keratin protf'ins. 
There are approximately 20 keratins derived from the independent genes [11, 15, 40), with 
molecular weight ranging fromlQ. 70 kDa, Tbis provides necessary rigidity of the dead cells 
in the upper layer to undertake their protectivE" flUlCtiOns. 
Epidermal cell growth in the lower sublayers balances those lost from the outer medium to 
maintain consistency in epidermal thickness provided there are no abnormalities. The whole 
keratinisation process ranges from 4-6 weeks; once the daughter cell leaves (sce Fignre 1.3) the 
basal layer it takes 2-3 weeks to reach the granular layer and a further 2-3 weeks to desquamate 
(cell shedding/sloughing), 
Cellular Attachments 
Cell.cell and cell-EC~I attachments provides tbe structural integrity in tissues and organs, 
They determine the tensility and binding strength intra- and illtercellularly, These cellular 
attachments can be categorised by three groups namely desmosomes, tight junctions and gap 
JUDctions as illustrated in Figure 1.4, 
Desmosomes are common in epithelia especially skin and have three structural forms described 
below [9, 119), 
1. Spot desmosomes- Cells are mecha.nically connected via intercOIUlccting filament struc-
tures. 
2, H emidesmosomes- Half desmosomes that attach epithelial cells to the basement mem-
brane and act as anchors for cells. 
3, Belt desmosomes- ContinuOIL< band between interacting cells, loosely connected to 
£PfDlR>WS 
i 
Figure 1.4: Th. different types of junctions in tbe epidermis looking at two adjoining cells 
[119}. 
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filaments on the cytoplasmic part of the membrane. 
Tight Junction Proteins (1'.1P) are a group of integral and impermeable proteins) t.ypically 
located on the boundaries, .of both the granular and horny sublayers. They allow neigh-
bouring cell to communicate without sharing their contents. Gap junctions are important 
especially during injury/wounding, and protect healthy c.ells by separating them from the 
damaged/dying ones [9, 11, 119]. 
Basement Membrane 
The ba.~ement membrane (81\'1) distinguishes the epidermis and dermis which are biologically 
active. Once this membrane is disrupted particularly in wounds, it must. be reformed to regain 
normal functionality as the B~d provides physical support, provision for cellular ~ttachments 
and is involved in almost every pathological process including neoplasia, inflammation, wound 
healing and immunological reactions [11, 40]. 
1.2.2 Dermis 
The dermis is the thickest functional membrane ranging between 0.G-3mm, that comprises of 
its own vasculature and intricate structure, where you will find hair follicles, sweat glands and 
sensory receptors. It supplies the epidermis with essential nutrients and growth factors as the 
epidermis does not have a vasculature of its own. It can be defined by two regions, which are 
the papillary and reticular layers as discussed below [11,40, 56,92] . 
• Papillary Layer: Located below the epidermis and composed of loose connective tissue. 
This layer contains dermal papillae sllch as nerve endings, capillaries and !vleisner cor-
puscles e.g. touch receptors. Papillae indents the epidermis and provides the fingerprint 
projection observed on the skin's surface. The derrno-epidermal junction 4 allows ker-
atinocytes to be embedded in the dermal papillae, and interaction with basal membrane 
produces a framework able to trap collagen fibres . 
• Reticular Layer: Is the thicker of the two dermal layers occupying approximately 
80% of the entire membrane, and is densely populated with connective tissue containing 
collagen and elastic fibres. There is a plentiful supply of blood vessels, nerves and 
Pacinian corpuscle which are deep tissue receptors that sense pain and pressure. 
The principal dermal cells are fibroblasts which are primarily found in the papillary layer, 
and low cell densities can be seen in the reticular layer. They are responsible for collagen 
and elastin production which provides tissue integrity, tensility, and play crucial roles to the 
wound healing complex, as they restore blood supplies and promote tissue growth, There are 
4 Dermo-epidermal junction is an area between the epidermis and dermis and includes the basement mem-
brane, 
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different forms of fibroblasts such as fibrocytes and myofibroblasts whose activity is mostly 
observed [2, 26, 56], during tissue damage and repair. 
1.2.3 Hypodermis 
The hypodermis is also known a.'> subcutaneous fascia. This membrane contains loose con-
nective tissue and fat deposits, where nerves, blood vessels and hair follicles reside as shown 
ill Figure 1.1. The cells contained are mainly of adipocytes, macro phages and fibroblasts. It 
acts as a energy reserve which cont.ributes to insula.t.ion, conservation of body warmth and 
protect.ing internal organs after injury. The t.hickness of the hypodermis varies around the 
body, and is absent in the eyelids and the shim, [46, 56j. \Ve will not consider this membrane 
in the modelling to come, however it is useful to envisage the skin in its entirety. 
1.2.4 Cell Cycle and Development 
Cells are essential for the growth and development of all organisms, achieved by cell division. 
A selection of cell cycle activities is presented in Table 1.1. There are checkpoints within 
the cycle which control cell division to ensure all steps have been successful, preventing un-
wanted overproduction of cells, refer to Figure 1.5. Failure of certain checkpoints results in 
complications such as tumour growth, abnormal healing and skin condit.ions e.g. psoriasis 
11191· 
...... 
""""'" 
''''' 
Cell Cycle 
Figure 1.5: Cell cyele: the phases. Gl· Gap: Duration can range from 10-400 hours. In this 
plJase we observe the growth and preparation of c11roIIlosomes mediated by eyelin-dependent 
kinases (Cdks), ready for the preceding stage. S- DNA synthesis: DL<;'continuous process 
and duration is relatively constant in most cells, where the genome is duplicated and controlled 
by S-phase promoting factor (SPF). G,- Gap 2: Cells prepare for mitosis. M- Mitosis: Cell 
division. Go- Gap 0: Cells are in 11 quiesccnt state. wllicll CilD enter the G 1 phase in response 
to proliferation or other factors. This diagram has heen reproduced with the permission of 
Sllj Liu 177}. 
8 
Anatomical location Type of cell division 
Bone marrow (produces blood cells) Constant renewal 
Gonads {gametes production} Constant renewal 
Epithelia {epidermis and gut lining} Constant renewal 
Skin (epidermis and dermis) after injury Active when needed 
Liver (part removal encourages growth) Active when needed 
Nerve cells Never 
Brain cells Never 
Table 1.1: Type of cell division in distinct parts of tbe body {119}. 
1.3 Growth Factors/cytokines 
Growth factors (GF) ar~ naturally occurring proteins released by a variety of cells and regu-
latory proteins: stimulating many cellular and physiological processes including proliferation, 
differentiation: reproduction and general growth and development. Cytokines are a distinct 
family of GFs, secreted from immune cells such as leukocytes and macrophages; they stimulate 
the immune responses [40. 67). 
These chemicals bind to specific high affinity rcceptors fonnd on cell membranes when acti-
vated, to allow signal t.ransduction which describes intra- and extra- cellular Signal movement. 
Signal transduction initiates many intracellular procet;ses, including a series of phosphorylation 
reactions that take place in the cell's nucleus and indue~ gene expression. These intracellular 
events result in protein synthesis, alter cellular activity and may also affect the proliferation 
of cells. Many GFs have multiple roles: where distinct concentration levels initiate different 
biological responses both inhibitory/stimulatory seen during wound healing, skin diseases and 
other physiological impairments (see Table 1.2) Ill. 40, 67). 
Skin characteristics are maintained by Illany chemical mediators, which include epidermal 
GF {EGF}, fibroblast. GF {FGF}, platelet. derived GF (PDGF), transforming GF (TGF}-/3 
and insulin GF (IGF). Their functions overlap and many GFs contribute to the same process 
[11, 15,40, 119). Table 1.2 shows a list. of selected growth factors involved in skin regulation 
and wound healing and highlights their functions and activities. 
GFs allow cells t.o communicate intracellularly and exert their effects in four ways: endocrine, 
paracrine, autocrine and juxtacrine. Endocrine signals act on distant cells: paracrine signals 
target adjacent cells and stay in close proximity to t.he emit.ting cell, autocrine signals affect 
cells of the same cell type alid juxtn.crine signals are channelled along the cell membrane 
directly to adjacent cells via protein/lipid constituents [40, 67J. 
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Cytokine Cell source Signalling Function Effect 
PDGF Platelets, MC Paracrillc Chemotactic for neutrophils, + 
macrophages, monocytcs & fibroblasts. 
EC, fibroblasts Promotes proliferation of fibroblasts 
& ECM production. Encourages 
fibrobla .. ')ts to contract collagen 
matrices & responsible for 
rnyofibroblast phenotype. 
FGF Platelets, MC Autocrinc Stimulates angiogenesis & + 
macrophages, proliferates dermal cells. 
keratinocytes Regulates migration & 
EC, fibroblasts differentiation. Role 
in activating signalling & 
receptors interacts with heparan 
sulfate protcoglycans 
EGF Ivfacrophages: Paracrinc or Stimulates kcratinocyte migration. + 
oesinophilRl EC juxtacrinc Important role in re-cpithciisatioIl 
keratinocytes & granulation tissue formation. 
& fibroblasts 
VEGF Keratinocytes, Paracrinc Stimulates angiogenesis & + 
macrophagcs granulation tissue formation. 
MC,fibroblasts Regulates lymphallgiogenesis & 
platelets, EC acts as a chcmoattractant. 
Angio- Platelets, MC Paracrine Ang-l needed to stabilise blood + 
poietins Ang-2 macrophages vesscls,acts as a destabilising factor -
kcratinocytes. loosening cell-cell and cell-ECM 
fibroblasts, EC contacts allowing EC motility. 
IGF Platelets, Autocrinc: Stimulatcs growth & differentiation + 
macrophages, paracrine or of dermal and epidermal cells. 
fibroblasts endocrine Promotes wound healing & 
tissue regeneration. 
TGF-iJ Platelets, MC Paracrine Mitogenic for fibrobla..<;ts, but + 
macro phages inhibits keratinocytc proliferation. 
-
kcratinocytcs Attracts macrophages to wound site, 
fibroblasts, EC stimulating them to secrete 
additional cytokines: 
FGF, PDGF, TNF" and IL-L 
Table 1.2: Cytokines, cell source, functions and the positive/negative effect during wound 
jleajing and repair [88, 138j, 
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Figure 1.6: Growth factors (a) at tbe wound site (b) present when re-epitbe1isation takes 
place. Tbese diagTams bave been reprod llCed with ,be permission of Antbony Carter from 
R&D Systems [117, 132} 
1.4 Wound Healing 
Wound healing (vVH) is an ongoing area of intense reS<Jal-cil that has developed substantially 
over the last few decades. A ma.jor concern in research is establishing an accurate insight into 
the biochemical and cellular mechanisms e.xhibited by wounds, and differentiating between 
norma1 and abnormal healing processes. This would contribute greatly to the development 
of more effective therapies and improvements to existing wound management strategies, es-
pecially for chronic and slow healing wounds [117, 124]. Figure 1.6 illustrates GF and cell 
activities, that allow successful re-epithelisation by replacing the fibrin clot in a wound fol-
lowing the normal healing course. 
1.4.1 Phases of Wound Healing 
Wound healing L. a complex dynamic process defined by a number of well orchestrated series 
of events, often presented a.s a tlu'oo stage process, namely the inflammatory, proliferative 
and maturation phases. These phases may overlap in a single wound, although it provides 
a guideline when assessing and monitoring wound healing behaviour [11, 25]. The cellular 
activity incorporated in one phase provides t,he environment necessary for successful entry to 
tbe proceeding phases [40]. 
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Inflamma tory Phase 
The inflammatory phase is the body's initial response and the two governing proce:;.se:; are 
haem<kltasis (clotting response which reduces further blood loss) and inBammation (protective 
reaction to injury signified by redness an.d swelling). The most important cytokines are POaF 
and TGF-,6 in this initial phase and following an injury large quantities are rele8lsed into 
the affected area, acting as chemoallractants for many cells. The inflammatory response is 
essential to recruit fibroblasts and immune cells lo restrict infection and initiate the repair 
process [2, 11, 15]. In this subsection, an overview of the normal healing proc('SS will be 
discussed. 
Al the onset of injury, platelets released from the compromised vasculature will form an eschar 
(or scab) comprised of fibronectin and fibrinogen to prevent further blood loss, cover the wound 
from infections and provide tC'mporary support to restrict further damage. The resulting clot 
formation acts as a scaffold for migrating cells, to rebuild tissue in the damaged area [11, 15]. 
The hydration of the fibrin clot determines the migration path of keratinocytes, and a moist 
clot is favourable for normal healing to persist. 
Neutrophils become active between 2-3 days after injury to help remove foreign bodies and 
recruit further leukocytes to the wound bed. ~jonocytes transform to macrophages and further 
phagocytose bacteria/ foreign material and ingest inactive neutrophils, also secrete 1110re GFs 
to encourage the migration of cells, such as fibroblasts essent ial for healing and preparation for 
the next phase. A flow chart schematic of key events during inflammation is givPIl in Figllrp 
1.7. 
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Figure 1.7: Inflammation process {11, 25}. 
This phase will be discussed in more details here, as it is the focus of the modelling in Chap-
ters 5 and 6, where we will consider dermal bealing between the proliferative and remod-
elling/maturation stages of healing. 
Fibroblasts begin to migrate int.o the wound bed from surrounding tissue in response to 
cytokines. growth factors. activated neutrophils and ma.crophages towards the cnd of the 
inflammatory phase and signi6es the beginning of this stage [15[. 
Fibroblasts are key to the repair process and have a. multiple roles in wound healing con-
tributing to the production of the extracellular matrix (ECM). collagen synthesis producing 
fibroncctin and protooglycans such as hyaluronic acid. During ECM production, the wow1d 
margin is decomposed by matrix metalIoproteinases (l\1l1-lPs) and plasminogen activators. 
Thl'Se MMPs are e&;<>ntial to a.ll st.ges of wow1d healing and are regulated by tissue inhibitor 
Ulctalloprot.cinascs (TTMP) ensuring that excess matrix degradation does not take place. which 
may be oue of the contributors to abnormal wound hea.lIng [11, 56, 138J. 
The key components in this stage are neoangiogen!'Sisjnoov .... cularisation. granulation tissue 
formation. collagf"n synthesis. contraction and epithelisatiollj the most active cytokine in this 
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phase are TGF-/3 and pnGF '. First two events occur simultaneously and interdependently 
occupying open spaces on the wound and producing new capillaries [2. Il). 
Granulation tis:me production re-places the initial fibrin clot and depends on neovsscularistion 
which allows blood vess<'1s to proliferate in tL""ue that does not usually contain tbem. Neo-
vascularisation is a combination of angiogenesis and vusculogenesis. and replaces the damaged 
blood vessels to establish a supply of oxygen and nutrients in tbe wound area. Angiogenesis is 
the physiological process where new blood vessel growtb restdts from pre-existing vessels. me-
dlat(-o by man.y 8.lIgiog(·nic factors «('.g. VEGF) and c-apillary production resulting in arteriole 
formation thM revascularL""" the injured area [2. 11 . 15). 
Kera..tinocytes present at the wound edge tuldergo a transformation, which enables them to 
pbagocytose debris and migrate into the wound site and also promotes the proliferation rate. 
This allows the wound to contract and graJlulation tissue to develop further. This combination 
prompts re-epitbelisation and wound closure [,6) and Figure 1. stunmarises the sequence of 
event.s in the proliferation phase. 
a.YCOSAMINOGLYCANS 
fNLY "YALUAONK AC 
......... 
c.~ 
Figure 1.8: Proliferation process [11. 40). 
GRANULATlON 
n SSUE IS 
.""""". AND fl..La 
WOUND SPACE 
5These GFs stimulate fibroblast proliferation, collagen production and r~pitheH8ation (supported by 
EGF). Continual suppUes of both are usually available throughout. the whole healing duration 14, 15, 67. 138]. 
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Relllodelling/Maturation Phase 
In the final phase of wound healing, collagen and E.C!vl synthesis continues to take place, 
the key cytokine here is TGF-,B and the primary cells are still fibroblasts. In adults, the 
remodelling of the granulation tissue often leads to scar tissue formation, which may take 
months or years to complete, whereby the tensile strength of the repaired tissue is increased 
by further collagen deposition and restructuring [11, 56]. 
1.4.2 Wound Types 
Skin mass caB be lost in Illany ways, mechanically through piercing or scraping, by burning 
from flames or chemicals or from blistering. There are a vast number of ways for injuries to 
occur and the effects on the skin's functional layers is varied and dependent on the severity 
of the wound. The depth, size and management of wounds, contributes greatly to the healing 
time and likelihoo~ of infections [5, 11]. 
''''ounds can be classified into four categories as follows [5, 11,69]. 
• Superficial thickness: Injuries affect the first functional membrane (epidermis), where 
the epidermal cell population is not greatly affected, leaving an adequate blood supply 
and encourages prompt re-epithelisation. 
• Superficial partial thickness: The epidermis and the upper layers of the dermis are 
affected and appear as abrasion or blisters. The moisture in these wounds should be 
controlled to prevent contamination and promote the healing process. 
• Deep partial thickness: Injuries extend further into the dermis, where the destruction 
of nerve endings, epidermal and dermal cell population affects regellcrat,ion. Second 
degree burns are in this category. 
• Full thickness: '''ounds that destroy both the epidermal and dermal layers, finding its 
way into the subcutaneous layer (hypodermis) and may damage any underlying struc-
turcs such as muscle, tendon or bone. These injuries lIlay appear as craters. 
1.5 Chronic Wounds 
A slow or non healing wound is referred to as Cl. chronic wound, and the normal wound healing 
pathology i~ severely impaired. The healing rate ranges from weeks to years and is dependent 
on many factors: such as age and severity, which affect wound pathology. Loss of large skin 
mass poses a great threat to an individual's life, by significantly impairing their lifestyle 
in terms of independence and quality as they will experience great discomfort and distress. 
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Typical sources of chronic wounds include pressure ulcers, diabetic ulcers and burn wounds 
affecting both epidermal and dermal layers [11]. 
The annual cost to the National Health Service (NHS) frolU regular monitoring and pal.ienL 
care is approximately £1 bn, whilst in the USA it is significantly greater and is estimated 
at $150 bl1. Patients with chronic illnesses like diabetes are likely to suffer more as they 
have certain dysfunction and impairments which inhibits normal repair. According to the UK 
Health Episode Statistics (2005), it was reported at one time that only a quarter of the 400,000 
leg ulcer sufferers were being treated due to resource limitation and prioritising patient needs 
[56, 1001. 
There are lIlany factors contributing to the onset of chronic wounds and it is believed that the 
ability of keratinocytes and fibroblasts to proliferate, migrate and synthesise specific growth 
factors and cytokines essential for the recovery reduces immensely. Also, keratinocytes exhibit 
partial activation and differentiation in the wound medium resulting in impaired healing. Over-
expression of c-myc (i in the basal layer produces the chronic wound phenotype and reduces the 
local epidermal stem cell population [124, 128]. This Illay be a result of the hypoxic medium 
a chronic wound exhibits, alld the accumulation of dead tissue and ce!lular exudate present 
[8]. Typical characteristics of chronic wounds arc given below [11,32, 124]. 
• Vascular insufficiency and inadequate supply of oxygen and nutrients. 
• Polymicrobial contamination (bacterial or fungal infections). 
• Tissue degradation frolll the toxic chronic wound fluid created in the damaged area. 
• Elevated levels of ROS (reactive oxygen species) and protcases 
• Reduction in essential GFs 
• Impaired keratinocyte migration. 
ROS include superoxide radical and hydrogen peroxide and are knO\vll to be cytotoxic, they 
are believed to affect central cellular processes such as proliferation and apoptosis. Increased 
levels of ROS that follow immediately after an injury, reach high levels \vithin chronic wounds 
affecting Illany key processes (133]. 
Chronic wounds remain for prolonged periods in the inflammation phase because of the per-
sistent infections which affect the clotting mechanism and begin to "attack" healthy tissue. 
In acute wounds, the concentratiOli of inflammatory cytokines is carefully controlled by an-
tagonists, which favour inhibition. However, in chronic wounds, Illany proinfiammatory cy-
tokines are released but are not regulated, which may be responsible for further tissue damage 
[7, 11, 341 .. 
6C_myc is a ollcoprotein that is responsible for the transcription of growth associated genes. 
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Chronic wounds express an imbalance bebveen the proteolytic enzymcs and their inhibitors, 
from the ovcr-expression of l\H\.'IPs. The disparity of .l\·JMPs and TI.MPs can lead to abnormal 
degradation of the ECM, CFs (including ECF, PDCF and TCF-fJ) and adhesion proteins 
such as fibronectin when TIJ\'IP levels are relatively low. Cell exposed to chronic wound fluid 
demonstrates low mitotic activity as DNA synthesis is impaired. It has also been suggested 
that macromolecules present in chronic fluid accumulate in the wound bed, which may bind 
or trap GFs making them unavailable for the healing process [34, 139, 124]. 
There are many observations that indicate differcnccs between normal and chronic wounds, 
but little is known regarding which factors are the cause and which arc simply the symptom 
responses to the situation. Poor vascularisation and bacterial infections commonly occur in 
chronic wounds, and the inability to improve a healthy normal wound medium will cause 
further complications in the healing process [134). 
Role of Bacteria 
Infections are likely to occur in deep partial and full thickness \\'ounds, because of the hostile 
environment provided, and accumulation of nonviable tissue. Bacteria can invade the wound 
in three stages as listed below Ill, 71,1161 
• Contamination: i\'Iicrobes present in low quantities but can reproduce. This is common 
in all wounds and provided the bacteria are kept in check complete healing is observed. 
• Colonisation: A more established bacterial population exists which is polymicrobial) 
and extensive proliferation Blay occur. 'rhey are localised to the superficial compartment 
of the \vound. On the surrounding skin) exposure to external stimuli and endogenous 
factors including mucous membranes are potential microbial sources, contributing to 
colonisation. 
• Infection: Bacterial colonies begin to expand and are no longer locali~ed to the superfi-
cial membrane, invasion begins deeper into the skin tissue affecting the dermis, damaged 
tissue and vascularisation. Infection may become systemic (gangrene and septicaemia). 
Invasion into the wound area, especially the deep tissue compartments, results in infections and 
contributes to the development and prolongation of chronic wound healing. Microbes produce 
destructive .l\UviPs, exotoxins and endotoxins to the host and this creates a pro-inflammatory 
environment, which aggravates tissue damage as discussed above. Common wound pathogens 
of aerobic nature include Staphylococcus Aureus and Pseudomonas Aurcus and anaerobic 
ones include Peptostreptococcus spp and Porphyromonas spp [11,71). Chronic wounds such 
as diabetic foot ulcers have Cl higher proportion of anaerabes compared to aerobes, which 
makes it more difficult to follow the normal healing process and requires vigourous intervention 
methods 171, 1161. 
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Wound Type Dressing Description 
Superficial partial thickness Adhesive film Transparent which allows 
monitoring of wound. 
l\'Iild - moderate exudate levels Hydrocolloid Self-adhesive pads are common. 
Thrns into gel when exudate 
is absorbed, providing warmth. 
Contaminated, moderate - Foam A bsorbs excess exudates 
heavy exudate levels & retains moisture. 
Dry necrotic tissue Hydrogel Complex water based gel. 
Helps rehydrate wound and 
retain moisture 
Table 1.3: The types of wound dressing a\'ailable (59). 
1.6 Treatments 
Chronic wounds are usually treated by means of wound debridement and applications of dress-
iugs which will prevent infection, contamination and promote healing. \Vound debridement 
involves the removal of necrotic tissue and microorganisms, and may be applied through sur-
gical/other methods to restore normal healing, some of which will be discussed in this section 
[11, 14]. The use of maggots for wound debridement has been in place since from as early as 
15571 where they not only clean the wound but also stimulate granulation tissue formation 
and prevent septicaemia. Their use declined with the introduction of antibiotics, but in recent 
years we have seen an increase in their application [14, 125, 126J. 
Advancing techniques ill tissue engineering has led to development of skin substitutes such a<; 
the tradcmarked products Myskin and Dennagraft, which initiate complete healing when com-
bined with other care management strategies. r\'lyskin is an autologous epidermal substitute 
which uses living skin cells from patients, and is administered in a viable state on a polymer 
coating. It has been successful in burn wounds, ulcers and other non-healing wounds by ini-
tiating healing and expressing natural GFs needed for repair. Dermagraft is a cryopressed 
dermal substitute, that comp·rises human derived fibroblasts, extracellular matrix (ECrvl) and 
a bioabsorbable scaffold. Its primary purpose is to promote re-epithelisatioll in full thickness 
wounds particularly diabetic foot ulcers after implantation, as living cells proliferate and also 
express essential GFs [1, 44, 90]. 
!vlany wound dressings are available and include adhesive film, alginate, hydrogel and hydro-
colloid and their usage is largely dependent on wound type and pathology, as summarised 
in Table L3. It is common to use more than one type of dressing for a single wound and 
these dressings target to maintain moisture within the wound, absorb excess exudate, provide 
thermal insulation and prevent bacterial contamination [59]. 
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1. 7 Skin Conditions 
The skin can be affected in Illany ways, whether it is hormonal, hereditary or contribution frolll 
environmental factors (SUIl, chemicals or personal habits) resulting in spots, rashes, plaques 
and lesions which surface visibly Oil the skin. Some common skin diseases include eczema, 
dermatitis and psoriasis, which can range from being highly localised or cover large areas 
of the body's surface [11, 40j. In chapter 4, we will propose a model for psoriasis and this 
condition warrants further discussion. 
1.7.1 Psoriasis 
Psoriasis is a COllllllon immunological chronic skin disease, characterised by hyperproliferation, 
impaired keratinisation and dermal inflammation, affecting both genders and is neither conta-
gious nor infectious. Although this condition was described in the early 19th century; it is only 
within the last three decades that detailed investigations have been conducted [75~ 115]. 
In the UK, 2-:3% of the population are alTcctcd by the condition and there are 7.5 million 
sufferers in the US. In males, it most often develops in two age groups, namely 15-22 and 
60-69 years old, and typically for females it is younger. The disease can be very intermittent., 
with periods of remission and relapse lasting weeks or years. 
This condition is characterised by red scaly lesions referred to as plaques and is believed to be 
multi-factorial (combination of genetic and environmental factors contribute and trigger this 
disease), although the heredity pattern is still under investigation. Factors that may contribute 
to the onset and perpetuation of psoriasis include, chemical injury, throat infections, stress 
and alcohol, which may stimulate or activate particular immune cells such as T- lymphocytes, 
which surface to. the skin. Patients with this condition may also develop psoriasis arthrit.is 
causing pain, swelling and stifrness of the joints [75, 108j. 
The most comlllon forms of psoriasis, affecting 80% of all sufferers is knO\\'n as Plaque psoriasis 
(psoriasis vulgaris). The characteristics of this form include raised inflamed skin and silvery 
white scales which vary in thickness. Upper scales come away easier than those deep within 
the skin as shown in Figure 1.9. Typical locations include elbows, knees, scalp and lower back. 
Less common forms include guttate) pustular and erythrodermis psoriasis that have differing 
characteristics and severity [93, 108, 123]. 
Psoriasis affects both the epidermal aild dermal membranes, but it is the former where it is 
most noticeable. The disease exhibits high infiltration of immune cells within the epidermal 
membrane, and is commonly believed to be a T-cell mediated autoiJlUIlUlle disease. Although 
lIlany GFs arc believed to be involved; two of the most significant ones are IGF-l and IGFBP-3 
178, 108, 12:11. 
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IGF-l promotes epithelial cell division and motility in both normal and abnormal skin states 
e.g. wound healing, whilst IGFBP-3 inhibits IGF-1 and prevents cell proliferation and dif-
ferentiation. These chemicals in balance are import.a.ut for skin structtue, however, a large 
presence of immune cells producing IGF-l in the epidermis will upset this, perhaps causing 
the symptoms described Ill. 28, 119J. 
Normal 
SKIN'S SURFACE 
o KERATINS 5/14 
11 KERATINS 6116 
11 KEAATlNS 1/10 
Psoriasis 
DERMIS 
INDEX DEMONSTRATES THE DIFFERENT KERATINS PRODUCED 
IN NORMAL AND PSORIATIC INVOLVED SKIN. 
KERATINISATION PROCESS 15 DISRUPTED IN PSORIAtS ALLOWING 
INCREASED CELL TURNOVER RESULTING IN BOTI-I LIVE AND DEAD 
CE~ AT THE SKIN'S SURFACE. 
Figure 1.9: Keratinisation process in normal and psoriatic epidennis {ll, 40, 78} 
Table 1.4 presents the activities of IGF-1 and IGFBP-3 in the epidermal membrane at the 
different layers, comparing normal and psoriatic skin. This results in chaotic maturation 
as the turnover period is shortened to 7-10 days, where both live and dead ceUs coexist at 
the skin's surface presented in Figure 1.9. although the severity and loca.tion contribute to 
the onset 128, 50, 61, 75J. Cells proliferate in the basal layer as well as one or two of the 
suprabasa.llayers, which would not normally prollferate accompanied by increased IGF levels 
as IGF-ffi (IGF-illsulin receptor) expression is more e.."'Ctensive. Figure 1.9 presents the keratin 
composition of normal and psoriatic epidermis and keratin types 6 and 16 166J are those 
typically present in a wound responcling to inflammation 128, 75J. Tins suggests that the 
body's immune system is untiated during the development of psoriatiC plaques 178J. 
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NORMAL PSORIASIS 
IGF-l Produced by fibroblasts Produced by fibroblasts, 
and melanocytes. I t acts melanocytes and 
on basal keratinocytes. inflammatory cells. Acts 
on basal and suprabasal 
keratinocytes 
IGFBP-3 Produced by keratinocytes Produced by se only 
se and TA. Expression in PMD and is low in TA 
may be suppressed by TOPs and PMD cells. 
and acts as an inhibitor. 
IMMUNE Present in lower Infiltrates in lower and upper 
CELLS epidermal layers. epidermal layers. 
Table 1.4: The difference in IGF-l, IGFBP-3 and immune cell behm'iour in normal and pso-
riatic involved epidermis, where SC-stem cells, TA-transit amplifying and PAID-post mitotic 
differentiating cells [73, 75, 50, 66}. 
1.8 Thesis Synopsis 
This chapter provides the background to dermatology and its associated components rele-
vant for our research, highlighting many integrated factors whose knowledge will benefit the 
understanding behind the terminology and mathematical model development. This includes 
introduction to skint wound healing, chemical mediators, treatments and bacteria in the wound 
medium. The problems associated with skin conditions such as chronic wounds or diseases, are 
discussed as a means of expressing the economic burden and strain on sufferers, also stating 
the common characteristics associated with these conditions. In the chapters to proceed the 
literature, mathematical models and development will be detailed. 
Chapter 2 examines existing mathematical models that investigate epidermal, dermal wound 
healing and psoriatic behaviour. There is a vast range of literature covering the modelling of 
wound healing, although many are specific and have only looked at in some depth a narrow 
part of the healing processes ~:iUch as angiogenesis or wound closure. Quite understandably, 
modelling the entire healing process has generally been avoided, as the resulting model would 
be somewhat unwieldy and a considerable challenge to investigate mathematically . 
. Chapter 3 introduces a mathematical model which investigates re-epithelisat.ion of superficial 
wounds by considering the keratinisation process, which controls self-renewal properties of the 
epidermis defining live and dead cell states. A ID reaction-diffusion-advection PDE system 
is applied by incorporating aspects of cell binding tissue, velocity, signal distribution and cell 
growth. The model predicts that during rc-epithelisation the live cell layer builds up first 
(regulated by a signal: OF or nutrient) and the keratinised layer after (governed by cell-cell 
binding strength an~ sloughing), which is in agreement with [15) 43]. 
Chapter 4 builds on the ideas and results from the re-epithelisation study to formulate a model 
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for the onset of psoriasis affecting the keratinisation process, characterised by hyperprolifera-
tion and parakeratosis. 'Ve introduced IGF-l, IGFBP-3 and immune cells, in addition to those 
variables already presented in Chapter 3) as this reflects the inflammatory response observed 
on the skin's surface. The problem is demonstrated by concentrating on immune cell activities 
and we assumed a promoter-inhibitor relationship between IGF-l and IGFBP-3, to examine 
and differentiate between normal and psoriatic involved epidermis. Simulations were obtained 
in the same manner as Chapter :1 and show that the model can describe many of the psoriatic 
characteristics discussed in medical literature. The model predicts that a topical application 
of IGFBP-3 can combat the psoriasis, leading to a recovered epidermal layer. 
Deep tissue wounds was the focus of Chapter 5 and we identified keratinocytes, fibroblasts, 
granulation tissue, signals, nutrients, norlllal healthy and damaged ECM as the key contrib-
utors to the healing process, during the proliferative phase and the processes towards wound 
closure. 1\-lany different wound scenarios were considered including the effects of key param-
eters that detract the norlllal healing course and the impact a change in geometry of wound 
bed exerts. Two parameters of particular interest in healing impairment) were ib ar.ld f3sm 
responsible for nutrient sufficiency and quality of clotting matrix in the wound domain. From 
the dermal components introduced at the wound si,te, we found a small bolus of nutrients in 
the wound was far more effective at enabling healing, than similar more generous treatments 
of OFs and fibroblasts. However "drip feeding" of GFs and fibroblasts from special dressings 
(observed in our model) and skin grafts can significantly improve healing. 
Chapter 6 builds on the modelling of Chapter 5, to investigate the role of bacteria in the 
system and their contribution to chronic wound development. The bacteria in the model 
interferes with dermal and epidermal repair with the ability to kill epithelial and fibroblast 
cells, also the breakdown of underlying tissue and the latter pro~ess can lead to an expanded 
wound area. The model predicts that bacteria can disrupt the normal healing course and as 
suspected, the greater the uptake of bacteria from the environment leads to increased wound 
impairment; which would result if a wound is poorly ~nanaged. A very interesting predict.ion 
of the model is the hypergranulation of tissue which may result when introducing OFs into 
an infected wound environment; this is illustrative of how a subtle inte·raction between GFs 
and bacteria can lead to considerable variety in wound pathology. 
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Chapter 2 
Overview of Mathematical 
Modelling 
2.1 "Introduction 
There are still countless open questions regarding wound healing, and potential avenues for 
improved treatment and reduced scarring. Many features are very difficult to observe and 
lIleasure JJJ situ, and mathematical models play a useful part in attempting to establish a 
quantitative understanding orthe important mechanisms involved in the healing process. Some 
of the most comlllon wound healing factors investigated are the roles of skin cell proliferation 
and migration, growth factors, wound contraction, angiogenesis, extracellular matrix (ECr-.,t) 
alignment and bacterial infections [2, 7,8,74,92]. 
Ivlathematical modelling of wound healing have been undertaken for 30-40 years or so [92) and 
involved a wide variety of mathematics and computations, ranging from descriptive models 
(including curve fitting to data [19, 103, 107, 134)) and mechanistic descriptions discussed 
below. In this chapter, we will give an overview of the relevant models to the areas considered 
in the thesis. 
2.1.1 Epidermal Wound Models 
There are a number of mathematical models investigating wound healing of the cornea, [20, 
21, 41, 42, 113] and others. Corneal wound healing is simpler in many ways to that of the 
skin as there is no angiogenesis, innervation and other complicated biological processes are 
also absent [41, 92, 101]. However it is relatively simple to investigate experimentally and 
data is readily available for model comparison. The most common approach is to assume 
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a continuum of cells and usually a system of reaction-diffusion-chemotaxis type models are 
derived. All these models predicted emergence of travelling wave (T\V) solut.ions of wound 
closure; the speed and profile shape of which can be affected by chemical factors regulating 
mitosis [20, 21, 41, 42, 92,101,113] and cell migration [20, 21, 41, 72]. The results of these 
models agree qualitatively in broad terms with experimental observations. However some of 
the details of the predictions of the earlier models [20, 21, 113j, were shown by Gaffney [41] 
not to compare well wit.h experimental observations, particularly in the timing and location 
of enhanced proliferation. He proposed a more detailed model, principally by distinguishing 
between quiescent and proliferating cells to address the inconsistencies. 
Cell invasion problem investigated by Landman [72L extended earlier models [20,41,113] using 
a multi-species continuum approach in which at.tachment and reattachment of cells during 
mitosis and migration were considered. The study found that if the attachment, cell division 
and reattachment activities we.re enclosed to a limited region of the wavefront, assuming 
reattachment rate is considerably faster than the detachment rate then the relatively simple 
and well studied Fisher's equation 1 is adequate in describing a wound healing scrape assay. 
This was found not to be the case for slower reattachment rates, where a more detailed model 
would be required. 
2.1.2 Dermal Wound Models 
The dcrmallllembrane is more intricate than the epidermis as it contains blood vessels, lymph 
vessels, nerves, hair follicles and sweat glands (refer to Figure 1.1). Injury to the dermis Illay 
take years to fully repair and will continuously remodel underneath the skin even after re-
epithelisation and scar formation, to regain optimum tensile strength. The healing processes 
in the dermis poses more problems in complexity, and mathematical modelling tends to focus 
on a small aspect or a single stage of the process. 
\Vound contraction and scar formation has been a continued focus of many mathematical 
models, with the ailll of understanding how wound could heal so not to leave scars and why 
hypertrophic scars and keloids occur; this being the main target designing treatments for der-
Illal healing [15, ~2, 92]. Initial dermal wound models introduced in the late 80s, investigated 
the mechanisms involved in wound contraction (e.g. [83, 92]). Since then the mathematical 
models have advanced greatly looking at multiple cells types and dermal funct.ions [92]. 
There are many reasons why dermal wounds may be disrupted; fibro-proliferative disorders 
such as keloids or hypertrophic scars resulting from overactive fibrous tissue Illay be one of 
them. In hypertrophic scars, healed wOUlld tissue exceeds that of normal skin and this may 
be caused by problems in the keratinisation process where cell death occurs at a later stage 
IThe Fisher Equation takes the form Wt = D~ + ru (I - f)' and has been employed to describe many 
situations in biology and ecology, including wound healing [92, 120). 
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than expected. In keloids, scar formation goes beyond the original wound margins and ex-
hibits elevated levels of collagen deposition and cellular activity. Deterministic models in 
[60, 97] were used to help understand dermal wound invasion and fibre-proliferative disorders 
respectively. Olsen [97] study was an extension of an earlier model developed looking at fibro-
phisia and wound contraction; the central processes between normal and abnormal skin \vere 
identified. The findings suggest that spatiotemporai dynamics of such disorders, highlights 
the mechanisms from which these pathologies muy occur, develop, regress and may provide 
details/recommendations for clinicians to develop effective management strategies. 
GFs mediate the wound healing process and the two that appear to have a central role in 
regulating normal behaviour are TGF-,6 and POGF which have been studied in [22,60] using 
ODE systems. Dales et a1 [22] found th'l:t early topical application of TGF-,6 in adult dermal 
wounds reduces the ratio of collagen I:III 2, improving wound quality and less visible scarring 
on the surface. The wound invasion model [60], indicates that PDGF concentrations stimulate 
fibroblast proliferation and enhance chemotaxis. The additional role of wound geometry was 
considered by Vermolen et a1 (2008) [131] to investigate the "Critical Size Defect" (CSO), 
showing that. irregularities in GF production and cell proliferation can lead to the observed 
phenomena. 
Angiogenesis was the focus of [101, 111] using POE models and both highlight the significance 
of oxygen concentrations for healing. In [l01]! ingrowth of new blood vessels at the wound 
site were represented by travelling wave (T\V) solutions, imp'lying that varying cell death rate 
could help determine the healing prospect of a wound. Schugart (2007) introduced a non linear 
POE model used to investigate wound angiogenesis by focusing on the role of oxygen tension 
w. Other interacting factors considered were capillary sprouts n, capillary tips h) fibroblasts J, 
inflammatory cells ffi) chemoattractants a and extracellular matrix p. The aim of the model 
was to provide a realistic model) supported by experimental data to resemble the success 
of angiogenesis in cutaneous wounds and highlight the key activities of oxygen. This study 
presented angiogenic behaviour in cutaneous wounds that compare well with experimental 
observations from patient based studies [Ill]. 
!dore challenging wounds are prone to persistent infections and polymicrobial contamination 
because of the hostile environment presented as mentioned in 1.2.4 and a number of studies 
use rOE models to describe its effects [16, 69, 74, 101]. Pueudomonas aemginosa :1 has 
been identified as an important. microbe, which has led to high mort.ality from burn wOllnds. 
The earlier models [16, 74], focused on reviewing bacterial activity in terms of exoprotein 
production, which are at high concentrations in infected wounds and the natural immune 
response (e.g phagocytes that ingest bacteria and prepare the wound domain) is unable to 
manage increasing levels) when bacterial growth is sufficiently large. A more recent st.udy 
2Collagen III is the type seen in granulation tissue and collagen I is present ill normal skin. 
3This is a virulent opportunistic pathogen and has become increasingly resistant to antibiotics.[69] 
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[69] investigated the role of quorum sensing (QS) in Pllelldomonas aeruginosa, which is a cell 
mechanism that regulates pathogenic activity 4. Effects of QS on the wound environment and 
the infection process are integrated into the model. It was found that the QSM diffusion within 
the wound impedes the blood supply, which could contribute to the development of infections. 
The model proposed that QSI\.J degrading components could prevent further infection as it 
would inhibit the signalling system and release of virulent agents into the wound environment. 
Although the complexity of the model was simplified using logical assumptions, it can be 
extended to account for bacterial invasion (which was not considered in this model) into 
healthy tissue and the blood supply. Such knowledge would be appreciated in this area. 
Although it is common knowledge that chronic wounds are characterised by persistent bacterial 
infections, the number of mathematical modelling studies presenting such investigations are 
limited. 
2.1.3 Psoriatic Models 
Psoriasis affects both the dermis and epidermis, however the characteristics are primarily seen 
in the epidermal membrane and it is commonly believed that hyperproliferatioll takes place, 
inhibiting cell loss [62, 49]. There are only a small number of studies conducted in this area 
[49, 62, 115, 75], which has focused on the spatial domain typically using partial differential 
equation (PDE) systems. 
One of the first models [62], explored cell renewal of the epidermis using data from normal and 
psoriatic patients, focusing on migration, cell loss and proliferation of the basal layer. Findings 
suggest that there is reduction in cell cycle time or increased GF distribution, and may lead 
to a less active stratUlll corneum and premature desquamation. This is supported by [75], 
where it was found that desquamation and cell detachment from the skin surface is greatly 
perturbed and abnormality in the keratinisation process leads to parakeratosis. Other factors 
such as Nitric Oxide (NO) [115] have been reviewed, which is an important signalling molecule 
that is highly active in this skin condition. The model predicts that there is a decline in NO 
flux followed by intense degree of erythemaf" which increases the release rate into psoriatic 
plaques, whether this is a cause or effect is still unclear. 
2.2 Summary 
The factors considered in these models do not account for the complete wound healing pro-
cesses, of any of the three phases known and discussed in Chapter 1. They focused on specific 
4QS is a mechanism used by bacteria to determine their population density to influence their behaviour 
appropriately. This is achieved by the production and monitoring of signalling molecules. 
°Redness of skin, which may result from inflammation. 
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processes of healing such as chemical regulators e.g. EGF, PDGF and TGF-,B or cell densities 
of keratinocytes and fibroblasts, thought to be essential for repair. 
IVJany mathematical models have been discussed in this chapLer that highlight key findings 
froln a selection of existing epidermal: dermal \vound healing and psoriatic models using PDE: 
ODE systems and deterministic approaches to name a few. They provide scope and support 
for the investigation that will commence in this thesis. 
The models proposed in Chapter 3~6, build on some of their ideas, with the focus on regular 
, 
and'irregular healing activity of the epidermal and dermal membranes, 
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Chapter 3 
Re-epithelisation 
3.1 Introduction 
The epidermis provides skin protection and is the first barrier between the internal organisms 
and the outside environment, preventing external stimuli entering the body and is particularly 
important during wound healing. In this chapter <;mr main focus is re-epithelisation, which 
describes recreation of the intact epidermal layers through the process of keratinisation. As 
discussed in Chapter I, keratinocyt.e reproduction occurs only in the basal layer. Cell differen-
tiation and death takes place in the subsequent layers mediated by GFs, as they move towards 
the skin surface and undergo morphological and structural changes (see Figure 1.2). 
To investigate superficial wounds which includes cuts, grazes and general wound recovery, we 
explore the keratinisation process in the latter stages of repair. This will help interpret the 
normal behaviour of skin repair, and identify the key components involved in re-epithclisation 
and wou~d closure. The model differs from other epidermal models as it focuses on key events 
in the re-epithelisation process, where keratinisation is highlighted. The modelling in this 
chapter. will provide insight and a foundation for further research, discussed in the chapters 
to follow where we consider skin conditions and deep tissue wounds. 
3.2 Mathematical Modelling 
3.2.1 Introduction 
The Illathematical modelling to come in' this section will focus on epidermal recovery in the 
re-epithelisation stage of wound healing. Although we have discussed Humerous biological 
factors involved in mediating the normal epidermal activities, simplifications will be made. 
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Variables Description 
n(x, t) Live cell fraction 
m(x, t) Dead cell fraction 
w(x, t) \Vater fraction 
b(x, t) Cell-cell binding protein concentration 
c(x, t) Signal concentration 
v(x,t) Velocity of cell movement 
Table :t 1: Variahles considered in the skin model 
\Ve present a simple model that takes into account growth at the basal lemma, the passage of 
keratinocytes from live to dead cell states, cell-cell binding and a regulator (e.g. EGF, KGF). 
Despite the complexity of the resulting model, it can be analysed in a biological reasonable 
limit discussed in 3.3.1. 
The main aims of the modelling to come are 
• To describe the rcepithelisation process. 
• Obtain insight into the epidermal behaviour of keratinocyte cell binding and signal usage. 
• Obtain insight into the effects of GFs on skin characteristics. 
• Obtain insights into the GFs in impaired healing e.g. chronic wounds. 
The one dimensional rDE system derived below will be used to investigate the relative im-
portance of signal molecules (could be GFs or nutrients) on live cell density (keratillocytes), 
intracellular binding strength and cellular velocity, arising from the volume creation of cells at 
the basal membrane. The model traces the evolmion of the keratinocytes as they grow from 
the basal layer and eventually slough off. at the surface. The mitotic activity near the basal 
layer will not be considered in detail and will contribute as a boundary condition. 
3.2.2 Governing Equations 
The epidermis is defined in the spatial domain 0 < x :$ JJ 00' where at x = 0 cells ·in the basal 
layer region enter the domain and x = H(t} is the skin's surface (see Figure 3.2). The skin 
domain is assuIlled to consist only of live cells (fraction n), dead cells (fraction m) and water 
{fraction w}, hence 
n+m+w= 1. (3.1 ) 
\Ve will therefore ignore for simplicity sweat glands, hair follicles and fine epidermal structures, 
such as undulating basal membrane [40j. The variables to be used in our mathematical model 
of the epidermis are listed in Table 3.1. 
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Modelling Skin Growth 
The main modelling 8SSumptions regulating live cells. dead eells and water are 
1. Live Md dead cells have fixed voltUJlcs where <!> is the ratio of dead and live cell voltUJle 
Md is given by 
'" = Volume of dead ceUs. 
Volume of live cells 
2. When" cell dies. a fraction", forms the dead cell and 1 - '" becomes water where 
OS<!>S1. 
3. If all tbe epidermal cells are aliV(l', then water fraction is given by 1 - nma;r as shown in 
Figure 3.1. 
4. If all the epidC'rmru cells are dead. then water fraction is given by 1 - mm(l;:!: as shown in 
Figure 3.1 
Live cells at the basat layer 
..... 
Dead cells near the skin 's 
surface . 
Figure 3.1: Representative skin tissue jlJustrating water frllCtions wben all epidermal cells are 
li vc or dead. 
5. The water fraction is lower in dead skin, hence 1lm.ll% < mmu. 
6. Wc 8SSume that the water fraction is a linear function of fi and m refer to (3.1) and 
Figures 3.1 and 3.2 
7. Live Md dead cells move at a local velocity t'. generated by growth in the basal layer 
and water fraction in between cells at a velocity Vw as presented in Figure 3.2. The 
velocity of epidermal cells chMges from the UVI' cell S\{lte to the dead cell states. where 
we expect 1'n > Vm· 
8. Cell death i, regulated by a signal molecule saureed from the hasaJ region. Cell death 
is enltaeeed as signal decrea<;cs. 
9. Only live cells maintain cell-cell binding materIal. 
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x = Htt.l- ----_, 
x=o 
Gel/lose 
moisture n+rn+w 1 
Dermis 
Figure 3.2: Schematic of a superficial epidermal wOUlld, iJlustrating the modelling domain 
indicated by tbe "green" cross section line (Le X-X) 
From (3.1) we can immediately write down w = 1 - m - Tt and the remaining constitutive 
relations will result from these assumptions\ to provide equations for cell and water velocity. 
Applying these assumptions the equations for live and dead cells are 
(3.2) 
(3.3) 
in 0 < X < H(t), which states that the rate of change of n and In in this medium is governed 
by the deatb rate function kd • defined by the Hill function [82J 
(3.4) 
where n~ CCI ." are positive constants and u is a constant such that 0 < a ~ 1. This is a 
mono tonic decreasing function of c, so that the death rate is reduced as c increases. Since 
the source of c is a.t x = 0, we expect the level of dml.d cells to increase as x increases. From 
(3.2) and (3.3), low c concentrations will result in hlgher deatb rate and live cells will die with 
lowering signal concentrations. 
From (3)-( 6) in the above assumptions, we obtain the following constitutive equation 
n m 
w = (1- nmax)-- + {1- mma.)--, 
nma:r 1nmo.:t 
(3.5) 
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which combined with {3.1} implies 
n m 
--+--=1, 
n max l1lmax 
(3.6) 
hence wand In can be expressed as an explicit function of n. 
The velocity v is created by cell movement between the basal layer and skin's surface. Cell 
growth at the basal membrane will drive motion at velocity Vo at x = 0, therefore v(O, t} = Vo. 
A typical cell is approximately 1OI1m and it takes about. 1 day for the cell to reproduce, we 
expect Vo ~ 0.01 mm/day and v{x, t) will vary in relation to loss or death of cell volume. To 
derive an expression for the velocity field (v) generated by cell movement we divide (3.2) and 
(3.3) with nmax and 7nmax1 respectively, giving 
(3.7) 
(3.8) 
which results on addition and using (3.6) the velocity field of 
- = kd(c)n -- - -- , Dv (<fJ 1) ox rHmax n max (3.9) 
\Ve note from the assumption <p ::; 1 and nma:r < 7nmax , that 
----- <0 ( <fJ I) Inmax nmax ' 
so that 8v/8x < 0 and hence the skin cellmovcment velocity decreases as cells move towards 
the surface. 
\Vater is only generated when a cell dies a~d is given by 
(3.10) 
where vw(t) (advection) is the local water velocity. Adding (3.2), (3.3) and (3.10) gives 
D 
Dx (v(n + m) + vww) = 0, (3.11 ) 
\vhere V(t) is a time dependent fllllction that defines the combined net material nux 
, 
v(n + m) + vww = V(t), (3.12) 
suggest.ing that volume is conserved in t.he skin medium. 
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Modelling Cell Binding 
\Ve will combine the'various cell binding components into a single variable b, which represents 
a suitably averaged concentration of desmosomes, gap junctions and tight junctions in the 
local epidermal medium. \Ve assume that binding proteins are generated by live cells, and 
decay naturally in the skin medium and move at a velocity v(x, t). 'Ve propose t.hat 
ab + a(vb} =/m-Jb 
at ax ' 
where J.L and 6 are positive constants. Here 
• J.Lu- Production rate of binding proteins by live cells 
• 6b - Death/natural loss of binding proteins. 
The steady state at x = 0 
where 
Vx = aav = kd(c}nmox (_if! ___ 1_) , 
x mmax 7lmax 
is therefore taken to be the normal binding state between healthy cells. 
Modelling Signals (GFs) 
(3.13) 
(3.14) 
\Ve consider a generic signal that mediates essential epidermal activities. Cells in the epidermis 
like all epithelia do not contain blood vessels, and rely on diffusion from the dermis and 
hypodermis to supply nutrients and chemical mediators. 
The general conservation equation for signal concentration is given ~y 
(:3.15) 
where Je is the signal flux and we assume that living cells degrade the GFs (e.g. by proteolysis 
which is degradation of proteins into smaller simpler molecules) and use nutrients available. 
The random motion of the OFs will be modelled by Fickian diffusion and water advection. 
Assuming the signals are present intra and extra- cellularly quickly approach an equilibrium, 
the flux .le is given by 
ac Dc 
J, = -D'n + Vwwc + v(n + 1n}c = -D'-a + V(t}c 
ox x 
(3.16) 
where using (3.16) 
• vw wc - Advection in water phase. 
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• v{n + 1n) c- Advection of c within live and dead cell phases. 
On substitut.ion into (3.11) and using (3.15), the signal concentration is given by 
(3.17) 
The funct.ion Ankc(C) is the signal molecule consumpt.ion rate by living cells, where we have 
implicitly assumed that the natural degradation rate of c is negligible (this is reasonable if c is 
a nutrient.). The function kc(c) is expected to be monotonically increasing to reflect incrco.scd 
consumption with signal concentration. The function we propose is 
which has the right qualitative features and is a useful form for the analysis later. 
We note that the only source of GFs is from the basal region. \Ve also assume t.hat the 
damage to the epidermis is fairly minor, such that. there is a minimal inflammatory response 
and signals produced by cells (e.g GFs) in the epidermis. 
Boundary Conditions 
The boundary conditions impose~ on the model arc as follows 
• At x = 0, denotes the end of I,he basal layer where only living cells are present in 
preparation for cell maturation, so we impose 
d b /lnmax n=nmax , C=Co, v=voan =---. 
. 0" +vx 
• At x = H(t) at the skin's surface, we assume a zero flux boundary condition on c (more 
details are provided in Appendix 8.2.1), hence 
(
dH ) Bc di - V(t) c+ DcBx = o. 
Desquamation at the skin's surface is given by 
(3.18) 
where Fo is a positive constant. Equation (3.18) states that the surface grows at a rate 
equal to t.he net difference between local velocity and sloughing rate, which is modelled 
as simply being inversely proportional to the concentration of binding proteins, hence 
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we can deduce from (3.14) 
(:3.19) 
for if > o. 
Suitable boundary conditions for Vw is unclear. In healthy skin very little moisture 
escapes through the keratinised layer, suggesting Vw = 0 on x = H(t), however if the 
keratinised layer is absent then Vw > O. In the next section it will be shown that the 
effects of the water flow seems to be negligible and Vw will decouple from the system, 
and the complication provided by the flow term will no longer be discussed. 
Initial Conditions 
rlb close the system we need to impose a set of initial conditions. In the simulation to follow 
we start with a superficial wound, that has cleared away the keratinised layer and we start 
with a domain x E (0, Ho), which consists of 2-3 layers of live cells at x = O. The initial 
conditions that define this specific problem is defined below 
• At t = 0 (basal layer x = 0), we suppose that all dead cells are removed 
f-Ln max 
n = n max , m = 0, c = Co and b = -J--. 
+vx 
Full System of Equations 
For purposes of clarity, we present the full system 
where the death rate function is given by 
and 
V(t) = v(l - w) + vww. 
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(:3.20) 
(:3.21 ) 
(:3.22) 
(:3.23) 
(:3.24) 
(3.25) 
Parruneters Description Experimental Values 
n Cell death constant 0.5 day-' 
(J Cell death constant Dimensionless 
J1. Birth of binding proteins -
Cc Death rate in signal concentration -
.x Natural loss of signal concentration -
(3 Natural loss by sloughing -
J Decay in binding concentration -
Dc Diffusion coefficient of signals 4.3 mm2 day-l [1111 
ry Cell death rale Dimcnsionless 
H Height of the epidermal medium 0.07-1.5 mm [40[ 
n mar lviaximulll fraction live cells occupy 80-95% [40[ 
mmax (I.·laximulll fraction dead cells occupy -
1> vol m/vol n Dimensionless 
Vw Advection in water -
Table 3.2: Parameters considered in the skin model and corresponding experimental "alues. 
This is a nonlinear coupled system of partial differential equations of mixed type defined in 
the domain x E (0, H(t)}. The dead cell and water fractions are obtained from (3.1) and (3.6). 
The model parameters are presented and defined in Table 3.2, where values are given for those 
available and suitable from literature. 
3.2.3 Nondimensionalisation 
We nondimensionalise the system using 
{x,i} = {nx, tn}, 
Vo 
{ - - _ _ _} {nu bn v Vw c} H,b,v,vw,c = --,-,-,-,- " Vo It Vu vo. Co 
where hatted variables denote dimension less quantities. Here, time has been rescaled with the 
maximum cell death rate, and space with the distance a cell would travel in this time near 
the basal lemma. 
Defining the following dimcnsionless constants as 
{_ - } {cc J Po} cc ,o,(3 = C:;' ri' VoDo ' 
{ ""} V5 {I .x I'} 
€,>',J-L = Dc ri' f!co ' boO ' 
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we derive the nondimensionalise system, dropping the hats for clarity, 
(3.26) 
av ( (Je") 
8x =n 1- e~+eT) (3.27) 
ab + a(vb) =n _ ijb 
at ax ' (3.28) 
( Bc ac) , at + V(t) ax 82e eT) =--An---8x2 c~ + cri· (3.29) 
In practice the timescales of diffusion of signals across the skin thickness will be considerably 
less than cell movement through growth (weeks), hence the Peclet number satisfies E « 1 i 
setting E = 0, equation (3.29) reduces to the quasi-steady equation 
The boundary conditions after nondimensionalisation are given by 
• At x = 0, n = nmax , m = 0, e = 1, v = 1 and b = ~+;:. 
• At x = H(t) 
and 
We note that the rescalings imply 
dH f3 
-=v--dt b' 
Bc = 0 
ax . 
f3 J-Lnmax <-ij-' 
The dimensionless form of the initial conditions discussed in the previous section are 
(3.30) 
(3.31 ) 
• At t = 0, n = n maX1 m = 0, b = ~+~; and H = 1, where an initial condition for c is no 
longer required due to the quasi-steady equation. 
Equations (3.26)-(3.28) and (3.30) together with the set of initial and boundary conditions 
form a closed system. Table 3.3 presents the nondimensionalised parameters and their "stan-
dard value" used in the siInulation to follow. 
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Parameters Description Dimensionless Value 
,\ c consumption rate constant 0.2 
E Peclet number of c «1 
f3 Natural loss by sloughing 0.001 
c, Death rate hill function coefficient 0.01 
6 b decay rate constant 2.0 
ry Death rate hill function exponent 10.0 
Ho Initial height of the epidermal medium 1.0 
n max ~v1aximum fraction live cells occupy 0.8 
rnmax Maximum fraction dead cells occupy 0.999 
<P Volume of dead and live cells 1.0 
u Cell death constant 1.0 
Table 3.3: Table of parameters used ill the dimensionless epidermal model, together with 
values used in simulations. 
3.3 Healthy Epidermis Analysis 
3.3.1 Steady State Solutions 
The skin in homeostasis is a d)rnamic steady state. In terms of the model proposed in Section 
3.2.2, the components satisfy the steady states of (3.26)-(:l.28) and (3.30), namely 
(3.32) 
(3.33) 
(3.34) 
(3.35) 
subject to 
• At x = 0 : n = H max , V = 1, c = 1 and b = ~+~; . 
• At x = Hoo : 
Bc = 0 and f3 
ox v=b' 
where the free boundary Hoo is the thickness of a healthy epidermis at steady state. This 
system is too complex for analytical solu~ions in the general case, however, in the limit of 
1] ---+ 00 and a = 1; kd(C) reduces to the step function enabling progress to be made. 
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The Limit of ryd --lo 00 
Writing kd(C) in terms of the Heaviside step function, by taking the limits ry --lo 00 and a = 1 
leads to 
The wound domain x E (0, Hoo) is distinguished by two regions corresponding to C > Cc 
aml c ::; Cc. \Ve define x = :CC to be the smallest value x such that C = CC) which marks 
the boundary between the two regions of live and dead cell states. Imposing continuity and 
continuity as appropriate at flux of x = Xc we have 
X = Xc: c(x;-) = c(xn = c" n(x;-) = n(x;;), b(x;-) = b(x;;), 
~~(x~) = ~~(xt) and v(x~) = v(xt). 
The condition at X = 0 and x = Hoo are as above. \Ve will find the solution c, n, b and v, for 
the two regions from which we can determine the co-ordinates of the free boundaries x = Xc 
and x = Hoo. The problem is summarised in Figure 3.3. 
0< x < Xc 
Denoting variables in this region with a superscript '-', where kd = 0, gives the system 
d 
dx (v-n-) =0, 
dv-
dx =0, 
d~ (v-b-) =n- - Jb-, 
d2c- _ 
dx2 ='\n 
Integrating (3.36)-(3.39) and using the boundary conditions at x 
tain 
n- =nmax 
_ '\nmax 2 
c =C, + -2-(x, - x) 
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° and x 
(3.36) 
(3.37) 
(3.38) 
(3.39) 
Xc we ob-
(3.40) 
(3.41) 
(3.42) 
(3.43) 
n= n=, 
b= "r 
c= 1 
v= 1 
x=O 
kd= 1 1-------
c :;: Cc. 
x :p Xc 
v= f!. 
b 
;r =1 Hoc 
Figure 3.3: Profile of kd(C) and tile cor~espondiI1g initial and boundary condWoIlS. 
where c-(O) = 1 provides the location of the free boundary XC) given by 
Xc < x < Hoo 
Denoting the variables in this region with Cl. superscript :+': where kd(C) = 1, gives 
where 
( r/J 1) r- -----l1tmax 11 max 
From (3.49) we have r < 0 and thus 
so F(n) > O. 
4J1lmax 1 + nr > 1 + Hmuxr = -- > 0, 
n~ma:r 
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(3.44) 
(3.45) 
(3.46) 
(3.47) 
(3.48) 
(3.49) 
A useful function in what follows is F(n), defined as 
1 F(n)=--. 
1 +nr 
(3.50) 
Integrating (3.48) using the boundary conditions at x = Xc and x = Hoe, we obtain immedi-
ately 
Equations (3.45) and (3.46) imply, 
d(v+n+) _.!. dv+ 
dx r dx 
===} v+n+ - nmax 
1 + 
=-y(v -1), 
using the condition at x = xc, froll.1 which we can deduce 
Substituting this into (3.45) gives 
which yields via the chain rule 
leading to the differentiated equation for n+ 
dn+ 
dx 
(1 + rnmax ) 
(l+rn+) . 
F(nmax)n+ 
F(n+)2 
(3.51 ) 
(3.52) 
(3.5:)) 
(3.54) 
(3.55) 
(3.56) 
using the fact that F'(n) = -rjF(n)'- We note that dn+jdx < 0, so live cell fraction is 
monotonically decreasing towards x = Hoo as expected, with 0 < n+ < nmax . 
By integrating (3.56) we obtain an implicit equation for n+ given by 
For b(x+) we expand the derivatives in (3.47) and using (3.45) and (3.54), we obtain 
db+ 
dx 
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(3.57) 
'Ve now change the independent variable to n+, \\"hich yields on using the chain rule and 
(3.56), 
db+ n+ F(nmax ) db+ 
dx F(n+)2 dn+' 
which results with the following differential equation for b+(n+) 
db+ (6 + I'n+)b+ 
dn+ - n+(1 + I'n+) 
substituting for F(n+). This has an integrating f<tctor 
from which we obtain the solution (using maple) 
1 + rn+' 
(3.58) 
using the condition b+(nmax ) = nmax/b at x = xc· The above analysis assumes that b i- 1, 
b = 1 is a very special case that the current analysis will not address. 
In order to determine the co-ordinate of the free boundary Hx from (3.57), we need to 
determine niX)) where Ttoc = n+(l1oo). Equations (3.54) and (3.58) express v+ and b+ as 
functions of n, hence the boundary condition at x = flc:c' v+ = (3/b+ can be expressed at 
P(Hoc ) = v+(noc}b+(noc} - (3 = 0, where P(n) is given by 
> F(n)n ( F(n)'-In'-I) 
1 (n) = 1 -., , I 'I - (3. F(nmax )(6 - 1) 6F (nmax ) - n max (3.59) 
We lIote that PlO) = -(3 < 0 and 
Pen ) ="max (1-~) -(3) Tlmax (1-~) _ Tlmax =0 
max 6 - 1 6 6 - 1 6 6 ' (3.60) 
sinc~ f3 < b+(xc) = llmax /b, hence by continuity, there exists a root Ttoc such that P(n,oc) = O. 
Suitable roots satisfying P(nx) = 0 can be routiriely computed using, for example the Newton-
Raphson method. Having found Hoc, the steady state for skin thickness Hoc can be found 
from (3.57), namely 
(3.61 ) 
. The time it takes for cells to move from the basal layer region to the skin's surface, T oc can 
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be obtained from 
IH~ 1 7~;:: -dx. 
" v 
(3.62) 
This can be obtained exactly using the above analysis) where (3.54) gives 
If1~ F{nmar) Toc =" F{n) <in, (3.63) 
\vhich changing the variable using (3.56)) we can solve (3.62) this to get 
(3.64 ) 
(3.65) 
which can be computed given nx . 
The analysis makes explicit what the model predicts as the key processes governing the epi-
dermal structure. For 0 ::; x :5 XC) the thickness of the live layer is governed by signal 
concentration refer to equation (3.44). From (3.61) the thickness of dying and dead layer 
Hx - XC) is dependent on n max and noo; the latter satisfying P(noo) = 0 from (3.59). This 
suggests noc is dependent on the binding parameters (3 and 0) and the cell volume parameters 
rand nmax . The thickness of the skin varies in the body) with a tendency to be thinner where 
skin experiences lUorc wear and tear (e.g. palms of hands and soles of feet). 
In the dimensional form of the model) the two parameters which can be altered for the adap-
tation to the external influence are Co (input signal concentration) and p, (binding produc-
tion rate); as the other parameters sllch as diffusi.on and dccay rates) arc intrinsic physical 
properties and cannot be changed so easily. III dimcnsionless terms) ,..\ and Cc arc inversely 
proportional to Co and {J is inversely proportional to It. 
\Ve wO,uld expcct that increasing Co and Jl would enhance skin thickness. From (:l.44L decreas-
ing both"'\ and Cc (= increasing co) will increase XC) thereby thickening the live cell co~nponent 
of the epidermis. It is more difficult to sec from the analysis the effects of decreasing {3 (= in-
creasing Jl) and we derive the expected result dHoc/dp, > 0 (in dimensional terms) by showing 
the (non-dimensional) equivalent relationship 
(3.66) 
\Ve note first that r < 0 implies F'(nx ) :; -r/F(nx,)2 > O. 'Ve will now determine the 
signs of dH:x:/dH oc and dnx,/d{3 so that (3.66) follows from the chain rule. From (3.61) we 
have 
-;0;-;--, (_1 + F'{1I00 )) < 0, 
F(nmax } noo Foe 
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since F'(noo ) > O. Writing P(n) in (3.59) as follows 
where A(n) = nF(n). Taking de'rivatives with respect to f3 gives 
hence 
dnoo F(nmax )(5 - l)A(nmax )'-1 
d{3 N(noo)(A(nmax )' 1 - A(noo )' 1)· (3.67) 
The function A(n) is strictly ll1onotonically increasing since A'{n) = F(n) + nF'(n) = 1/(1 + 
nr)2 > 0, hence, the denominator is positive (negative) when cS > 1 (0 < I), thus with factor 
(6 -1) in the numerator dnoc/d(3 > O. Using the chain rule (3;66) holds, and as expected, up-
regulat.ing the binding material production (:::::: decreasing (3) will have the effect of thickening 
skin. This analysis further suggests that the binding factor and signalling molecule should be 
regulated to control the epidermal structure. 
3.4 Results 
3.4.1 Numerical Methods 
For purposes of simplicity we rescale the nonlinear system ,be,fore computing using finit.e differ-
ence methods (FDrvl). rIb accommodate the moving boundary, we write t = T and x = Z/ H(t) 
and solve in the Z domain over the unit interval 
Using the chain rule, the rescalings imply 
and 
Since az at _ ZHH and ez ex 
a aT a az a 
at =7ft. aT + 7ft. az' 
a az a 
ax iJx az' 
(3.68) 
(3.69) 
(3.70) 
-It the rescaled form of equations (3.26)-(3.28) and (3.30) 
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Parameters Values 
,\ 0.2 
c, 0.01 
6 2.0 
ry 5.0 
Uma:z: 0.8 
rnma:z: 0.999 
<P 1.0 
a 1.0 
(3 0.001 
Table 3.4: Parameter values used [or the superficial wound model. 
are 
an (v - ziI) an 
aT + H az = - kd(c)n, (3.71) 
-- =nkd(C) -_._--1 av (<p 1) 
H az mmax nma:z: ' 
(3.72) 
ab (v - ziI) ab 
.Efl' + H az =I'n - 6b, (3.73) 
1 a2c 
H2 aZ2 ='\nkd(c), (3.74) 
subject to the initial and boundary conditions 
• At T = 0, n = nma:z:, rn = 0, c = 1 and b = :;+~; 
• At Z = 0, n = nma:z:, ut = 0, c ~ 1, v = 1 and b = 6+~; 
• At Z = 1 at the skin's surface 
Dc 
az = 0, 
and desquamation is given by 
(3.75) 
Details of the finite schemes applied to the rescaled system are given in Appendix A.I. 
3.4.2 Numerical Results 
The solutions for the nondimensionalised ID reaction-advection-diffusion system are discussed 
in Appendix A.I. The initial conditions applied are 
t = 0: n = 0.8, m = 0, b = 0.8, c = 0.01 w = 0.2 and v = 0.1 
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Figure :1.4: Evolution of tlIe (left) live cell fmction (n) and (riglIt) cell-cell binding (b) in 
the epidermis at steps of t = 10 Onitim curves are represented by the pink line at n(x 1 0) = 
b(x,O) = 0.8) where the first arrow points to injtial desquamation and the second arrow 
indicates the recovered skin thickness. The first dllSJwd line illustrates the point where cells 
begin to die, the second dashed line (red) SllOW the midpoint wilere live and dead cells coexist 
in equal numbers and the tl1ird line denotes the upper epidcl'Iua1Jayers and development of 
the llOIIlY layer. 
The parameter VA.I1H~ Ilsed in this model to represent' healing of a superficial wound, are given 
in Table :1.4. 
The evolution of the model variables (live cell fraction n(x. t). dead cell fraction m(x, t), 
signal concentration c(x, t) and velocity v(x, t)) towards the healed/healthy steady state, which 
defines the removal of all live celL~ as they reach t.he skin's surface (Hoo ~ 17.59) arc illustrated 
in Figures ;jA -3.5. They appear as hair like profiles protruding away froIll the solutions that 
evolve. The simulation suggests that the re--epithelisation process occurs in two stages defined 
below 
1. Stage 1- Epidermal cell differentiation to the granular layer. 
2. Stage 2- Epidermal cell death (and keratinisation I) from the granular layer to the 
skin's surface. 
This model predicts full recovery of the live layer before keratinisation takes place i23j, after' 
a superficial wound or incision has taken place where the epidermal membrane is lost. As 
discussed in 3.2.2, the live cell density n(x, t) is the greatest at the basal layer due to mitotic 
activity. Cells then progress further into the epidermal medium due to cell division at x = 0 
in an upward directions Wldergoing maturation and phenotypic changes, where live and dead 
I Keratinisation is the self-renewal process of the epidermal membrane and provides a protective membrane. 
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cell regions become more pronounced. The initial stages of desquamating cells defines the 
transition from live to dying cells and is indicated by the first arrow (refer to figures 3.4-3.5). 
The steady state recovered thickness Hoo :::::: 17.59 (to 2 d.p) is given by the second arrow in 
the simulations. 
In Figure 3.4, we observe the keratinisation process and the two cell states that takes places. 
A plateau of cells evolves initially with n:::::: n max , which falls away when x :::::: 8 due to a decline 
in c(x, t} to approximately cc:::::: 0.1 (see Figure 3.5). In turn the binding strength declines at 
the same point, due to the decreased presence of their live cells producing the material. The 
model predicts that re-epithelisation process consists of a period in which all cells are alive 
(between x = 0 and x ~ 8). Only after a period of time (between x = 8 and x = 12 both 
live and dead cells exist), cells prepare for death and there is a full development of the dead 
(horny) layer between x = 12 and x :::::: 17.59 . The time taken for skin cells to move from A 
to B is given by 
lA--'B = rB ~dx, lA v 
which was approximated numerically using the trapezium method and the values of 'V obtained 
from the full system's solutions. 
The typical duration of cell keratinisation is estimated to last 2-3 weeks and a further 2-3 
weeks for desquamation, our results 'Show an almost equal thickness for the two stages and 
there is a transitional period where live cells begin to die in the region 8 < x ::; 12. In this 
, 
simulation, a ('cll traverses the fully live region (0 < x ::;; 8) in 
18 1 Tlive :::::: -dx = 16 days, o v 
and traverse the dead cell region 
l Hoo 1 Tdead :::::: -dx = 27 days. 8 v 
The total time taken is approximately 6 weeks which is roughly the time in the thicker ep·i- ' 
dermal regions, such as the sole of the feet. 
At the skin's surface H 00 there are negligible b(x, t) as only dead cells are present and cell-cell 
binding is no longer needed (see Figure 3.4), as to be expected with f3 = 0.001. vVe can see over 
the first few timesteps that f3/b(Hoo) «v(H) so the model predicts negligible desquaming for 
a large part of early epidermal healing. 
We observe from Figure 3.5 (left simulation) the change in signal behaviour when the re-
epithelisation process takes place. It can be interpreted that due to the domain size, c(x, t) is 
more elevated initially, before more rapidly dropping as the domain size increases (0 < x < 8). 
It is observed that as skin repairs, molecules such as growth factors and nutrients, are at ele-
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Figure 3.5: Evolution of tIle (Ieft) signal concentration (c) and (right) velocity (v) at steps of 
t = 10 (initial curves are represented by the grey line at c{x, 0) = 1 and pink line at v{x. 0) = 
1 rcspcctivelyJ: where the first arrow points to initial desquamation and tile second arrow 
indicates the recovered skin thickness. The first (i;l.<;lwd liuc illustrates the point where cells 
begin to die, the second dashed line (red) show the IIlidpoint where live and dead cells coexist 
in equal numbers and t1w third line denotes the upper epidermal layers and development of 
t1le llOrny layer 
vat~rllevp.ls d.ming an illjllfY and declines to 0.1. The model predicts tillS behaviour, moreover 
interestingly this (increase of initial c(x, t)) does not result from a greater production, however 
the geometry of the shallower skin is responsible and naturally elevates signal levels. 
The velocity profile is shown in Figure :t5 fluctuates between 0.8 and 1 where the velocity 
generated by cell movemcnt is greatest bctween the basal and granular layers defined by x = 0 
and x ~ 8 within the live cell region. The velocity declines as cells dic/desquarnate due to cell 
volume loss ill the later phase: reflecting dehydration and keratinisation. It should be noted 
that the velocity incorporate."l cllallge of live cells as they lose moisture and undergo challge in 
cellular structure within the epidermal membrane. The model predicts also that the velocity 
becomes constant as it approaches the surface, bnt. never reaches 0, which is supported by 
literature as cells are in continual movement, unt.il they reach t.he skin's surface [11, 40]. 
Manipulating ,\ alters tl~e delivery of growth factors to the epidermis, the different scenarios 
using .\ = 0.05, .\ = 0.2 and .\ = 0.8are presented in Figure 3.6 (left silIlulation). The 
standard simulation used .,\ = 0.2, in which the live and dead cell regions are approximately 
equal thickness and the parameters were chosen appropriately to ellsme this. As.,\ increases 
the growth fact.or delivery becomes less efficient and does not penetrate as deep, impeding 
full recovery as cell die quickly. The resulting skin has thinner live cell region and a dead cell 
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Figure :l.6:. (left) Plot of skin thickness H(t) for A = 0.8 (green line), A = 0.2 (blue line) and 
,\ = 0.05 (red line) and (right) live cell fraction n(x, t) for A = 0.8 (green line), A = 0.2 (pink 
line) and ,\ = 0.05 (red line). 
region of the same thickness (as expected from the analysis of Section 3.3). The thinness of 
the live cell layers preswnably weakeufl the skin ami makes it morc prone to further damage 
such as infections: as it will be easily exposed if damaged. 
The corresponding live cell distributions obtained by altering). arc given in Figure 3.6 (right 
simulation). The plots show that as ,\ increases the thickness of the live cell layer decreases, 
although the dead cell layers arc similar in each case. This is predicted in the analysis in Section 
3.3.1 in which Xc 0( I/../X and the profile of n(x. t) is independent of A for X > Xc. 
3.5 Summary 
In this chapter we considered superficial wounds de~cribing epidermal growth and the kera-
tinisat.ion process in the epidermal sublayers as they divide, differentiate and die to ensure 
epidermal self-renewal. Re-epithelisation is a key process in wound healing, in which the 
epidern~al membrane is reinst.ated to enable wound recovery and closure, and is a significant 
means of protection against the external environment from furth~r insults. 
A simple model was proposed, describing t.he evolution and interaction of live cells, cell-cell 
protein binding concentration and GF signals. The movement due to cell growth and death 
was accounted for using a velocity variable V{t). The resulting ID reaction-advection-diffusion 
model was solved and analytically studied in a steady st~te limit, also numerically using finite 
difference methods (refer to Appendix A.I). 
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The results suggests that the model can produce a quantitatively reasonable description of 
epithelial recovery and development. In a particular limit we can assess in terms of the model 
parameters epithelial thickness, thickness of live and dead cells and timescale for growth. The 
numerical results obtained followed closely profiles expected from biological literature, and 
provides a replication of the re-epithelisation process after superficial injuries using mathe-
matical modelling. \Ve also investigate the effect of growth factors on recovery rates and skin 
structure. This provides a basis to look more closely at impaired epidermal healing and will 
be an area considered in Chapter 4. 
The key predictions frolll the model are as follows 
• Re-epithelisation reforms the live cell layer (signal dominated) and once complete builds. 
the keratinised layer which enables cell shedding/sloughing at the skin's surface (refer to 
Figures 3.4 left simulation). The time taken for the whole process agrees with biological 
literature as our model predicted:::::: 6 weeks. 
• Signal molecules frolll the dermis and binding protein production rate arc sufficient to 
regulate the thickness and structure of the epidermis (refer to Figures 3.4 and ;3.5 left 
simulations). A simple extension of the model could make the binding protein production 
rate a function of signal concentration, which lIlay predict that the whole process can 
be regulated by a simple signal. 
• Elevated signal/GF levels in the skin are not necessarily due to greater production 
resulting from injury. The geometry of a reduced domain can explain this observation, 
as signal concentrations are substantial, initially after skin loss (refer to Figure 3.5 left 
simulation). 
The model was aimed at reproducing observed behaviour with minimal complexity. Factors 
believed to be important that were neglected in the model formulation include 
• Independent GFs and their unique activities. 
• Specific cellular aLtachments at the different stages of keratinisation. 
• Calcium impact on cell binding or cell movement within the domain. 
• Immune cell activity. 
Some of the limitations imposed in this model as stated above will be addressed in the next 
chapter) when we consider the skin disease psoriasis which is characterised by defects in the 
keratinisation process. 
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Chapter 4 
Psoriasis 
4.1 Introduction 
This noncontagious chronic, inflammatory, lifelong skin disease is diverse and appears in a 
variety of forms, severity, location and scaling pattern, with distinct characteristics affecting 
treatment strategies, as discussed in Chapter 1. The condition cannot be cured and treatment 
is aimed at reducing the symptoms instead. 
This is still a relatively new research area and we are being more knowledgeable about the 
pathology, biological and physical properties of the constant developments that have been 
made. l'l.'fany components have been identified which may be responsible or contribute to the 
onset of psoriasis and this will aid further expansion in this area. Globally there are over 80 
million sufferers with a higher prevalence in Caucasians when compared to popuiations from 
South America1 Nigeria and China [78 1 123]. 
It .is not uncollllllon to suffer froIll more I..han. one type of psoriasis silllultancousiy~ or the 
transition of one form to another mediated by certain trigger factors which are not fully 
understood [33, 93, 94[. 
This skin disease is characterised by hyperproliferation and unsystematic cell maturation. 
It shou'ld be noted that unlike Sherratt et ai's model 1115], we do not consider blood flow 
regulation by NO or the dermal membrane, but only the effects exerted within the epidermal 
membrane. It is believed IGF-l and IGFBP-3 are important in the abnormal behaviour of 
keratinocytes [50, 75, 123], and we v:.ill investigate normal and psoriatic skin behaviour by 
focusing on the keratinisation process. 
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4.2 Mathematical Modelling 
4.2.1 M ode l Discussion 
The epidermal model presented in Cha.pter 3 is extended to incorporate psoriatic components. 
The effects of this skin disease are visible on the surface ill the form of psoriatic plaques, 
and many biological activities take place in the epidermal membrane as presented in Figure 
4.1. 
We have introduced additional variables to those stated in Chapter 3. namely immune cells, 
IGF-1 and IGFBP-3 concentrations (refer to Table 4.1), to obtain greater understanding that 
will allow comparisons to be made between normal and psoriatic skin. 
The main aims of the modelling in addition to those mentioned in Chapter 3 are 
• To describe epidermal and abnorma.l self renewal seen in skin, by focusing on the ken\.-
tinjsation process. 
• Obtain insight into the inflammation and immune cell behaviour typical in tltis skin 
disease. 
• Describe the effects of IGF-1 and IGFBP-3 on norma.l and abnormal skin development. 
A continuulTI approach will be applied 1 to model mathematically the normal epidermal renewal 
process (keratinisation) and abnormal activities that arise from keratinocyte maturation in 
psoriasis. The model will be discussed in more details in Section 4.2.2 and the full nondimen-
sionalised system will be presented in Section 4.2.3. 
NORMAL 
- -- - - - ---
x = H(t) SKIN'S SURFACE 
~~ CELLS LOSE 
NUCL£lAND 
BEGIN TO DIE 
EPIDERMIS 
.:z;=o I- --- I- -l· • • • • • 
F F ,/ ,/ F 
-
-
• 
PSORIASIS 
CL~~ 
CJ ~ ~ 
LlVE A ND 
DEAD CELLS 
CO-EXIST 
NOT All CELlS LOSE THEIR NUC l.El 
ON AND THIS INinAm INFLAMMATI 
---
• • 
• • • 
--
, , , 
Figure 4.1: Schematic model illustrating normal and psoriatic skin. 
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Variables 
n(x, t) 
m(x, t) 
w(x, t) 
b(x, t) 
c(x, t) 
v(x, t) 
A(x, t) 
/3(x, t) 
/(x, t) 
Description 
Live cell fraction 
Dead cell fraction 
\Vater fraction 
Cell-cell binding protein concentration 
Signal concentration 
Velocity of cell movement 
IGF-l concentration 
IGFBP-3 concentration 
I mmune cell.:fcCr",ac,::t::io~n~ ___ -.l 
Table 4.1: Variables considered in the skin model. 
4.2.2 Governing Equations 
In this section we will discuss the model in independent sections for more details regar~ing 
their purpose and functionality. The variables and parameters considered in our model are 
presented in Tables 3.:3 and 4.1. 
The following assumptions are applied (in addition in those in Chapter :3) 
• Cell birth can occur in the presence of IGF-l and signal molecules [40, 75) 108]. 
• Binding protein production is reduced in presence of IGF-l [62, 781 
• IGF-l is produced by immune cells and removed by the inhibitor IGFBP-3 [49, 75]. 
• IGFBP-3 is produced by living epithelial cells and removed by immune cells also through 
the inhibition of IGF-1 [50,61, 75]. 
• Immune cells diffuse in the epithelial layer [40, 56, 123]. 
• Inflammation is simply modelled as increased immune cell presence from the basal region 
[75, 78]. 
Modelling Skin Growth 
In psoriatic epidermis there is an excess of IGF-l secreted and lack of IGFBP-3 in selected 
ke~atinocytes. This elevates proliferation of TA cells, expanding the proliferative compartment 
and allowing hyperplasia and abnormal differentiation. Collectively these events are responsi-
ble for the coexistence of live and dead cells at the skin's surface disrupting the keratinisation 
process [28, 50, 75]. 
\-Ve assume IGF-l promotes cell birth [75] and we introduce a birth rate term 8(c, A) given 
by 
C'11 A'12 
e(c, A) ~ 0: C~l + C'11 A~l + A'12 1 
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and the equation for live cells become 
an a Ft + ax (vn) = (8(c, A) - kd(c))n, (4.1 ) 
bearing mind the equation for dead cells remains unchanged from Chapter 3 hence 
( ac') kd(C) = (l 1 - -,-- . 
• Cc + cT} 
The constitutive relations (3.5) and (3.6) are unchanged so that water and cell velocity equa-
tions become 
aw a 
-a + o(vww) = kd(c)n(l- 4» - 8(c,A)n, 
t ox 
(4.2) 
av (4) I) 71 
-a = kd(c)n -- - -- + 8(c, A)--, 
x rnmax Hmax n max 
(4.3) 
where the last term results from the volume exchange of water to cells during cell division. 
vVe should note that v(O, t) = VI) will be rescaled as before wit.h maximum growth at the basal 
layer. 
Modelling Cell-Cell Binding 
Applying the assumption t.hat binding protein production rate is reduced during cell division 
1 [401 56L gives the modified equation for b 
The equation for cell-cell binding protein is given by 
ab a Iln 
-a + o(vb) = 8( A) - bb, t ux 1 + i Cl (4.4) 
where the factor 'Y governs the inhibitive effect of mitosis on binding protein production \Ve 
note that at the steady -state we have 
db 
v-= 
dx 
1171 _ bb _ b dv 
1 +,8(c,A) dx' (4.5) 
so that rearranging gives 
b _ J1H max 
- (I + ,8(c, A))(6+ vx)' (4.6) 
which \\rill be used in the boundary conditions for b. 
1 Daughter cells from the basal layer arc forced to move into the suprabasal layers, so binding proteins 
production at great quantities are nut required. 
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Modelling Signals 
The signal equation (3.17) deri\'e~ in Chapter 3 and will be the main contributor lo birth and 
death processes within the epidermis. Although this will be distinct from IGF-l and IGFBP-3 
as they contribute to abnormality seen in psoriasis. 
Modelling IGF-l 
IGF-l exhibits antiapoptotic properties and overabundance in psoriatic involved skin could 
lead to disruption in maturatioll) leaving nucleated cells in the upper epidermal layers which 
under normal conditions would be absent [11,28,40) 75]. For simplicity we assume non-cell 
and cell associated fGF are at equal concentrations. 
The equation for IGF-l is given by 
(4.7) 
where V(t) is given by (3.12) represents the flux of mass of Istuff' (cells and water) and 
• (lAB represents IGF consllmed by IGFBP-3. 
• (2A1 represent production by imlllune cells. 
Modelling IGFBP-3 expression 
IGFBP-3 controls the early stages of keratinocyte differentiation hence acts as an inhibitor 
displaying apoptotic behaviour. Inefficient IGFBP-3 expression is typical in psoriasis allowing 
hypcrproliferation to persist: as it is unable to counteract the excess IGF-l levels [28, 49, 
781. 
The rate of change of IGFBP-3 is given by 
[)B [)B [)' B 
-[) + I'(t)-[) =DB -[) , + ",,, - ",AB - ""BI, t x x (4.8) 
where 
• ,'\;tn represents the production by keratinocytes. 
• H'].AB denotes TCFBP-3 consumption by IGF. 
• li:lBI refers t.o loss/removal by immune cells. 
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Modelling Immune cells 
The immune system is activated during wound healing and chronic inflammatory conditions 
such as psoriasis, involving excessive Iymphocytes, macrophages and leukocyte recruitment 
into the skin [11,40[. 
Immune cells such as T-cells and Langerhans (they have a uniform distribution in normal 
epidermis) usually reside in the lower epiderlllallayers; although they infiltrate upper layers 
and are present close to the skin's surface as the inflammatory response is initiated, during 
the onset of psoriasis [78]. 
\Vc assume these cells migrate in the epidermal layer and drift with the cells and intracellular 
fluid. \Ve suggest 
&I 01 02 I 
- + \I(t)- = DJ - - pI Ut ox ox' ' (4.9) 
where immune cells diffuse into the epidermal medium and are lost via natural lIleans e.g. 
apoptosis, with the rate constant p. 
Boundary Conditions 
The following boundary conditions are imposed 
• At x = 0, representing the end of the bflliallayer IGF-l concentrations and immune cell 
levels will be at its greatest in response to the presence ·of live cells, hence 
where;.vor is given in (4.5) at x = O. 'Ve note the basal layer is assumed to be a source 
for both A and I, and a perfect sink for B . 
• At x = H(t), this represents the skin's surface, hence zero flux conditions are given by 
( dH ) Dc dt - \I(t) c + D, ox =0, 
( dH ) oA dt-\l(t) A+DAox =0, 
( dH ) DB dt - \I(t) B + DB ox =0, 
( dH ) {JJ dt - \I(t) . [ + DJ ox =0, 
and desquamation is given by 
dH F'o 
-=v--
dt b 
as defined in Chapter 3. 
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Full System of Equations 
The full system of equations for the extended model are given below 
where 
and 
an a 
-a + -a (un) =8(c, A)n - kd(c)n 
t x 
Bm a 
at + ax (vrn) =kd(c)n1> 
aw a 
at + ax vww =kd(c)n( 1 -1» - f:I(c, A)n 
av =kd(C) (_1> ___ 1_) + 8(c, A)-"-
Bx Tnmax Tt max n max 
ab a I'" 
at + ax (vb) 1+ ,8(c, A) - ob 
ac Dc a'c 
at + V(t) ax =D, ax' - Ank,(c) 
aA aA a'A 
at + V(t) ax =D" ax' - (lAB + (,AI 
aB aB a'B 
- + V(t)- =D8 -- + "In - ",AB - ",BI 
at ax ax' 
8I al a'l 
at + V(t) ax =D/ ax' - pI. 
( UC'I) kd(C) =!1 1 - -'-I--Cc + e'l 
(4.10) 
(4.11) 
(4.12) 
( 4.I:l) 
(4.14) 
(4.15) 
(4.16) 
(4.17) 
(4.18) 
The equations for m and e remain the same, and have not been modified for the extended 
model. Our model consists of a nonlincar coupled PDE system defined on the moving domain 
(0, H(t)) and to close the system we consider the initial conditions stated below. The full list 
of parameters are shown in Table 4.4. 
Initial Conditions 
In the following simulation ''le will consider the self-renewal of the epidermis starting from 
the end of the basal layer and maturing as it tends towards the skin's surface. The initial 
conditions are given below 
• At t = 0 given at the basal layer (x == 0) all dead cells and IGFBP-3 are absent, hence 
b - /-Ln max A A I I d B 0 
- (I + ,8(c, A))(o + v,), = 0, = I}, c=c" an =. 
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Parmneters Description Experimental Values 
Q Production of 8(c, A) -
I b produced by 8(c, A) -
i' b prod uction -
A Natural lossjusuage of signals -
DA Diffusion coefficient of IGF 13.73 Illlll' day-I [95] 
DB Diffusion coefficient of IGFBP-3 -
Dj Diffusion coefficient of immune cells 8.6 x 1O-2mm2 day-l [74] 
ry Hill function exponent of c Dimensionless 
ql Hill function exponent of c in e(c, A) Dimensionless 
q, Hill function exponent of A Dimensionless 
A, Death rate Hill fUllction exponent for A -
(I IGF-! used by IGFBP-:l -
(, IGF-l production by immune cells -
"I IGFBP-3 expression by keratinocytes -
"2 IGF-! used by IGFBP-3 -
K;:I IGFBP-3 removal by immune cells -
n Cell birth constant 0.5 day -I 
p Natural loss of illllllune cells -
Table 4.2: Parameters considered in the psoriatic model and corresponding experimental 
values. 
4.2.3 Nondimensionalisation 
Here, time has been rcscaled with cell death and space with velocity over time as before. 
{x,i} = {~:,nt} 
In addition to the rescalings in Chapter 3, we apply the following 
{ - - -} {A B I} A,B,! = Ao' Bo'k ' 
where the hatted variables define the dimensionless quantities used to nondimensionalise the 
system, refer to Appendix B.2 for more details. 
Dropping the hats for clarity, the nondimensionalised system becomes 
- + - vn =0 n - 1 - --~ n an 8 C'11 A'11 ( rIC") at 8x () C~l + C'11 AJ2 + A '12 c~ + c'1 ' (4.19) 
Dv ( rIC") (1) !) 
8x =n 1 - c~ + c'1 mmax - Tt
max 
(4.20) 
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ab a 
- + -(vb) at ax (4.21) 
(4.22) 
(4.23) 
(4.24) 
(4.25) 
Assuming that diffusion of C, A, B are rapid compared to growth, we expect Eel tA, Ea « 1. 
Furthermore immune cells are actively mobile and we expect also that El « 1. Hence wc 
obt~in the quasi-steady approximations. Hence cc) (A, £a and E[ « 1 
a'c (ac,) o =-a 2 - An -,-- , 
x Cc + c'1 
(4.26) 
il' A o~ ax' -(IAB+(,AI, (4.27) 
a'B o ~-- + ~ln - Ii,AB - /i"BI 8x2 ' , ( 4.28) 
a'I 
o ~ ax' - pI. ( 4.29) 
The corresponding initial and boundary conditions arc given 
• At t ::::; 0 hence n::::; 7tmax1 b = (l+"YH(~:';iY)(J+v.r») B ::::; 0 and m = O. 
• At x = 0 then m = 0, b::::; (1+"re(~:';{)(6+v7)' where Vx given by (4.5) with A = 1, c = 
and n::::; n max 
• At x ~ H(t) 
dH (3 
Tt ~ v- b' 
and frolll the quasi-steady reduction 
ac ~ 0 
ax ' 
aA ~o 
ax ' 
aB ~o, 
ax 
aI 
ax ~ o. 
\Ve note the coupled non-linearity with the A and B equations means that it is not possible 
to repeat the analysis seen in Section 3.~) in order to get the full solutions in the 1] --4 00 limit 
of the healthy skin case. 
This ID nonlinear PDE system presented by equations (4.17)- (4.21) and (4.26)-(4.29) is an 
59 
Parameters Description Experimental Values 
0 Production of 9(c, A) 3.0 
.\ Natural loss/usuage of signals 1.0· 
'A Pecict number of A «1 
'B Peclet number of B «1 
'I Peclet number of 1 «1 
Ac Death rate Hill function exponent for A 1.0 
ry Hill function exponent of c 3.0 
'11 I-lill function exponent of c in 8(c, A) 3.0 
'72 Hill function exponent of A 3.0 
(1 IGF-l used by IGFBP-3 0.5 
(2 IGF·l production by immune cells 1.5 
"1 IGFBp·3 expression by keratinocytes 2.0 
"2 IGF-l used by IGFBP-3 2.5 
ti3 IGFBp·3 removal by imIllune cells 0.5 
p Natural loss of immune cells 2.0 
Table 4.:.!: Tahle of parameters ill the dimensionless psoriatic model, together whh values IlS(.'(1 
in simullltiollS. 
extension of skin model discussed in Chapter 3. The boundary conditions defines a closed sys-
tem and numerical results will be presented below. Table 4.3 presents the nondimensionalised 
parameters and corresponding values that will be used in the simulations to follow .. 
Time: x 0 -. x x* 
In this chapter wc modify (3.62), used to derive time taken for cell movement in the keratini· 
sation process, due to the zero boundary condition hence v = 0 at x = 0 suggesting that there 
are cells retained in the basal layer which is a reasonable assumption. To overcome this issue, 
we introduce Xo where 
• Xu, defines the initial estimated position of the interface where v ::j:. 0 bordering the basal 
and suprabasal layers. 
• x*) defines the interface between live and dead cells. 
• The number of cell layers is given by x * /xo. 
This alteration applies to the live cell region and we write 
l XO 1 Tlivc = -dx . ., v (4.30) 
GO 
4.3 Results 
4.3.1 Numerical Methods 
As seen in Chapter 3, we rescale the system using t = l' and x = Zj H(t) and apply the chain 
rule to give 
8n (v - ziI) 8n 
iYr + 11 8Z ~8(c,A}n- kd(c}n, 
1 8v n 
I.{ 8Z ~nkd(C}r - 8(c, A}--, 1l max 
8b (v-ZiI)8b 
8T + H 8Z 
n _ bb 
1 + ,8(c, A} , 
1 8'c 
H' 8Z' ~'\nk,(c}, 
1 8' A 
H' 8Z' ~(lAB - (,AI, 
I 8'B 
H2 aZ2 =1i:JBI + 1i2AB - t\,l 1l, 
1 8'1 
H' 8Z' ~p[, 
subject to the initial and boundary conditions 
• At T = 0, Tl = Tlmax , m = 0, B = 0 and b = (l+l'e(~:'A{)(.5+V ... )l 
• At Z = 0, n :::;; n max , m = 0, c = 1, I = I, v = 0, and b = (1+1'e(~:!Ar)(o+v",)' 
• At Z ~ 1 then 
and 
8c 8A 8B ~ 0 8[ 
az = 0, ox = 0, ox 1 ox = 0, 
dll {3 
dT ~ v - jj' 
Details of the rcscalings are given in Appendix A.2. 
4.3.2 Normal 
(4.31 ) 
(4.32) 
(4.33) 
(4.34) 
(4.35) 
(4.3G) 
(4.37) 
In Figures 4.2 - 4.4, we show the re-epithelisation process which replicate the norlllal keratin-
isation scenario investigated in Chapter 3. The parameter values given in Table 4.4, and the 
arrows point to H=, hence represents the healed skin surface (x ~ 6.2 in this case). 
The initial conditions are as follow, 
n = 0.8, c = 1, b = 0.18, v = 0, A = 1, B = 1 and 1=1. (4.38) 
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Parameters Values Parameters Values 
a 3.0 a 1.0 
c, 0.01 A, 1.0 
<5 2.0 (1 0.1 
I 1 (, 1.5 
'I . 3.0 
""'2 2.5 
nmax 0.8 Ii.;J 0.5 
lnmax 0.999 <P 1.0 
A 0.5 P 2.0 
"1 2.0 
Table 4.4: Standard set of parameter values used ill the extended model. 
\Ve can observe the live and dead cell states in the keratinisation process from Figure 4.2 
(left simulation), where cells start to desquamate from x ~ 2.2 are almost equal periods. The 
distribution of nand C are qualitatively similar, however, there arc differences in c and v. 
The time cells (each timestep represents 2 days) spend in the live and dead states (if we take 
x* = 2.2 and Xo ::::: 0.2) can be given using 
T/ive ~ rx * ~dx = 6 days, Jxo v 
j,(i.2 1 Tdead ~ -dx = 18 days. 
2.2 v 
The whole process takes ~ 24 days, which falls into the time period expected from normal skin 
activity. It is relatively simple to adjust the thickness of the layers as required, by changing 
Cc and (3 as with the model of Chapter 3. 
The signals (see right simulation of Figure 4.2) and birth rate (see right simulation of Figure 
4.4) decline 1Il0notonically in the live layer and reaches a low level near constant solution 
thereafter, as the dependency on signals diminishes with cell death. This correlates well with 
the binding material available (see Figure 4.:l) which also decline in the desquamation period; 
cell death inhibits production levels and velocity (see right of Figure 4.3) also becomes constant 
as a result. 
IGF-l levels subside monotonically as illustrated in Figure 4.4, decreasing as cells die towards 
the surface. The immune cells can only penetrate to x ~ 1 so production of A is very limited 
to the basal membrane region. The inflammatory response is modelled silllply by reducing the 
death rate, a...:; this will init.iate immune cell infiltration. IGF13P-3 expression amplifies from 
initial onset reaching high concentrations where B ~ 3.2, in the dead cell region shown in 
Figure 4.4. Because cell division requires IGF-l to be at sufficient quantities, this only occurs 
in the basal region. Here, the binding levels are reduced, but moving away from x ::::: 0, cells 
are less inclined to reproduce and binding strengthens, hence the initial rise. As cells die, the 
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Figure 4.2: Evolution of the (left) live celJ fractioD (n) and (right) signal concentration (c) 
using values iD Table 4.4 at steps oft ~ 20. 
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Figure 4.3: Evolution of (left) eell-celJ binding protein concentration (b) (rlliddle) immune cell 
fraction (l) and (rigbt) velocity (v) using values in Table 4.4 at steps oft ~ 20. 
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Figure 4.4: evolution of (left) IGF concentration (A) (middle) IGFBP-3 concentration (B) 
and (right) birtb rate 8(c. A) using values in Thble 4.4 at steps of t = 20. 
binding strength is reduced and declines towards the surfa.ce. 
The results present normal activities and rughl.ights the promoter-inhibitor relationship be-
tween IGF-I and IGFBP-3. which work together to regulate the proliferative and apoptotic 
cell activity sy::;tematically in this maturation phase. Immune cells are only visible in the lower 
epidermal layers in agreement with literature 149. 501. 
4.3.3 Psoriatic Epidermis 
The psoriatic involved epidermis is characterised by overablmdant IGF-l and low levels of 
IGFBP-3 concentrations causing an inflammatory rcspons(', where immwlC cell production 
increases a.nd Dlay penetrate further into the upper epidermal layers. Here the 88JllC parameters 
in Table 4.4 apply. except for the natural loss of immune cells is reduced. hence p = 0.5 
([('duced from p = 2) to simulate the initiation of the inflammatory response. The simul8,tions 
are given in FiglUes 4.5-4.7 which could resemble the common psoriatic case discussed in 
Chapter I . and tbe arrows point to H"" "" 8. 
Immediately we notice that epidermal activities of the live cells (refer to Figure 4.2) takes place 
on an larger domain going from x E (0.6.2) to x E (0.8). which is almost a third increase from 
the normal case and suggests that skin thickness has elevated and exceeds the surface (see left 
simulation of Figure 4.5 to compare). Tbe cell birth mte dO€S not decline iru;tantly (see right 
simulation of Figure 4.4 to compare) ... , there is a phase when x E (0.2) where birth remains 
unchanged and diminishes very rapidly thereafter. 
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Tbe steady state times for live and dead cells (if x'· . 6.2 and Xo = 0,6) are n.vo = 4 days 
and Td,ad = 5 days. where live cell region h; thinner than tbe dead ceU area and a total of 9 
days to complete the maturation process suggests that psoriatic involved cell ttu110ver rate is 
considocably qltieker, when compared to the ,tandard C!\S(' seen in Figure 4.2. This results in 
lhe coexistence of live and dead celb at the surface (fi ~ 0.2) affocting the skin homeostssis, 
wbere we observe a greater production of binding proteins (b ~ 0.3) also (set' left simulation 
of Figure ~.3 to compare) . 
IGF-l levels increase initially then declines to oonstaut wlit concentration I~vel of A ~ 1, and 
remains unaffected ss an outcome of inade<luate IGFBP-3 concentrations (w,der expres..o;ed) 
in tbe suprabssaJ layers (see Figure ·1.7); Illlable to exceed B ~ 0.6 in the keratiuisation phase 
and is reduced towards the skin surface. hence B ~ 0.2. TIlls stimulates the inflammatory 
rcspolL~e wbere immune cell distribution (see Figure 4.7) penetrate a little furtber than tbe 
normal case (see Figure 4.3). Tbis highlights the promoter-inhibitor relationship between the 
two proteins, and how change in production levels eau aff('('t live cell distribution. (sce Figure 
4.5). Consequently the velocity increases substantially (by 3 fold) reaching a maximum of 
t'::::: 3.4. which could be due to incomplete desquamation and increased live cell activity near 
the !\kin surface. 
The results arc consistent with biologicallitcra.ture that supports tUlder-expression of IGFBP-
3, overabundant IGF-1, shorter turnover rate (7-10 days [75]) and small penetration ofimmune 
cells into suprabssal layers could result in hyperproliferation and some parakeratosis (49). 
There are trea.tments available to regulate inflamed Hkin b<-haviour in psoriasis and treatment.s 
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Figure 4.5; E,'Olution of (left) signals (c) (middle) birth rate 9(c. A) and (right) 11> .. cell 
fraction (n) at steps oft 20, using values in Table 4.4 except for p = 0.5. 
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Figure 4.6: Evolution of (left) velocity v (middle) colI-celI binding protein concentration (b) 
and (right) immune celI fraction (n) at steps of t = 20, using values in Table 4.4 except for 
p =0.5. 
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Figure 4.7: E,,,lution of (left) IGF contentration (A) and (right) IGFBP-3 conceDtration (E) 
at stel's of t = 20, using ,wues in Table 4.4 except (or p = 0.5. 
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will be considered next. 
Treatment of IGFBP·3 
As we have identified a relationship between IGF·l and IGFBP·3, we can introduce a topical 
application of IGFBP·3 to regulate the excess IGF·l concentrations th.t exist in a psoriatic 
domain to inhibit its proliferative activity. The treatment takes the form of a dressing which 
releases IGFBp·3 into the wound at a fiLL" dB(H, t)ldt = 3. The simulations for IGF·l, 
IGFBP·3, cell binding and live cell distribution are given in Figures 4.8-4.10. 
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Figure 4.8: Evolution of (left) live cell fraction (n) (right) cell-cell binding protein production 
(b) at steps of t = 20, using values in Table 4.4 except for p = 0.5, when B.(H, t) = 3 is 
imposed. 
The results suggest that increasing IGFBP·3 at the bouudaoy elevates its concentration by 5 
fold (B "" 3) and penetrates beyond the lower epidermal layers with sufficient concentrations. 
Tllis inlpacts on cell proliferation and lowers IGF levels considerably (A"" 0.1) and inhibits 
the extent of immature keratinisation. The combined effects of the proteins stimulates cell 
death at the surface (n "" 0.1) and the live cell region increases (x E (0,3)). Although not all 
the cells are able to desquamate in response to treatment it certainly helps regulate abnormal 
activities, and lower binding protein concentrations at the surface supports this (see right of 
Figure 4.8). Consequently the inflammation visible at the skin' surface lessens, and domain 
changes from x E (0,8) in the psoriatiC involved case to x E (0,7.1) with treatment. 
The topical application of IGFBP-3 applied to a psortatic involved epidermis can help stabilise 
hyperproliferation, which in reallty could lead to reduced inflammation and allOIV the skin to 
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Figure 4.9: Evolution of (left) IGF-l (A) and (right) IGFBP-3 (B) at steps oft = 20, using 
values in Thble 4.4 except for p = 0.5, wben Bx{H, t) = 3 is imposed. 
retmn to a normal homeostatic state, by forcing IGF -1 concentrations to decline and help 
the k<'C8.tinisation process. There is noticeably less live cells and binding proteins at the 
skin surface in respollS(' increase in IGFBP-3. This is just a temporary solution in managing 
psoriatic involved skin, and one that requires further investigation to remove the fu ll extent 
of the inflamed skin. 
4 .3.4 Over a bundant IGFBP-3 E xpression 
Up to now we have considered the normal and overabundant IGF-l cases, in this section we will 
investigate over expression of IGFBP-3 to see how this contributes to the re-epithelisation. as 
this scenario will promote inhibition of cell proliferation at all stages. The parameters va.1ues 
in Table 4.4 are applied except for "I = 10. and the simulations for live cells, IGF-l and 
IGFBP-3 are given in Figure 4.10. 
We can observe from the results that cells die very (Iuickly, and their behaviour is supported 
by rapid mOllotOllic decline in IGF levels which is localised in the lower epidermal layers. 
inhibiting proliferative ability of these cells, in respolL'" to great quantities of IGFBP-3 present 
in the epidermis. This will result in a less substantial membrane as the desquamation phase 
is lengthened. 
In general the results suggest that overabundant IGFBP-3 may create a tiliuuer epidermal 
membrane than in the healthy case, or the behaviour observed in psoriasis where there is 
inflammation beyond the skin's surface [99[. 
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Figure 4.10: E,'Olution of (left) live cell fraction (n) (middle) IGF-l (A) and (rigbt) IGFBP-3 
(B) at steps of t = 20, using values in Thble 4.4 except for "I = 10 
4.4 Summary 
Psoriasis is a chronic inflammatory disease that impedes the keratinisation process and cell 
turnOVE'f is mor('- irregular. although many factors oontribute to the onset of tltis disease, 
it is not clear what the causal processes are. This chapter provided a model extension to 
that already S€('n in Chapter 3, to investigate the role of immune cells. IGF-l and IGFBP-3 
concentrations in both Jlormal and psoriatic epidermal situations. It is generally believed that 
irregular immune cell activity is involved and it has been reported that the imbalance of IGF-I 
and IGFBP-3 is an important consequence, leading to the symptoms. 
The results obtained from ID reaction-advection-diffusion model suggest that we can repro-
duce epithelial recovery for normal epidermis with thf' additional components and psoriatic 
behaviour when IGF-l concentrations are plentiful. causing inflammation and coexistence 
of live and dead cells Ilt the skill'S surface. The coudition can be managed by introducing 
IGFBP-3 via the skin surface in the form of a dressing; although this improves the complete 
keratinisation process and reduces inflammation it is unable to return to the normal skin 
margin after treatment. and may suggest an overactive functional membrane. 
The model was aimed at providing details and comparisons between the nonnal and abnormal 
epidermal behaviour, where we highlighted a relationship between IGF-l and IGFBP-3. For 
purposes of simplicity we excluded mallY eomponents such as, 
• Dermal and epidermal cell interaction. 
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• Other treat.ment.s available that. lar·get t.he inflammat.ion at the surface. 
• Size and frequency of psoriatic plaques. 
• Factors such as infections that. may trigger its onset. 
The limitations in t.he model provides scope for further investigation 1 as it is stiU a relatively 
a new research area and one that. requires further developments. 
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Chapter 5 
Deep Tissue Wounds: Normal 
and Compromised Healing 
5.1 Introduction 
The normal wound healing process is disrupted greatly in chronic wounds as discussed in 
Chapter 1. These long term wounds exhibit protracted periods in the inflamed stat.e, and are 
commonly aggravated by intrinsic factors including excess innammatory cytokines and poor 
vascularisation. Such wounds require clinical intervention to restore or aid normal repair, 
where the wound bed is prepared by means of debridement or alternative treatments p 7, 
561, 
Superficial partial, deep partial and full thickness wounds affect both the epidermal and dermal 
membranes , and healing is dependent on the extent of injw'Y and tissue lost. The epidermal 
and dermal membranes communicate via the cross talk of cells, however the dermis also 
provides essential nutrients and GFs to the epidermis, which is not equipped with its own 
vasculatw-e [8, 11, 25, 261, 
To invesligate more challenging wounds the dermal functions are considered. The dermis 
consists of an intricate structure and is the skin's thickest functional membrane as shown 
in Figure 5.1. I.n this dla.pter we will explore the healjng between the proliferative and re-
modelling stages of deep tissue wounds as shawl) in Figure 5.2, and key activities that occur 
include angiogenesis, tissue growt.h replacing the init.ial clot., cell migration, collagen depo-
sition, immune response and wound closure. Acquiring a greater knowledge of Lhe primary 
processes and their interactive mechanisms during norlUal wowld healing will help identify 
relative differences that develop in abnormal healing patterns; where key characteristics can 
be examined in more detail. 
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Figure 5.1: Functional layers of tbe skin bighligbting tbe intricate structUIe of tbe dermis. 
Natural Phases of Wound Healing 
INJURY PROLIFERATION REPAIRED WOUND 
Figure 5.2: Stages of wound bealing and tbe transition from one pbase to tbe next [63}. 
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Deep t.issue recovery wiIJ be considered in this chapt.er and the main aims of t.he modelling to 
come are 
• Obtain insight into normal and abnormal healing. 
• ldentify key parameters responsible for impeding normal healing. 
• Assess variable beha.viour, interaction and its significance to healing and repair. 
5.2 Model D evelopment 
To develop the mathematical model and understandjng of dermal healing, the functions and 
activities need to be considered in order of significance. We should note that dermal factors 
interact and work collectively to maintain skin homeost.asis and tissue integrit.y. The schematic 
diagram in Figure 5.3, provides a simplified overview of key events initiated upon dermal injury 
and the transition to repair, emphasising the significance of cell behaviour. ' Ve wi!! assume 
we have gone beyond the inflammatory phase, as our int.erest lies in modelling proliferation, 
which comprises of t.issue generation and deposits to occupy the wound domain. 
Numerous studies discussed in Chapter 2 (such as [11,17,22,29,34,40,92]) have highlighted 
many important wound components. Given the extensive literature in the area, research only 
exposits independent dermal processes such as angiogenesis. In our model we will consider a 
general overview of the proliferative phase, and focus on key events from preparing the injured 
domain to wound closure. 
Our aim in this chapter is to key factors that contribute to the heali ng process and incorporat.e 
this into the mathematical modelling to come. This will hopefully provide greater insight 
into healing progression, migratory behaviour and impact on re-epithelisation. Note that 
granulation iissue defined in this chapter is distinct from the "granular layerlJ discussed in 
Chapters 3 and 4, which is confined t.o the epidermal membrane defining cell appearance 
("granules") in the mat-w·at.ion process. 
5.2.1 D ermal Compone nts 
To include all the dermal functions discussed in Chapter 1 would lead to a very complicated 
system of equations. Tt. is clear that fibroblasts, keratinocytes, damaged dermis, healthy 
dermal EeM, signals (GFs and cytokines), nutrients 8Jld granulation tissue formation are key 
element.s, that together impact greatly on normaJ skin development during wound healing. 
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AND AND GRANULATION 
CLOTTING TISSUE FORMATION 
WOUND 
REPAIR 
Figure 5.3: Schematic Bow diagram of dermal bc,-,jillg bigblighting cellular activities that 
enable wound repair. 
The proposed model aims to include all the key features, although some simplifications will 
be made. The following assuroptions are applied. 
• Dea.d wound material and clotting components (fibrin, fibrinogen. fibronectin and ECM) 
will be combined into oue variable. This will be a SCUTce of GFs and will be removed 
during healing. Platelet activity can also be accounted for by the damaged tissue, as 
their functionality is largely dependent on the extent of injury and repair processes 
stimulated. 
• Both fibroblasts and immtme cells are present in the wound throughout the healing phase 
of interest. They are both activated by GFs aud chemotactically migrate towards the 
wound (Figure 5.5). TheiT combined effects allows tbe normal healing course as immune 
cells remove foreign material and allow debridement, whereas fibroblasts help restore a 
blood supply and replace lost tissue. For SimpliCity. t.hese densities will be accounted for 
by a single variable that will be involved in laying down granulation tissue, removal of 
dead material and further GF secretion. 
• Elastin and collagen forms the component of the granula.tion tissue and the effects will 
be accotmted for by fibroblast activities. 
• Blood supply and wound perfusion will be incorporated into a function of dermal and 
granulation levels. TIllS reflects dermal health status to support a vasculature and 
angiogenesis. as healthy tissue growth will perfu.e tbe wound environment. 
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• Birth and death of tissues and cells are nutrient dependent. 
• \Vound healing is considered complete when keratinocytes migrate over the entire wound 
domain, representing complete re-epithelisation. 
• Fibroblasts/immune cells and keratinocytes move chemotactically in response to GF 
gradients at speeds that are enhanced by the health of dermal and epidermal tissue. 
• GFs will be combined into one variable which will exhibit the generic characteristics of 
the healing process. Some of the most important GFs and cytokines actively involved 
in the would healing process can be summarised below as a reminder 13, 11,32]. 
- PDCF -Promotes chemotaxis and proliferation of fibroblasts and granulation tissue 
production. 
- TGF-J3 - Promotes chemotaxis and proliferation of fibroblasts and cytokine pro-
ducLion, although it inhibits keratinocyte proliferation. 
- EGF - Promotes keratinocyte migration and is significant for re-epithelisation. 
- ICP - Promotes cell growth in ilermi? and tissue generation. 
The wound environment is of course a 3-D structure, which can be made 2-D (x, z) a..'l an initial 
approximation (see Figure 5.4). To simplify further we will consider the model's components 
in terms of total or mean cross sectional densities/thickness. Let P(x, z, t) denote the local 
volume fraction of either (1) dermal, (2) epidermal, (3) granulation tissue or (4) damaged 
dermal tissue and the quantity of interest p{x, t) is defined as follows 
p(x, t) = rH P(x, z, t)dz In 
i.e. the quantity p(x, t) is the cross sectional thickness of a certain component of the skin. 
Thus the thickness z = H (Xl t) will be the sum of thickness of these four components. Let 
Q(x,z, t) be the local density/concentration of either fibroblasts/immune cells, nutrients or 
growth factors then 
q(x, t) = ~ IH Q(x, z, t)dz, 
q(x, t) is the llIean concentration of these components. Using these ideas we avoid the COIll-
plications of analysing a model in high dimensions and the explicit treatment of the moving 
boundary z = /lex, t), as this drops out naturally from the model. The model variables are 
listed in Table 5.1. 
Using these as the leading dermal constituents of healing the model will consider the interaction 
of 
• Birth and death processes of cells and granulation tissue. 
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Variables Description 
n(x,t) Keratinocyte cross sectional thickness 
m(x, t) Damaged dermis cross sectional thickness 
d(x,t) Normal (healthy) dermis cross sectional thickness 
g(x, t) Granulation tissue cross sectional thickness 
f(x, t) Fibroblast and immune cell cross sectional density 
c(x, t) Nutrient cross sectional concentration 
s(x, t) Signals (GFs and cytokines) cross sectional concentration 
Table 5.1: Variables consjdered in the ma.thematical model 
• Transport and diffusion of nutrients, signals and motile cells. 
• Degradation of eschar / dead material. 
The one dimensional system proposed in Section 5.3.2, will investigate the relative import.ance 
of signals and nutrients, on cell migration of fibroblasts and keratinocytes, granulation tissue 
formation and vasculature of the skin, with the intention to gain insight about the integrated 
dermal functions and problems that may arise in deep tissue injuries. 
5.3 Mathematical Modelling 
5.3.1 Model Derivation 
In healthy skin we have (n,d,9,m) = (no,do,O,O), where no and do are the cross sectional 
thickness of the epidermal and dermal layers. Consequently we expect a wound to have d < du 
and n < no which reflects the tissue mass lost. Figure 5.4 shows a schemat.ic of an idealised 
wound, showing a typical set-up of the model with the initial and boundary conditions imposed 
in the simulation to come, where we will assume symmetry at x = 0 for modelling convenience 
which will simplify data output. 
The main modelling assumptions are 
• c(x, t) and s(x, t) mediate the repair process. 
• g(x, t) deposited at the wound site indicates norlllal healing hence repair. 
• f(x, t) is responsible for g(x, t) production. 
• Generic immune response has been incorporated into f(x, t). 
• Cell motility of f(x, t) and n(x, t) governed by diffusion and up s(x, t) gradients. 
• Birth and death processes of all variables are regulated by c(x, t) 
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HEALTHY 
SKIN 
= 
x=o 
HEALTHY 
SKIN 
n nu 
, '0 
(" = f'O 
It = 80 
d - ,£" 
m - (J 
9 0 
x=L 
Figure 5.4: Schematic of the wound domain used in th(' sin)U/ation. This is an idealised 
situation, but we can adjust tbe injtjal conditions CO represent general initial damage . 
• c(x,I) bas dependency on d(", I) and g(T,t) which reBeets the extent of existing and 
DC'W vnsculature . 
• d(x, t) and g(x, t) arc responsible for providing a perfu.ed and functional medium allow-
ing for J(x, I) and n(x. I) to ent!'r the repairing domain as they provide a scaffold for 
migration. 
DERMIS 
HYPODERMIS 
Z=o 
• X 
Figure 5.5: Scbematic diagram illustrates migration of fibrobJasts and immune cells into a 
wound medium to remove eschar and foreign bodies present. 
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5.3.2 Governing Equations 
The system of equations are derived below. As expected with a problem of this complexity, 
there are many parameters. To assist in the interpretation, parameters of the fOfm fj. represent 
birth rates, 6. denote the death/removal rates and "{. are inhibitor threshold parameters, 
the subscripts indicate the model variables involved in the corresponding expressions in the 
equation. 
Heaviside Functions 
Heaviside functions are introduced to incorporate wound behaviour of signals and nutrients 
where 
H(S-S)={~ 
H(c - c) = { ~ 
if s > s (active) 
if s < s (inactive) 
if c < c (unhealthy) 
if c > c (healthy). 
and will be applied appropriately to the governing equations described below. 
Dermis d(J;, t) 
Upon injury we assume there is damage to the dermis, which results in removal of skin mass. 
We suppose that some healthy dermal EeI .... I d is retained and not 'compromised, as it remains 
in a perfused state maintaining uniformity during wound healing, as degradation is assumed 
absent [11, 70]. \Vhercby in the proliferative phase there is no new "healthy" dermis being 
created. \Ve further assume that it is non-diffusible so that 
hence a general equation 
Rate of change 
of d(x, t) 
ad =0 
at ' 
0, 
(5.1) 
implying d(x,t) = d(x,O) = dJ(x) so the healthy "dermal bed" in the wound remains in-
tact during healing (this will not apply to the next chapter as dermal removal will be an 
issue). 
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Damaged dermis ru(T" t) 
The damaged dermis m(x, t), comprises of dead material, fibrin clot and eschar where nutrients 
and GFs lllay be "trapped" in this domain. The necrotic tissue that accumulates ,vill release 
panic messages (noiception) to inform the local area of change, promoting repair processes. 
The main role of this component in the model is as a source of GFs and the general expression 
for m(x,t) in word terms is 
hence 
Rate of change 
ofm(x,t) Loss/degradation, 
am at = -Am(m,J,s), (5.2) 
where Am denotes the removal and natural loss via sloughing. Damaged tissue is removed by 
the immune cells (component of density f(x, t)) in response to chemokines and GFs {1I, 40j. 
Hence, we expect 
aAm 0 
--> 
as 
and mm 0 --> am ' 
where f removes dead tissue/cschar rn, which is enhanced by s and will prepare the wound 
,bed for repair [46, 32]. The simplest functional form describing this is given by 
Signals (Growth Factors & Cytokines) s(T" t) 
Signals s represent the GFs, cytokines and chemokines produced by all living cells (including 
lllacrophages) and have the ability to diffuse through the ECIvl. These chemical stimuli me-
diate many healing processes by allowing cells to communicate, and respond accordingly by 
recruiting repair cells into the wound medium [53, 56]. 
There are many GFs released in a wound environment SOIne which have been mentioned in 
Table 1.2. The two most important ones are TGF-,6 and PDGF, which remain actively 
involved throughout the entire process, exhibiting both promoting and inhibitory actions. \Ve 
assume one generic signal for purposes of simplicity} acting as a chemoattractant for both 
fibroblasts and keratinocytes. 
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\Ve propose 
Rate of change 
of s(x,t) 
and we suggest 
Production by all live cells 
+ Dispersion via diffusion 
Loss from cell usage and natural decay, 
(5.3) 
where ks denotes rate of signal secretion by platelets in the wound/clot, fibroblasts and ker-
atinocytcs, As represents natural loss, usage by cells and granulation tissue production, 
For the fate of production ks(n, c, j, rn, s), we expect 
ak, 0 
an> , 
ak, 0 Bc < , Ok, af > 0, ak, 0 -> am 1 and 
ak, 0 
as > 
so that signal production by keratinocytes and fibroblasts is enhanced in the presence of 
endogenous signals and reduced when nutrient supply is sufficient. \Ve adopt 
For the degradation rate .As(n, j, s) and we expect, 
aA, 0 a:;;< , aA, 7iT < 0, and aA, -a <0. s· 
as cell usage and granulation tissue production will cause decline or removal of signals as they 
are ~~senscd" by such cells, Hence 
A, = s (0, + o,nn + 0,/ J). 
Fibroblasts/lmmune System f(x, t) 
Fibroblasts and immune cells arc pivotal to the wound healing process, responsible for syn-
thesis of ECM components, collagen production, wound bed preparation, removal of foreign 
material and wound contraction. These cells migrate to the wound bed from the surrounding 
tissue by lIleans of diffusion and chemotaxis (directed cell movement) in response to signals 
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(PDGF and TGF-/l) [11, 29, 68, 92,1111. We assume 
Rate of change 
of f(x, t) 
and this can be written as 
Birth 
+ !vligration via diffusion 
rvIigration via chemotaxis 
- Loss/degradation 
(5.4 ) 
From (5.4), the constant XI denotes the chemotaxis coefficient, which is prominent in the 
presence of dermal or granulation tissue and mediated by signals s. Here kf is the cell birth 
by fibroblasts (logistic growth) and vasculature activities in response to nutrients and signals 
(particularly GFs), and Aj is removal rate of J which is lost via inadequate nutrient supply 
or apoptosis, as healing progresses. 
These cells become activated in the elevated presence of various GFs, in that they increase 
cell division and reduce their turnover rates [53]. For the rate of cell birth k,(c,d,/,g,s), \\'e 
expect 
8k, Dc >0, 8k, Dd <0, ak, ->0 ay ak, > 0 and as 
their production is enhanced by nutrients (first term) and growth factors (fourth term) sourced 
from vasculature (second & third terms) [37,38]. Hence 
For the death rate parameter )..,(/, c, s) we expect 
aA, 8J >0, aA, -<0 ac and 
aA, 0 
-< as 
which means the cell death rate is reduced in the presence of high GFs and inadequate Le low 
nutrient levels [32, 56]. Hence, 
The nutrient source function is key to the model, and defined as 
(5.5) 
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which describes the health of the vasculature as a fUllction of dermal and granulation tissue. , 
This term assumes that angiogenesis occurs in concert with dermal repair. The constant Pb 
governs efficiency of granulation tissue relative to dermal tissue in supporting vasculature, and 
"ib is the "critical" level of (d + Pbg) between poor and adequate vascular perrusion. 
Granulation Tissue g(x, t) 
Granulation tissue formation contributes to the reinstatement of the blood supply of a wound, 
being a prerequisite for the angiogenesis process that takes place in the provisional matrix. 
The two processes occur simultaneously after wound bed preparation occurs. A well perfused 
medium is needed for this to occur effectively. In impaired wounds granuhition tissue formation 
is inhibited al!d may co~tribute to the vascular insufficiency typical in such wounds [32, 40, 
53, 79J. \Ve assullle it remains static once laid down. \Ve suggest 
Rate of change 
of g(x,t) 
and in mathematical form 
= Natural birth 
- Natural loss/degradation, 
Dg 
Dt = kg (c,!, s) - Ag(g, c), (5.G) 
where kg signifies granulation tissue production in response to fibroblasts, signals and nutrients 
and Ag is the natural loss as nutrient supply declines. 
For rate of granulation tissue formation kg(c, r s), it is assumed that 
fJk a: > 0, and fJkg 0 -> Ds 
where fibroblasts produce new tissue and this depends on supplies of nutrients and signals 
[67, 70]. \Ve also assume that no more granulation tissue is laid down when nutrients have 
reached a ';good" level c or when GFs are below a level .5. Hence 
Here we have assumed granulation tissue is activated only when GFs are high 5 > sand 
nutrient levels are low c < C. Thus granulation tissue production will subside once normal 
healing and repair is noticeable [56]. 
For the rate of natural decay ).g(9, c) we expect that 
DAg 0 
-> fJg and 
82 
reflects lower granulation tissue and limited nutrient supply will promote decay and natural 
loss [58, 79]' hence we write 
A _ ( Og, ) 
g-9 l+c(cg . 
Nutrients c(x, t) 
The nutrient supply is essential for normal repair and development and we suggest a generic 
nutrient oxygen or carbon source for purposes of modelling. Nutrients are consumed by all 
living material and diffuse into the dermal ECl\'l. They are transported through plasma or 
blood which itself consists of other essential nutrients, required for cell fUllctionality and 
development. The nutritional composition in a skin medium especially after injury is very 
important, as it sustains cellular growth and repair towards homeostasis. Limited oxygen 
supply referred to as hypoxia, can result in abnormal healing with chronic characteristics, 
leading to vascular insufficiency which is common in diabetic sufferers, where the cit'culatory 
actions are impeded [11, 40, 112J. \Ve assume 
and we write 
Rate of change 
ofc(x,t) Natural birth 
+ Dispersion via diffusion 
Cell consumption & natural loss 
(5.7) 
where kc are the nutrients obtained from skin vasculature and >'c are the nutrients supplied 
to keratinocytes and fibroblasts, allowing the production of granulation tissue and restoring 
healthy skin char.acteristics. 
The only nutrient source is from the vasculature, which we assume is a function of d and g, 
reflecting the health statui; of the Ussue supported by the healing structure. The functioll 
kb(d ,9) discussed above describes this, and in general \ve expect the source of nutrient to 
satisfy k,(d,g) = k,(kb ) where 
and we assume the simplest concentration 
Nutrients are consumed by keratinocytes and fibroblasts. For the death rate function >'c(c, n, I), 
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we expect 
The simplest form being 
Keratinocytes n(x, t) 
&>.c>o 
an 
and 
Keratinocyte density is affected by many factors which include signal concentration, cell death, 
migration and proliferation. They are important as we are modelling the partial thickness 
and deep partial wounds where both the epidermal and dermal membranes are affected. I<er-
atinocytes play a significant and versatile role in wound healing, but primarily involved in re-
epithclisation which protects the underlying wound area. These cells migrate from surrounding 
healthy tissue at the wound edges via diffusion and chemotaxis when prompted, although they 
require granulation tissue as et scaffold/matrix in deep tissue wounds [40, 53]. 
\Ve assume 
and write 
Rate of change 
. of n(x, t) Birth 
+ ivIigration via diffusion 
+ rvligration via chemotaxis 
- Death, 
an a ( an) a ( as) 
-a =" Dn-a --a nx,,(d+(7,,9)-a. +kn(n,c,s)-An(n,c). t, (IX X X X (5.8) 
The assume.cl main role of keratinocytes is to cover the wound site, which will allow the 
. succession of healing provided the entire wound is concealed by these epidermal cells. From 
(5.8), kn is the growth rate of keratinocytes in response to nutrients and signals (GFs and 
cytokines), and .An denotes natural loss via apoptosis as nutrient supply diminishes and wound 
recovery is observed. 
For the birth rate function kn (n, c, 8) we expect 
akn Bc >0, and 
which means that c enhances production and s inhibits birth [56,43]. 
The function has to be limiting in n(x,t) to reflect keratinisation and sloughing, for simplicity 
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we use a logistic type crowding term to describe this. Hence, we write 
k - (June (1 --' ~) 
n - 1 + sj-Yncs fi.n · 
For the death rate function An (C, n), we expect 
8)," 
-<0 and De 
8)'n 
-D >0, 
n 
as nutrients help to maintain cell numbers, reducing their death rate [Il, 40j. The functional 
form is given by 
5.3.3 Full System of Equations 
For reasons of clarity we present the system in full 
where vasculature is defined by the hill function 
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(5.9) 
(5.1O) 
(.5.11) 
(5.12) 
(5.13) 
(5.14) 
(5.15) 
This is a highly nonlinear coupled system of PDEs of mixed type, defined on t.he fixed domain 
(0 , L). The initial and boundary conditions defined below present a closed system. 
Initial and Boundary Conditions 
Figure 5.4 illustrates a typical domain of interest. It is important that the domain is large 
enough so that the solutions change regularly from the perfectly healthy stale in the vicinity 
of x = L. 
• At t = 0 we assume a partial-deep thickness wound which affects the first two functional 
membranes (epidermis and dermis) and suggest that n = nI(x), m = TnI(X), 9 = 0, 
d = d/{x), c = c/{x), f = f/{x) and", = s/{x). 
• At x = 0 we will assume symmetry and impose zero flux, conditions which become 
an -0 
ex - 1 af =0 and ax 
as _ 0 
ex - 1 
noting that there is no chemotactic contribution due to g~ = 0 as the initial wound 
occurs. 
• At x = L we assume healthy skin where n = n0 1 / = /01 C = COl 8 = 80, d = dOl m = 0 
and 9 = O. 
5.3.4 Model Para'meters 
Table 5.2 lists the model parameters, giving their biological interpretation and where possible, 
an estimate from literature which closely resemble those used. The experimental values are 
highly dependent on control conditions imposed and purposes of research, which can result in 
great variation across studies. In many cases, especially for the diffusion coefficients \\'e can 
obtain multiple values. In addition to those stated in Table 5.2, other values for D'll Dc, DJ 
and D, [60, 82, 921 are, 
• Dn = 1.9 X 10- 12 mm 2 h- 1 vs. 1.26 x 10-:1 mm-2 h- 1 in Table 5.2. 
• Dc = 7.2 mm2 h- 1 vs. 0.18 mm2 h- I in Table 5.2. 
• DJ = 6.12 X 10-5 mrn2 h- 1 vs. 3 X 10-4 in Table 5.2. 
• Ds = 0.44 mm2 h- 1 vs. 0.01 rnm 2 h- 1 in Table 5.2. 
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Parameters Description Units Values 
L \Vound size mm Varies 
Dn Diffusion coefficient of n mlll2 le l 1.26 x 10-:1 [92] 
Xn Chemotaxis coefficient of n mm" (gh)-I -
an Chemotaxis ratio of 11 for 9 Dimensionless -
(In n birth rate mm' (gh)-I -
"(ncs n cell birth constant g 1ll11l-2 h- 1 -
" 
Keratinocyte threshold mm -n 
"Ine n inhibited by nutrient availability g mm-2 -
one n cell death rate from lack of nutrients h- I 8.75 x 10-" [39] 
oml m removed by fibroblasts mm' (cells h)-I -
Om, Enhanced removal constant of m due to s mm4 (g h cells)-I -
Om Natural decay rate of III h-1 8.3 X 10-4 [Ill] 
(Jg'l Enhanced 9 production rate due to s mm5 g-' (cells h)-I -
Oge 9 loss rate due to lack of c mm" (gh)-I -
(JgI 9 production rate by f mm1 g-' (cells h)-I -
ii Critical signal concentration g mm-2 
-
C Critical nutrient concentration g mm-2 -
DI Diffusion coefficient of f 111m2 h- l 3 x 10-4 [60] 
XI Chemotaxis coefficient of f mm3 (gh)-1 -
al Chemotaxis ratio of f for 9 Dimensionless -
(JIb f infiltration rate from vasculature cells 111m-2 h- 1 -
Pb Vascular nutrient source constant Dimcnsionless -
"Ib Critical vascular nutrient source constant mm Varies * 
'1 Nutrient source function exponent Dimensionless -
(Jle Fibroblast birth rate mm 2 (gh)-1 -
"I Fibroblast threshold cells 1111ll-2 1 x 10-" [12] 
(J/cs Enhanced f birth rate due to signal mm' (g h)-I -
"Iics f production rate by signals cells mm-2 -
°le Fibroblast death rate h- I 2 x 10-4 [82] 
PI Fibroblast death rate constant Dimensionless -
De Diffusion coefficient of c 111m2 h- 1 0.18 [111] 
(Jeb Nutrients source rate from vasculature g mm2 h- 1 -
Qen Nutrients consllmption rate by n 111111- 1 h- 1 0.5 [!3] 
oel Nutrients consumption rate by f mm' (cells h)-I -
D, Diffusion coefficient of s mm 2 h-1 0.01 [92] 
(J,n Signals production rate by n g mm-2 h-1 -
(JSSll Further signal secretion rate by n (mm h)-I -
(J,I Signals produced by f g (cell h)-I 4.2 x 10-9 [I :J6] 
(Jssi Further signal secretion by f mm2 (cells h)-1 -
(J,e Signal production rate due to lack of c Dimensionless -
(J,m Signals release rate from m g 111111-2 h- 1 -
!i Critical granulation tissue density nun -
0, Decay rate of signals h- 1 . 0.1 [60) 
o,n Signal consumption rate by Tt (nun h)-I -
0'1 Signal consumption rate by f mm' (cells h)-I -
Table 5.2: .For illustrative purposes, the uIlits are taken to be time (hours), distance (mm), mass (g) 
and "cells!',- hence the UllitS of n, d, m and g arc mm, sand care g/mm2 ad J is ceJJs/mm2.'" ,b will 
depend on l'arious factors including location of "'ound and other chronic illnesses such as diabetes. 
f3&m is mriable and depends on extent and quality of clot. 
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Equivalent 
Parameters Experimental Value Dinlensionless Value 
to 24 hours 1 
Xo 50 mill 1 
no 0.01-2 HUll [401 1 
mo - -
do 1-5 mm [111 1 
go - -
10 10-(; g 111111-" [1111 1 
Co 5.4 x 10-0 g mm-" [1111 1 
So 10- 11 g mm-:l 1 [llll 
Table 5.3: Dimensionless parameters miues for the healthy skin state. 
Paranleters Dimensionless Value 
Dn 1 
on, 0.21 
Om 1.9 X 10-2 
Df 0.238 
"1 10" 
Of' . 4.8 X 10-3 
D, 142.9 
Om 9 
D, 7.9 
(3'1 0.01 
0, 2.4 
Table 5.4: Dimensioniess parameters values for the experimental data obtained. 
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5.3.5 Nondimensionalisation 
\Ve nondiJllcnsionalised the model based on the keratinocyte birth rate ('"" 1 / f3l1co) for the 
timescale and the distance these cells diffuse during t.his period (~ VDnl/3nco), 
\Ve rescale using 
(5.16) 
(5.17) 
(5.IS) 
(5.19) 
(5.20) 
(5.21 ) 
(5.22) 
(5.23) 
(5.24) 
(5.25) 
The nonclimensionalisation of a system forces the steady states for the healthy skin cOllditions, 
and the variables n, J, C, and s are normalised so that they are equal to unity; this implies the 
following parameter relationships 
I n , =-1/: (I - ~) (I + llin,), 
"fnes Kn 
J t, = (/3 tbkb( 1,0) + /3 t, ( I - "IJ) (I + (I + Pt))1' t")' 
/3,b = {J,b = (J:" + Jot), 
eo{Jn kb( 1,0) 
~ 08~ A A A A A A 
8s =-{J = {Jan + {3ssn + {3sf + {Jss! - Oan - Os!, 
eo " 
and the climensionlcss parameters arc given in Table 5.5. 
S9 
(5.26) 
(5.27) 
(5.2S) 
(5.29) 
Dropping the hats for clarity, the nondimensionalised system is given below 
1 + (c + P[s)!"![,, 
ac a'c 
at =D, ax' + {J,bkb (d, 9) - c( 5,n n + 5,[ J) 
8s a2 s ~ 
at =D, ax' + (n({J,n + (J"n s ) + !({J,[ + {J,,[s))(1 + (J"Jl(c - c)) 
+ (J,mrn - s(5, + 5,nn + 5,[j). 
The corresponding initial and boundary conditions are 
t = 0: 
x = 0: 
X= L: 
n = nl(x),! = h(x), d = dt(x), S = Sl(X), C = Cl(X), m = 9 = O. 
8n -0 QL-O Bc -0 as_O ex - ) ax - '8x - '8x - , 
n=!=c=s=d=l,m=g=O. 
(5.30) 
(5.31) 
(5.32) 
(5.:13) 
(5.35) 
(5.36) 
The nondimensionalised system given by equations (5.30), (5.31), (5.32), (5.33), (5.34), (5.35) 
and (5,36), with corresponding initial and boundary conditions will be investigated numerically 
in Section 5.4.2. 
5.4 Model Analysis 
5.4.1 Numerical Methods 
1b solve the nonlinear PDE system we used finite difference schemes, in particular central 
differencing in space and standard explicit forward Euler time-step in time. The methods 
were encoded using Fortran. H.efer to Appendix A.3 for marc details on the schemes applied. 
\Ve will consider different scenarios by highlighting important parameters that will change 
healing behaviour which will be compared to the normal and expected repair process. 
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Para.neters Values Parameters Values Parameters Values 
L 40 DI 0.5 "I 1.1 
Xn 0.001 XI 0.01 f3!e8 3.0 
an 1.0 al 1.0 'Y!C8 1.0 
'Ync8 1.0 Pb 0.6 ale 0.4 
ton 1.2 (JIb 0.04 PI 1.0 
'1ne 1.0 '!b 0.6 De 1.5 
one 0.2 0," 0.4 (Jcb 1.0 
amI 0.2 0'1 1.0 0= 0.2 
om, 0.05 {381n 6.0 Oel 0.6 
Om 0.0 ii 0.3 D, 1.5 
(Jg, 0.4 0, 0.64 (J,n 0.2 
age 0.0 ry 10.0 f3ssn 0.2 
(JgI 0.3 (Jle 0.8 (J'I 0.8 
S 3.0 {388! 0.2 C 0.3 
(J,e 0.4 
Table 5.5: Standard set of parameter values IIsed in simulation for norJlllll healing. 
5.4.2 Results 
Table 5.5 presents the standard set of parametcr values applied for the ~~Ilormal healing case" 
and will be discussed below. Following this. the main parameters we investigate the effects of 
are 
• "'Ib - which determines the nutrient delivery to th~ wound hence descrihes the extent and 
efficiency of the vascularisation . 
• {3sm- which describes quality and extent of clot. formation. 
Normal Healing 
Figures 5.6 -5.12 shows model solut.ions for a successfully healed wound using the standard 
paramct.er set given in Table 5.5. The results show that the profiles form into travelling \vave 
(T\V) fronts, moving right to left from healthy (repaired/uninjured) denoted by x = 40 to 
unhealthy (injured) skin at x=:o as indicated by the arrows. 
The injured wound corresponds to x E (0,32) and the initial conditions are as follows 
0<x<32: 
32 S x S L: 
n = 0, c = 0, f = 0, s = 1, m = I, d = 0.1 and 9 = o. 
n=d=c=s= I,g=ln=O. 
Figure 5.6 shows the distribution of GP at equal time steps, demonstrating a retreating front 
towards x = 0 of elevated s within the wound. The increase in GF levels exceeds the thresh-
old seen in normal skin, and initiates the wound healing cascade of events by recruiting 
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Figure 5.G: Evolution of signal concentration (s) in steps of t = 6 llsing parameters given in 
Table 5.5. 
repair/imrnlln.e cells to the affected area (Figure 5.7L which in turn lays down granulation 
tissue (Figure 5.8). In this simulation the recruitment of f is from the healthy surrounding 
tissue, which generates a chemotactic peak at t.he edge of the wound. Because n ~ 0 and 
f ~ 0 in the wound domain: the maximum signal concentrat.ion can be found from (5.3G) to 
be 
f3smm 
8 = ---r;-l (5.37) 
which approximates to 8 ~ 9.4 llsing the values in Table 5.5. 
From Figure 5.8 we observe granulat.ion tissue produced by f is consistent in t.he wound 
medium and fills the wound space but is raised at the wound edge (which is common is any 
wound), where x = 32. We expect the wound edge to harden during and after repair in 
a ;(rear' wound, which will eventually contract and return to normal skin level with time. 
The non uniformity of the granulation tissue is interesting, and perhaps OIle of t.he reason as 
to why the remodelling process in the maturation phase can lead to scar tissue formation. 
This behaviour was not incorporated into the model, but is predicted naturally as a model 
solution. 
From Figure 5.9 wound recovery is obtained with vasculature providing 80% of the llutrients 
of healthy tL.'iSue, and the wound domain (d + Pbg) > '"'fb = O.G; indicating successful revascu-
larisation as gmnulation and dermal tissue, are adequate to support successful angiogenesis 
to resupply nutrients for healing to take place (sce Figures 5.8 and 5.12). It should be noted 
that there is a noticeable gap at x ~ 32 (see Figure 5.9 compared to excess 9 in Figure 5.8) , 
where a small amount of granulation t.issue is laid down and suggests nutrients sources from 
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Figure 5.7: Evolution of fibroblasts/immune cell density (f) in steps oft = 6 using parameters 
given in Table 5.5. 
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Figure 5.8: Evolution of granulation tissue thickness (9) in steps of t = 6 using parameters 
given in Table 5.5. 
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Figure 5.9: Evolution of vasculature (k) in steps of t = 6 using parameters given in Table 5.5. 
vasculature arc adequate here. 
Keratinocytes are responsible for re-epithelisation and cells migrate from the wound edges, as 
shown in Figure 5.10 over a pcrfllsed domain defined by adequate nutrient alld granulation 
tissue levels. Consequently the whole wound is eventually covered by the epidermis, enabling 
the wound to progress to the maturation phase and restore the skin's barrier. 
As normal healing persists, wc see from Figure 5.12 that the damaged dermis retreats, being 
replaced by granulation tissue tUld eventually the epidermis as shown in Figures 5.8 and 5.10. 
In this simulation the fEw8Scuiarisation and nutrient. supply within the healed domain are 
slightly lower than t.hat of the healt.hy skin. There is paucity of quantitat.ive data in the 
literature, regarding whether the levels in a healing wound should be above or below that 
of healtllY skin. Though it is st.raightforward to change the predicted nutrient supply by 
appropriately adjust.ing parameters Tb and {lb· 
\Ve observe from the results that dermal recovery and wound closure are obtained, with a 
healing speed of::::: 3.2 and is completed within t -;:;;: 16 days. This accounts for repair from 
initial damage to wound coverage, replacing dermal aud epidermal tissue in the normal hea.ling 
domain, for a partial/deep thickness wound. The healed wound is close to homeostatic levels of 
keratinocytes, nutrients, fibroblasts/iuunnne cells and signal levels. Adequate nutrient supply 
is obviously a key factor and effective to ensure skill hOlllcostasis and complete wound repair. 
The effects of a less efficient blood supply is explort~ next. 
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Figure 5.10: Evolution of keratinocytes thickness (n) in steps oft = 6 using parameters given 
in Table 5.5. 
Fignre 5.11: E\'olution of nutrient concentration (c) in steps oft = 6 using parameters given 
in Table 5.5. 
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Figure 5.12: Evolution of damaged dermis thickness (cl) in steps of t = 6 using parameters 
given ill Table 5.5. 
Effects of Poor Vasculature 
The importance of vascular efficiency of transporting nutrient to the wound is highlighted in 
Figures 5.6-5.12. Here the same parameters in Table 5.5 apply) except for the. vascular hill 
function parameter being /a ==:' 0.85 instead of Ib = 0.6; this represents a reduction in vascular 
effectiveness in delivering llutrients. These simulations could re~ect the circumstances of 
chronic conditions such as diabetes, where nutrient supply is severely impaired as a result of 
poor circulation. Figures 5.13-5.15 presents abnormal/non-healing wounds due to the increase 
in ')'b and the initial and boundary conditions remain unchanged. 
The figures show the healing process starting as normal i.e. similar to the previous simulation, 
but slows down and eventually tends to steady state. The lack of wound closure (right simula-
tion of Figure 5.15) indicates a failure of wound healing in this simulation. Despite signal levels 
(see left simulation of Figure 5.13) approximately the same within the wound 8..') in Figure 5.6, 
produced by the "dead material" (see right of Figure 5.14) and dispersing into a large propor-
tion of the injured medium; and other dermal components are unable to sustain this supply. 
Fibroblast/immune cell levels at the edge of the wound are initially high (right simulation 
in Figure 5.13), however insufficient granulation tissue is being laid down to support a func-
tioning vasculature (Figures 5.14). Consequently inadequate nutrients infiltrate the wound 
(Figure 5.15), which disallows cell activit.y, migration, tissue growth and signal usage beyond 
the localised wound edge within the region of x E (20,32), as they are unable to function 
normally or recruit further reinforcements to the wound area (Figw·es 5.13, 5.14 and ,5.15). 
We note, in this simulation that €Schar material does not decay naturally, and hence remains 
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Figure 5.13: Evolution of tlw (left) signals concentration (8) a.nd (right) fibroblastsjimII1ImB 
cell density (f) in steps oft = 6, using values ill Tahle 5.5 except for Ib = 0.85. 
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Figure 5.14: Evolution of the (left) graJltIlatioll tissue thickness (9) (middle) Vasculature (k) 
and (right) daJIlaged dermis thickness (m) in steps of t = 6, using values in Table 5.5 except 
for Ib = 0.85. 
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in the unhealed part of the wound; there being insufficient nutrients for fibroblasts/immune 
cells t.o penetrate and degrade it. (see right simulation in Figure 5.14). 
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Figure 5.15: Evolution for (left) nutrient concentration (c) lilld (rigllt) keratinocyte thickness 
n in steps of t = 6, using values in Table 5.5 except for {b = 0.85. 
The results here shows the crucial role of supplying nutrients to the wound area to drive the 
healing components. A small shift ({b = 0.6 t.o {b = 0.85) of vascular effect.iveness due to 
for example, poor circulation can lead to significant differences in the wound healing process, 
result.ing in non-healing profiles and wound closure failure. 
Bolus Treatments to Promote Healing 
We can attempt t.o restore normal wound recovery or prom.ote vascularisation to t.he non-
healing wounds presented in Figures 5.13-5.15 by focusing~:m key components, namely fibrob-
lasts, signals and imtrient.s both indepeudently and/or comb~ned to sce the effects on t.issue 
production, vasculature and re-epithelisation. \Ve will retain {b = 0.85 from the previous 
Simulation, but. to emphasi')e the features, the simula.t.ion here are performed on a domain size 
of L = 20 and a wound domain of size x E (0,16). change to the wound environment, by ma-
nipulating initial concentrations in the wound site. In this section we simulate the treatments 
detailed below. 
1. Introduce bolus of fibroblasts/immulle cells f(x,O) = 10 into the wound site as shown 
in Figures 5.16-5.21 (left simulat.ions). 
2. Introduce bolus of GFs s(x,O) = 10 into the wound site, shown in Figures 5.16-5.21 
(middle simulat.ions). 
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3. Combined therapy of (1) and (2) into the wound site and simulations are given in Figures 
5.16-5.21 (right simulations). 
4. Introduce bolus of nutrients c(x,O) :::;:; 0.01 to the wound site and simulations are given, 
in Figures 5.22-5.24. 
We note from the left simulations in Figures 5.16-5.21 that the healing distance is about 
5 - la significantly less than 20, so wound closure will not occur. "Ve can interpret from the 
results that a poorly vascularised wound (-rb = 0.85) responds better to s(x,O) = 10 when 
compared to f(x,O) = la. Imposing equal densities/concentrations we a..<;sume GFs have a 
greater impact in the initial wound, which can be supported by the standard set of simulations 
(Figures 5.6 and 5.7). 
GFs enhance repair through greater infiltration of fibroblasts/immune cells and secrete further 
Rignals to the wound domain, which helps remove dehris although decays too quickly to allow 
wound closure. Treatment (2) dcmonstratcR f ::leaking" into 'the wound area, but they are 
not. sus~,ained hence impa.ct little on the overall healing profiles. Other dermal components arc 
inhibited as a result of treatments (1) and (2), where Jlut.rient delivery to the wound domain is 
limited and is defined by the vascularised regions which work in conjlUlct.ion with one another; 
enhanced by granulat.ion tissue growth and t.he retreat of the damaged dermis. The result.s of 
t.reatment (:~) explores combined applications of fibroblasts and signals at. t.he initial wound 
site, as presented in (right simulations) Figures 5.16-.5.21. 
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Figure 5.16: Evolution for fibrolJlasts/immune cell density (f) in steps oft = 2 using values 
in Table 5.5 except for 1'b = 0.85 and applying the following treatments (left) f(x,O) = 10 
(middle) s(x,O) = 10 and (right) f(x,O) = 10 and s(x, 0) = 10. 
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Figure 5.17: Evolution for signal concentration (8) in steps of t = 2 llsing values in Table 
5.5 except for rb = 0.85 and applying the following treatments (left) f(x,O) = 10 (middle) 
s(x,O) c= 10 and (rigl]t) f(x,O) = 10 and s(x, 0) = 10. 
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Figure 5.18: Evolution for nutrient concentration (c) in steps oft = 2 using values in Table 
5.5 except for rb = 0.85 and applying the following treatments (left) f(x,O) = 10 (middle) 
s(x,O) = 10 and (right) f(x, 0) = 10 and s(x, 0) = 10 
Introducing treatment (3) shows improvement to the wound domain: as cells (right simulation 
of Figures 5.17 and 5.20) are able to infiltrate deeper into the wound and coverage is greater 
than sand f applied independently. Granulation tissue within the vascularised region is 
deposited in great quantities, increasing the thickness which peaks immensely at the wound 
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Figure 5.19: Evolution for granulation tissue thickness (g) in steps of t = 2 using values 
in Table 5.5 except for'lb = 0.85 and applying the following treatments (left) f(x,O) = 10 
(middle) s(x,O) = 10 and (right) f(x,O) = 10 and s(x,O) = 10. 
edge and declines thereafter which is directly reflected by high signal concentrations within 
the healing domain, also the uutrient delivery and fibroblasts/imIllllIle cells made available 
(Figures 5.17 and 5.18). 
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Figure 5.20: E~rollltion for vasculature (k) ill steps oft = 2 using values in Table 5.5 except 
for'lb = 0.85 and applying the following treatments (left) f(x,O) = 10 (middle) six, 0) = 10 
and (right) f(x,O) = 10 and s(x,O) = 10. 
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Figure 5.21: Evolution for keratinocyte thickness (n) in steps oft = 2 USiIlg values in Table 
5.5 except for I'b = 0.85 and applying the following treatments (left) f(x,O) = 10 (middle) 
s(x,O) = 10 and (right) f(x,O) and s(x,O) = 10 . 
The fibroblasts/iIllIllUne cells available cannot be sllstained by the wound environment, and 
increase in both f and s limits distribution within the injun.'<l domain, resulting in insufficient 
granulation tissue deposition, vasculature <Uld Ilutrient supplies (Figures 5.18), as we can 
observe from Figure 5.21 (right simulat.ion) where \ .... ,QUIld closure has failed. These results 
do not differ much from inputting f alone, although it penetrates further as shown in Figure 
5.16 (left simulation). The nutrient distribution and vasculature prevents complete wound 
recovery, and cannot support the damaged region inellrred from injury. 
In treatment (4) we introduce a relatively small bolus of nutrients into the wound (from 
c = 0 to c = 0.01). We can see from Figures 5.22-5.24 that this has a remarkable effect 011 
healing, as it re-establishes the collective behaviour of dermal components, where the wound 
domain transposes from a hypoxic to a hyperoxic medium (see Figure 5.23) and improvement 
in vaseulature (sec Figure 5.24) ref!ects this. ThL<;; treatment expresses importance of perfusion 
to a compromised wound domain. 
We can conclude that.. a small supply of nut.rients at the wound sit.e sufficiently supplements 
t.hat. from vasculat.ure, and provides impetus to t.he repair process at the edges. These results 
arc comparable with standard healing seen in Figures 5.7-5.10. Applying signals or fibroblasts 
bot.h combined or independently, arc unable to provide the appropriate levels that remain 
consistent. t.hroughout the wound medium to stimula.t.e repair. The time for healing is t :::::: 21 
days with a healing speed of:::::: 0.8, and is slower than the standard case (sec Figures 5.G-5.10). 
The simulations in thL') section emphasises the vital role of nutrients in wound healing, which 
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Figure .5.22: Evolution for (left) signal concentration s (right) fibroblasts/immune ceJl density 
(f) in steps of t = 2 using ",lues in Table 5.5 except for ,. = 0.85 and applying treatment 
c(x.O) = 0.01. 
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Figure 5.23: Evolution for (left) nutrient COllcentmtioIl (c) and (right) granulation tissue 
thickness (9) in steps of t = 2 using values in Table 5.5 except for " = 0.85 and applying 
treatment c(x,O)=O.01. 
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Figure 5.24: Evolution for (left) vdSculature (k) (riglJt) kemtinocyte thickness (n) in stcps of 
t = 2 IJsing values in Table 5.5 except for "/h = 0.85 and applying treatment c(x, 0) = 0.01. 
can be supported by literature 12, 25, 34, 47, 1111. 
Effects of Poor Clotting 
The clotting mechanism is important for the initial stages of injury, providing a barrier of 
protection preventing further damage and allows healing to take place underneath. Wound 
healing can be pertmbed if the clotting matrix is Hot efficient, providing a poor foundation 
for wound bed preparation and may inhibit the onset of essential dermal and epidermal_activ-
ities ill the proliferative stage. Abnormalities in clotting cau develop in chronic wounds and 
investigation may also provide insight into platelet disorders (such as von \VillebranJ disease)' 
where haemorrhaging and thrombosis are common, although our interest lies in wound repair 
aspect of healing. 
In this section the standard parameter values in Table 5.5 apply bb = 0.6), apart from fJsm 
which is reduced to [3sm = 4 (from /3sm = 6). and implies that signal secretion from the dead 
material region is reduced. Figures 5.25-5.27 present. the effects of initial clot insufficiency and 
how this reflects on the overall healing process. 
The signal levels (left simulation in Figure 5.25) are approximately two thirds (here s ~ 6.2) 
of that seen in the normal healing C8.<;e (refer to Figure 5.6), and cannot suffuse the whole 
wound to sufficient levels for successful cell recruitment (fibroblasts/immune cells), or initiate 
clotting processes (right of Figure 5.25) beyond x'" 20 adequately (Figures 5.27). 
The low signal concentrations are reflected in the fibroblast/immune cell distribution, levels 
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Figure 5.25: Evolution of (left) signal concentration (8) (right) fibroblllSt/immune ce1I density 
ill steps of t = 6 using values in Table 5.5 except for /jsm = 4. 
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Figure 5.26: Evolution of (left) granulation tissue thickness (g) (middle) vasculature (k) and 
(right) damaged dermis thickness {m} in steps of t = 6using values in Table 5.5 except for 
f3am = 4. 
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Figllfe 5.27: Evolution of (left) nutrient conccntration (c) (right) keratinocyte tijickness (m) 
in steps of t = 6 Ilsjng values in Table 5.5 except for {ism = 4. 
that are lower than the normal density seen ill Figure 5.7 (/ ;::::: 2.5 here). The limitation 
011 f implies that granulation tissue formation is restricted, and the removal of the unhealthy 
tissue will be delayed (see right simulation in Figure 5.26), inhibiting angiogenesis and nutrient 
availability (left siumlations of Figures 5.26 and 5.27). 
It can he interpreted that the profiles resemble those observed when nutrient delivery was 
reduced. bb = 0.85) in Figures 5.13-5.15, although they arc even more localised to the wound 
edge and variable activities arc bounded, particularly not.iccable in the signals and damaged 
dermis distribution (Figures 5.25 and 5.27). Figures 5.26 and 5.27 demonstrate failure of 
wound closure of granulation tissue and recovery of the epidermis, the former leading to 
inadequate revascularisation and deficient Ilutrient supply (Figures 5.26 and 5.27). 
This simulatioIl emphasises the crucial role of the clott.ing scaffold within the cschar, during t.he 
process of healing via the release of GFs. TIle small reduct.ion of GF production rate by m, from 
(3sm = 6 to f3sm = 4 can result in wound healing failure. \Vc can conclude that an inefficient 
clotting scaffold only allows partial repair at the wound edges as s levels are insufficient with 
the inability the cover the wound, when proliferation processes arc stimulated. 
Nutrient Bolus Treatments for Poor Clots 
To investigat.e a means of restoring defects in healing as a result. of poor clotting qualit.y we 
focus on adding an initial bollL'i of nutrients of c(x, 0) = 0.01 as before. It. was found from the 
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Figure 5.28: Evolution of (left) fibroblasts/immune cdl density (I) and (right) signal concen· 
tration s in steps oft = 2 llsing values in TabJe 5.5 except for f3sm = 4 and applying treatment 
c(x.O) = 0.01. 
previous simulation.') when '"'Ib = 0.85 that applying Hand f independently or combined, did 
not retrieve the normal healing path and we will only cOllsidcr the nutrient treatment. The 
results arc shown in Figures 5.28-5.30. 
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Fignre 5.29: 
in steps of t 
c(x. 0) '= 0.01. 
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Evolution of (left) granulation tissue density (g) and (right) va,culature (k) 
2 (using V"dlucs in Table 5.5 except for f3sm = 4 and applying treatment 
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Fignre 5.:~O: Evolution of (left) Ilutrients (c) and (right) keratinocyte thickness in steps oft = 2 
((3sm = 4) using values in Table 5.5 except for f3sm = 4 and applying treatment c(x! 0) = 0.01. 
Applying c to the wound site, immediately improve~ the wound domain as f migrates into 
the region, and encourages cell secretion as presented in Figures 5.28 and 5.30. This allows 
. new tissue growth once cschar/clot has been fCplaced. This reinstates vascular ability of the 
wound area ena.bling efficient nutrient delivery to the whole wound area, as shown in Figures 
5.29 and 5.::l0. The integrated variable efforts to restore healing ensures that a suitable scaffold 
is provided for keratinocyte to migrate over and allow wouud closure, presented in Figure 5.30 
(left simulat.ion). 
Wc can conclude from the a.bove rcsults that an inefficient clotting matrix created by a small 
reduction in /3sm (/3S11I = 6 to fJsm = 4) can disrupt the healing process, and provid~ similar 
behaviour to those seen in a poorly vascularised wound when 'Yb = 0.85 (Figures 5.13-5.15). V\7e 
found that healing was restored with additional nutrients at the wound site, which compares 
well with the healing traits in a poorly vascularised wound as it provides the stimulus for 
complete recovery. 
Varying Wound Geometry 
So far wc have only considered the rather ideal rectangular shaped wounds and to attain 
greater insight into healing behaviour, more irregular wound shapes call be examined. In this 
section a more rounded wound bed prescntt.>d in Figure 5.:n, will be investigated in the same 
domain as before (Figure 5.~1) by varying d(x, 0) which defines the wound edge at. t.he init.ial 
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injury, given by 
(X)' d(x,O)=dmin+(I-dmin) L ' (5.38) 
to see how this alters the healing behaviour. In (5.32), dmin is the lowest point in the wound 
and the exponent <;" governs the stt>cpncss of the damaged area. \Ve apply <;" = 1 and dmin = 0.1, 
for the following simulations presented in Figures 5.32-5.34. The standard parameters in Table 
5.5 apply and we manipulate 'Yb to determine a relationship, if any between wound shape 
and vascularisation and we compare the standard (-rb = 0.6) and poorly va.')cularised cases 
Cl'b = 0.85). 
The healiI~g process differs little from the standard simulation, presented in Figures 5.6-5.11 
for the rectangular wound case. The major dispa~ities appear in the deposition of granulation 
tissue at the wound site (Figure 5.34), where the ::raised" tissue (which peaks) call be seen 
across t.he wound domain (x E (0,10», and is not localised at t.he edges (Figure 5.8). Fibrob-
last/immune cell levels peaks to f ~ 5 (see Figure 5.:13) at the wound edge, which is greater 
than the standard simulation ill Figure 5.7. This supports and furthers the stimulation of 
vasculature, which ((dips" at x = 10 although retains high levels thereafter and resembles the 
rectangular wound bed in the region of 0 :$. x < 10. The components allow re-epithelisation 
hence wound closure (sec Figures 5.:{2). 
A wound of this shape retains healthy tissue underneath t,he dalIlaged area for x E (0,32) 
(Figure 5.32) and could contribute the healing process especially in a poorly vascularised 
wound. By changing rb froIll normal to the poorly va...qcularisoo case, where "Yb = 0.85 as given 
in Figures 5.35-5.36, we can compare the simulations to the rectangular wound case (Figures 
n= no 
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Figure 5.31: Schemiltic of the wound domain after change is jmposed to the, wound bed and 
imposing the idealised conditions from the standard simulation. 
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Figure 5.32: Evolution of (left) keratinocyte thickness (Tt) (middle) normal dermis thickness 
(d) and (right) damaged dermis thickness (m) in steps oft = 6 using values in Table 5.5 and 
we apply <; = 1. 
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Figure 5.33: Evolution of (left) signal concentmtion (8) and (right) fibroblast!immune cell 
density in steps oft = 6 using \'ruUe5 ill Table 5.5 a1J(I we apply" = 1. 
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Figure 5.34, Evolution of (left) granulation tissue tlIickness (g) and (right) vasculature (k) in 
steps of t = 6 using vdlues in Table .5.5 and we Hppl)' C; = 1. 
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Figure 5.35, Evolution of (left) signal concentration (s) (middle) fibroblast/immune cell den-
sity and (right) damaged dermis thickness (m) in steps of t ~ 6 using values in Table 5.5 
except for "Ib = 0.85 and we apply c; = 1. 
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Figure 5.36: Evolutioll of (left) grallulatioll tissue thicklless (g) (middle) ya,culature (k) alld 
(rigllt) keratinocytc thickl1csS (11.) in steps of t = 6 using values in Table 5.5 except for rb = 0.85 
and we apply <; = 1. 
5.6-5.11). \Vc observe that reducing vascular efficiency in a wound of this shape has the ability 
to successfully heal (see Figure 5.:W). Appropriate signal and fibroblasts levels (see Figures 
5.35 ) are available to t.he wound domain, although granulation tissue formation is slightly 
lower (g;:::;: 0.75) when compared to the normal simulation in Figure 5.:!4. In both cases using 
the exponent.;;- = 1) bb = 0.6 and "rb = 0.85) the damaged dermis retreats and re-epithclisation 
takes place, indicating a relationship between wound shape and healing. 
To investigate further the healing dependency on the wound bed shape, we increase the expo-
nent to c; = 2 which reduces steepness of the damaged region hence healt.hy tissue surrounding 
the wound. The simulations are given in Figures 5.~n-5.38 for the poorly vascularised case, 
hence when ib = 0.85. 
Healing fails when we increa.'3C t.he exponent (c; = 2); although wound coverage is greater than 
the rectangular non-healing case (Figures 5.13-5.15) and the appropriate signals levels and 
supporting vasculature are observed (Figures 5.37 aud 5.38). The fibroblasts/immune cell 
density peaks to f ~ 4.5 and declines steadily to the non-healing steady state near the wound 
centre (x = 0). This allows granulation tissue format.ion in the vascularised region (Figures 
5.:n and 5.38). \VolUld closure is not achieved, howcver~ and only a small region remain" 
unhcaled for x E (0,10). 
The simulations in this section suggest that varying wound geometry has a significant impact 
on the wound healing behaviour. and we have shown that wound closure is successful in a 
,. -
poorly vascularised domain of a shallow wound where <' = I, as the healthy tissue underneath 
112 
stimulates healing of localised deep tissue areas. R(.'(iucing the steepness of the damaged area 
impedes wound closure by leaving a small area unhealed. 
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Figure 5.37: Evolution of (left) signal concentration (8) (1IIiddle) fibroblast/immune cell den-
sity and (right) gmnulatioJl tissue thickne..<>s (9) in steps of t = 6 using values in Tllblc 5.5 
except for 1b = 0.85 and we apply <;" = _2 
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Figure 5.38: E\'Olution of (left) vasculature (k) (middle) kemtinocyte thickness (n) and (right) 
normal dermis tbickness (d) in steps oft = 6 using values in Table .5.5 except for 1b = 0.85 
and we apply,' = 2. 
In 
Topical Application of GF 
Up to now, the model predicts that the crucial elements in healing arc the nutrient supply 
and GFs from the clot as seen in Figures 5.13-5.15 and Figures 5.25-5.27~ where non-healing 
occurs. Bolus treatments of GFs and fibroblasts are relatively uIlsuccessful~ when applied 
to the initial wound site. In practice it may not be favourable to maintain the cschar, as 
wound debridement may be necessary to keep the area clean and free from infection. In this 
section we investigate the topical application of GFs to a poorly vascularised wowld defined 
by "Ib = 0.85: e.g. from a specially designed wound dressing. This will compensate for loss of 
signal source from the blood clotted material, and secrete further signals to the injured area. 
\Ve extend the signal equation to describe the additional infusion of GFs with the introduction 
of a source term 
{3,H(n - 11), (5,39) 
so that the s equation becomes 
88 8's _ 
fJt =D, 8,,' + (n(r;,n + {3,w) + f({3'f + {3"f ))(1 + {3<eH(c - c)) (5.40) 
+ {3,mm + {3,H(n -11) - 8(8, + 6,n1l + 8'f f), 
where f3s represents the signal infusion rate so that the additional term provides a ::drip-feed" 
of GFs in a wound defined as n < n. We have assumed that infusion L" only possible if the 
keratinised layer is relatively thin i.e. n < n; the Heaviside function here implying 
H(n - n) = { ~ if 11 < ii (GF application needed) 
if 11 2: n (GF does not penetrate). 
In this simulation we assume wound debridement removes the dead material in preparation 
for GF application, which is. denoted by m(x,O) = 0 and that signals present at the wound 
domain arc also removed during this process hence f3sm = O. Parameters in Table 5.5 apply 
and we use ::mode.'it" infusion rate of fis = 2 and let ii = 0.3. The simulations for signals, 
fibroblast.s, granulation tissue and keratinocytes are presented in Figures 5.39-5.42. 
The simulat.iolls show a snccessfully healed wound as keratinocytes are able to migrate over the 
wound area. to ensure closure, enabled by adequate signal presence in t.he wound (Figure 5.39), 
to recruit fibroblast.s/immune cells to t.he damaged area (Figure 5.40). Wc note t.hat signal 
levels here (8 ~ 3-5): arc somewhat lower that in the normal healed case where s ~ 9 (Figure 
5.6). Granulation tissue production is apparently over stimulated as a result (Figure 5.41) and 
larger deposits are observed wit.h 9 ~ 1.7 as opposed to 9 ~ 1 in the normal case (compare 
to Figure 5.8). \Vith "Ib = 0.85 and Pb = 0.6, more granulation tissue is needed to provide 
the adequate dermal tissue for an effective blood supply, which may offer an explanation to 
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Figure 5.39: Evolution of signal concentration (s) in steps of t = 6 after GP applica.tion where 
(3.~ = 2 and we use values in Table 5.5 except for 'Yb = 0.85. 
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Figure 5.40: Evolution of flbroblasts/immune cell density(J) in steps of t 
application where f3s = 2 and we use values in Table .5.5 except for I'b = 0.85. 
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Figure 5.4l: Evolution of graIlUlatioll tissue density (9) in steps oft = 6 after GF application 
where f3s = 2 and wc use values ill Table 5.5 except for rb = 0.85. 
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Figure 5.42: Evolution of kcratinocytes thickness (n) in steps of t = 6 after GF application 
where f3s = 2 and we use values in Table 5.5 except for "fb = 0.85. 
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increas(.>d levels observed above. 
We can conclude that clinical application of GFs in a non-healing wound can activate the heal-
ing components, to restore the normal healing processes and successful re-epithclisation. 
Surface Nutrients 
The bolus nutrients have been successful in the compromised healing scenarios considered and 
presented in Figures 5.28-5.:~O), although up until now atmospheric nutrients present at the 
wound surface (imposed. as a boundary condition) have not been investigated. Continuous 
oxygen (02 ) consumption in the wound tissue allO\\'s healing to progress, and encourages the 
wound to become resistant to infections. Therapy based on O2 treatments, applied either 
locally or through a hyperbaric chamber improves epithelial recovery and polymorphonuclear 
fUllctjom; in removing necrotic tissue [46, 48]. 
If we extcnd the nutrient equatioll to include sur~ace nutrients (resembling hyperbaric chanl-
bers) with the introduction of the source term 
Q(Co - c)H(n - n), (5.41) 
and wc write 
(5.42) 
whcre Q represents transfer coefficient of nutrients into the wOlmd domain and CO are the 
critical nutrient concentration at tile wound surface. Infiltration into the wound domain will 
depend on the thickness of the keratinised layer (n < n.) defined by the heaviside function 
given in (:).:~9). Parameters in Table 5.5 apply and we impose n = 0.3 and the critical nutrient 
concentration Co = 1.0. The simulations presented in Figures 5.43 and 5.44 illustrate the 
different healing profiles for both nutrients and keratinocytes, when the transfer coefficient 
differs and Q = 0.0001 and Q = 0.1 arc invest.igat.ed. 
It can be interpreted from Figures 5.4:~ and 5.44 (left. simulations) that an inadequate atmo-
spheric nutrient supply (Q = 0.0001) results in a retarded wound, which is deprived of essential 
oxygen concentration and may be unable to reach the deeper wound area. This could be ex-
plained by debris or necrotic tissue t.hat accumulates on t.he wound surface and may prevent 
oxygen entering the damaged. domain. Increasing the transfer coefficient to Q = 0.1 (as pre-
sented in right. simulations of Figures 5.43 and 5.44) helps restore the healing profiles as we 
would expect in a normally healed wound. This additional supply or abilit.y t.o enter the wound 
may help remove debris and initiate many of the key healing processes, as the wound is highly 
perfused and encourages processes such as vasculature and wound coverage (right simulation 
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Figure 5.43: E\'ollltion of kcratillocytc tlIickness (n) in steps of t = 6 using values in Table 5.5 
and (left) q = 0.0001 a11(l (rigllt) q = 0.1. 
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Figure 5.44: Emlutioll of nutrient concentration (c) in steps oft = 6 using values in Table 5.5 
and (left) q = 0.0001 and (right) q = 0.1. 
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in Figure 5.44). 
The delayed healing profiles presented in Figures 5.43 and 5.44 (left simulatiolls), can be 
compared to previous results presented in earlier sections when vasculature (refer to Figures 
5.25-5.27) and the clotting matrix (refer to Figures 5.13-5.15) \vere impeded and healing was , 
greatly affected. In these compromised healing cases) we found that bolus nutrients helped 
retrieve the normal healing course and enabled full wound recovery and essentially highlights 
the importance of this variable in the wound healing phenomena. Our findings frolll this 
section suggests that atmospheric nutrient delivery in the host tissue, contributes to the healing 
process provided the transfer nutrient is of a sufficient quantity to allow wound debridement 
and the keratinised layer supports the nutrient delivery within the damaged region. 
Overall we can conclude that nutrients play a vital role in the wound healing process whether it 
is obtained atmospherically or as a bolus treatment to a severely impaired/delayed wound and 
can restore norlllal healing profiles, provided debridement is effective minimising the necrotic 
tissue that Illay accumulate. 
5.5 Summary 
This chapter explored the loss of deep skin tissue referred to as partial/full thickness wounds, 
where both the epidermal and dermal membranes are removed. A simple model was proposed 
describing dermal behaviour during the proliferative and repair stages of wound healing and 
the overall healing process was key to this model. The model investigated collective and in-
teractive behaviour of fibroblasts, keratinocytes 1 granulation tissue, signals, nutrients, healthy 
and unhealthy wound area as healing persists. Influx of cells, nutrients and signals was ac-
counted for by diffusion and chemotaxis termsj consequently a large number of parameters 
(approximately 45 parameters in the standard simulation) are inputted into the model to 
accommodate for the key healing components. 
The resulting 1 D reaction-diffusion model was solved numerically in Fortran, and si1l1ulations 
presented in this chapter illustrate normal (refer to Figures 5.6-5.12) and abnormal healing 
scenarios (delayed or arrested healing). The key parameters 
• 'Yb defines the nutrient delivery to the wound domain and determines vascular efficiency 
and 
• f3sm describes the quality and extent of clotting, 
were investigated to highlight the normal and delayed cases. It was found that small reduction 
("'fb = 0.6 to"'fb = 0.85) in nutrient delivery hru;l detrimental effects on the vascular effectiveness, 
inhibiting granulation tissue growth, cell migration and callsing healing arrest (refer to Figures 
5.13-5.15). Similar behaviour was observed after reduction in clotting ability hence f3sm = 4 
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(refer to Figures 5.25-5.27 ), where lower signal concentration available to the wound domain 
and localised cell migration near the wound edge also delayed wound healing. 
Retrieving the delayed/arrested healing using bolus treatments was the most successful with 
nutrients in both cases. The simulations suggest. the role of nutrients are critical and even 
small amounts available in bolus form can make the difference between healing and non-healing 
(refer to Figures 5.22-5.24 and 5.28-5.30). This is supported fUI."ther by atmospheric nutrients 
which improve the healing ability when the transfer coefficient is adequate, enabling tissue 
perfusion and promote wound closure (refer to Figure 5.43 and 5.44). In contrast, a bolus 
of GFs is less effective, but a continuous influx provided naturally by the clot components 
of the esehar or artificially from a special dressing can restore the normal healing course. In 
reality a single nutrient or GF is unlikely to have such a notable effect as nucleated by the 
model simulations, however a suitable mix of nutrients and GFs planted in the wound could 
significantly enhance healing and revert a chronic wound scenario. However, the modelling 
of lllultiple nutrients and GFs is beyond the scope of this study and we present this as a 
hypothesis based on, the results of the model. 
\Vound shape was also shown to be an important factor when considering nutrient delivery 
"tb, where shallower, healthier tissue surrounding the wound can help promote the healing of 
neighbouring deeper parts of the injured areas, even when vascular efficiency is compromised 
as illustrated in Figures 5.35-5.36. 
The results obtained provide awareness into realistic behaviour and reproduce dermal healing 
scenarios, during the proliferative and repair stages to maintain skin homcostasis, emphasising 
the significant role of nutrients. To simplify the modelling we concentrated on the most 
significant components to demonstrate normal healing characteristics and excluded et number 
. of factors believed to be important, such (IS 
• Bacterial invasion and infections. 
• PH levels and toxicity of wound fluid. 
• Body temperature. 
• Independent GFs and their influence on healing processes. 
• Individual nutrient constituents. 
The first of these is probably the most significant and bacterial infection will be considered in 
the next chapter. 
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Chapter 6 
Bacterial Infections 
6.1 Introduction 
Once damaged skin is exposed to the external environment, it will naturally come into call-
tact with micro-organisms such as the bacteria. Examples include Staphylococcus Al/rellS, 
Streptococcus spp and Pseudomonas AerugiJ]osa. They are routinely removed by the immune 
system to allow complete wound recovery, as discussed in Chapter 1. Figure 6.1 presents the 
normal stages of healing from injury to wound closure and successful removal of foreign bodies 
entering the damaged area. Deep wound tissue provides an ideal habitat for bacterial inva-
sion. This may impair wound bed preparation and contribute to chronic wound development) 
if unattended or with insufficient wound management. The severity and spread of infections 
is often dependent on the wound size and anatomical location (2, 8, 18,53, 71, 116]. 
J'vIany species of infecting bacteria metabolise nutrients both aerohically and anaerobically, 
with the ability to adapt to hypoxic conditions resulting in overabundant bacterial burden or 
critical colonisation in the affected area. Invasion can delay the healing process and in some 
cases patients become unresponsive to antibiotic or other available treatments. l'dicrobial 
infections are an important part of the wound healing process, and can be the major cause of 
chronic wounds (25, 26, 34, 71J. The dermal model seen in Chapter 5 is extended here with 
the introduction of bacteria into the system, to investigate their role in the wound healing 
process. 
121 
• Ha" 
Epidermis 
L 
~m'{ ::=~9~~~~~~~~t:~~! ,~=:. 
" I gland 
b 
PI.I("lel 
NtjluhQPhiI 
MOnOCY,e/ / 
Macrophage 
c 
Sebaceous 
aland Cot agen Capillary 
G,..nuldtro", 
tl",we 
Figure 6.1: Normal wound bealing in tbe presence of bacteria. (a) Infl8DlDlation- 3 fibrin dot 
is formed and an abundance of bacteria, neutrophil, and platelets. (b) Fibroblast migration 
stullulates grllDulation tissue formation and angiogCllesis. (c) Re-epitbeJisation and wound is 
contracted altbougb remodelling underneatb wjJJ continue. This diagram bas been reproduoed 
witb tbe permission of Sabine Werner [53}. 
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6.2 M athem atical Modelling 
6.2.1 Model B ackground 
The addition of bacteria changes the model slightly. as wotmd debridement and removal of 
necrotic tissue is essential to prevent infections and provide a. clean wound bed for tissue growth 
and wowld closure. A simple schematic diagram is presented in Figure 6.2 illustrating the 
key dermal {'ve-Ilts and immune reIl activities become morE' promw£'ut in response to bacterial 
infections. 
Figure 6.4 presents a schematic representation of th(' wound domain and the cross sectional 
quantities considered and listed in Table 6.1. This is the sanle set up as the model disclL'l8ed 
in Chapter 5. except bacteria will inha.oit the wound (egion. 
Tlu~ main aims of the modelling in addition to thoS<' mentioned in 5.3.1 are 
• [nvcst igate th(' role of bacteria in normw and abnormal bealing . 
• Identify parameters key to the onset of infections. 
Bacteria call infiltrate where there is broken skin. although thE" escbar region ean act as a 
barrier. S<'e Figure 6.3. The host responds by recruiting immune cells to the wound site 
CELL 
BINDING 
TISSUE 
INTEGRITY 
••• ~ REMOVAL Of ANGIOGENESIS 
,. NECROTIC TlSSUE ••• ~ND 
AND INFECTIONS GRANULATION TISSUE 
FORMATION 
Figure 6.2: Se/lematic of dermal wound bealing witb bacteria. 
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z=o 
Figure 6,3: Sdlema.tic diagrBlll illustra.tes migration ofiibroblasts and immune cells in response 
to bacteria invasion into tbe wound medium. 
Variables D escription 
11.(x, t) Keratillocyte cross sectional thickness 
rn(x, t) Damaged dermis cross sectional thickness 
d(x. t) Normal (healthy) dermis cross sectional thickness 
g(x, t) Granulation tissue cross sectional thickness 
I(x, t) Fibroblast and immune cell cross sectional density 
c(x, t) Nutrient cross sectional concentration 
s(x, t) Signals (CFs and cytokines) cross sectional concent.ration 
w(x, t) Bacteria cross sectional density 
Table 6.1: Variables considered in tbe bacteria-dermal model 
to remove the bacteria. The assumptions of Chapter 5 are carried through and we add to 
these. 
• We assume a single Ilgeneric" species of bacteria. 
• 11.(x, t) prevents w(x, t) entering wound as it provides a barrier to external stiml~i. 
• Bacteria are removed by I(x, t) and decay due to natural death from sloughed material. 
• Presence of bacteria will induce further secretion of s(x, t) by fibroblasts and ker-
atinocytes. 
• Birth rate of bacteria. is dependent on nutrients and dead cell material. 
• Living tissue is broken down by bacteria to create mme m(x, t). 
The latter assumption is relevant in the severe of C8."'" of bacterial infections, as they destroy 
healthy tissue, which cowd lead to an expanding WOlUld. 
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6.2.2 Governing Equations 
Amendments will be made to the equations seen in 5.3.2, by incorporating the influence of 
bacteria to the model. As before parameters of the form rh will describe birth rates, 0* 
will refer to death/removal rates and 'Y* represents inhibitor threshold parameters of model 
variables involved. vVe introduce Ct* which describes ratio of selective terms (bnw1 f3mnl f3mg, 
(Jmd, Odw, 6gw , a/w " bew and ow! as stated in Chapter 5), to the maximum eschar/dead 
material produced by bacteria. 
Bacteria w(x, t) 
Microbial presence can be observed immediately after injury and in most cases the immune 
response ensures removal, hence wound closure under normal healing conditions [11, 14]. The 
rate of change is given by 
hence 
Rate of change 
ofw(x,t) Infiltration from environment 
+ Birth 
Loss/degradation 
aw Ft = kw(w, c, m) - Aw(W, f) (6.1) 
where kw is bacteria production rate promoted by poorly keratinised presence and the expected 
proportion of kw are nutrients and damaged dermis. We expect 
ok ~ >0 and am 
akw 0 
an < , 
We assume that keratinocytes form an effective barrier whim Tt > n (where n < no), and 
infiltration occurs when n < ft, and the corresponding rate of infiltration is taken as f3wnH(n-
n), where 
H(n-n)={~ if n < n (open wound) 
if n > n (closed wound) 
we also assume a linear dependence on c and m on the birth rate. Hence 
kw = w(f3wcc + f3wmm) + f3wnH(n - n). 
However microbial movement relies on n, as they are responsible for re-epithelisation and 
progressive wound closure will prevent influx of microbes [32, 53]. 
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The bacterial removal rate Aw depends on fibroblasts, immune cells and natural loss. It has 
the expected properties 
hence we assume 
Dermis d( x, t) 
a>.w 
--<0 and aw 
>'w = w(ow + owl f). 
The normal dermis can become damaged by bacteria. In the model of the previous chapter 
there was no dermal removal, hence Ad = O. HO\\'ever the presence of bacteria will modify 
these properties, and we expect 
and 
and write 
Damaged Dermis m(x, t) 
The destruction of living cells by bacteria generates more damaged/necrotic material, which 
changes the production rate km with the following properties, 
and 
Although bacteria consumes dead/damaged material,' it is assumed that the volumes con-
cerned are negligible compared to the total volume of material so that 
we write 
Nutrients c(x, t) 
In addition to 5.3.2 we extend the consumption rate function Ac by introducing a bacteria1 
depletion term, and we expect 
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hence 
Signals s(x, t) 
Bacteria present at the wound domain will initiate imlllune cell migration and secrete further 
s(x, t) and we expect an additional property of ks to be 
and write 
Dk, 0 
8w > , 
where the last term being the most recent addition. Although it should be noted that signals 
secreted in response to fibroblasts and immune cells are dependent on the level of bacterial 
levels. 
Fibroblasts f(x, t) 
Immune cells help remove foreign bodies from the wound area, though fibroblasts are likely 
to be vulnerable and we expect 
we write 
Granulation Tissue g(x, t) 
The granulation tissue production can be inhibited by bacterial infiltration, which largely 
depends on the severity of the deep tissue colonisation [241. Both birth kg(c,J,s,w) and 
death >'g(g,c,w) functions are extended from that seen in 5.3.2. 
For birth rate kg(c, /, s, w) in addition to what is already known, we expect some suppression 
in this production, hence 
and we assume 
Dkg 0 
fJw < ) 
kg = cf({3g,/ + (3g,s) H(s _ ii)lJ(c _ c). 
I +w/i,w 
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Like the dermis! granulation tissue Illay also be removed by bacteria! hence we expect 
\Ve write 
Keratinocytes n{:c, t) 
8)'g 0 
iJw < . 
( 
Ogc ) Ag = g / + O:gmwW . 1 + C "{gc 
Though keratinised skin tissue is an effective barrier! non-keratinised epithelial cells are likely 
to be vulnerable to bacteria! hence we expect 
and write 
BAn 0 
-> GW 
( 
Onc ) An = n / + O:nmwW . 
1 + C "{ne . 
6.2.3 Full System of Equations 
For purposes of clarity we present the full extended system 
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(6.2) 
(6.3) 
(6.4) 
(6.5) 
(6.6) 
(6.7) 
(6.8) 
(6.9) 
Z= 
HEALTHY 
SKIN 
= 
x=o 
HEALTHY 
SKIN 
t'1 '10 
1 = 10 
d-do 
r" - 0 
9 0 
w=o 
Figure 6.4: Cross section of wound domain with bacteda. 
where the vascula.ture function is defined as before by 
(d+ Pbg)" 
kb(d, g) = 'Y~ + (d + Pbg)"' 
x=L 
The system is defined on the fixed doma.in (0, L) and the initialll.Dd bOlUldary conditions are 
provided below and define a closed system. 
In itial and Bo undary Condi t ion s 
To close the system the following conditions are imposed and Figure 6.4 presents the typical 
WOlllld domain conside-red 
• At T = 0 signifies the centre of tbe wonnd and the initial damaged doma.in. We apply 
the zero-flux conditions 
an 
{)x = 0, {)I = 0 {)x ' {)e = 0 {)x . Il.Dd as = 0 {):r . 
• At. x = L this is the healthy skin state provided normal repair bas occurred Il.Dd the 
traru;ition to wonnd closure is observed then n = no. I = 10, e = Co, s = 80, m = O. 
d = do. 9 - 0 and w = o. 
• At t = 0 as skin mass is lost we assume n = n/(x), d = d,(x), m = m,(x), c = e,(x). 
1= h(x). S = s,(x), ID = w,(x) Il.Dd 9 = O. 
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Parameters Description Units Values 
Q nmw Death rate of n by w mm' (cells h)-' -
Q gmw Death rate of 9 by w mm' (cells h)-l -
O:dmw Death rate of d by w mm' (cells h)-l -
'Ygw 9 inhibited by w presence cells mm-2 104 [i4] 
C'i/mw Death rate of f by w mm2 (cells h)-l -
/3wc Bacteria production rate due to nutrients mm' (gh)-l -
/3wm Enhanced bacteria production rate due to m (mm h)-l -
/3Wfl Bacteria seeding rate from environment cells (mm2 h)-1 -
n Critical keratinocyte level mm 
-
dw Natural loss of bacteria h- 1 10 [i4] 
dWf Removal rate of bacteria by fibroblasts mm2 (cells h)-1 -
"cmw Nutrients consumption by bacteria mm' (cells h)-l -
/3,w Signal production in response to w g mm2 (cells2 h)-1 -
Table 6.2: Additional parameters considered in tile bacteria-dermal model using the units set 
h, 9/111111 and IIcelIs", as with Table 5.5 where the units oEw is taken to be cell/l11Il12 . 
Model Parameters 
The model parameters from the extended model are given in Table 6.2, with their biological 
interpretation. \Ve also include corresponding experimental values where possible. 
6.2.4 Nondimensionalisation 
\Ve nondimensionalise the model based on the keratinocyte birth rate and in the timescale 
where cells travel given by, 
{x, i} = { /1l!1;' tco/3n } . 
Refer to Appendix B.4 for more details. 
As before the rescalings for common parameters stated in Chapter 5 apply, in which the 
healthy states corresponds to n = I, f = 1, c = 1, s = 1, d = 1, rn = 0, 9 = 0 and w = O. The 
additional rescalings are 
(6.10) 
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and the parameter relationships remain unchanged from that given in Section 5.3.2. 
Dropping the hats for clarity, the nondimensionalised system is given below 
ad 
at = - G:dmwwd 
ag cf({3gf + (3g,) H( -)H(- ) ( Ogc + ) 
- s-s c-c-g Q: w at 1 + w/"(gw 1 + c/"(gI gmw 
af a' f a ( as) Ft ~Dfax' - ax fXf(d+ 17 fg)ax + (3fbkb(d,g) 
+Cf ({3fc (I_L)+r3fc,H(S-S))-f(1 ( °fc )/ +Ufmww) 
KI + C + PIs "IIcs 
ac a'c 
at ~Dc ax' + (3cb kb(d, g) - c(Ocn" + Ocr! + Qcmww) 
aw Ft ~w({3wcc + (3wm m ) + (3wn H (f! - n) - w(Ow + Owf!) 
as a's 
at ~D, ax' + (n({3'n + (3 .. "s) + f({3'f + {3"f 8 ))(1 + (3,cH(c - c)) 
{3,mm + (3,wfw - s(O, + O,nn + O'f!)' 
The nondimensionalisation implies that the initial and boundary conditions become 
t ~ 0: 
x ~ 0: 
x~ L: 
n ~ n[ (x), f ~ !I (x), d ~ d[(x), s ~ S[(x), c ~ C[(x), m ~ 9 ~ w ~ O. 
an :::; 0 II = 0 Bc = 0 as = 0 8x ' ax ' & ' ex . 
n = f ;::: C = S = d = 1, 17t = 9 = 11,; = O. 
(6.11) 
(6.12) 
(6.13) 
(6.14) 
(6.15) 
(6.16) 
(6.17) 
(6.18) 
'Ve are looking at Cl 10 Ilonlinear PDE system as presented by the equations (6.11)-{6.18). 
The additional parameters introduced to the extended model are given in Table 6.3, note that 
the standard parameter values given in Tables 5.3, 5.4 and 5.5 still hold. 
131 
6.3 Model Analysis 
6.3.1 Numerical Methods 
The nonlinear system is solved using finite difference schemes and wc apply central differencing 
to the spatial domain and Euler time-step in the temporal domain. Refer to Appendices A.3 
and BA for more details. 
6.3.2 Ftesults 
The simulations presented in the following subsections will investigate the normal and delayed 
healing course! with the exploration of key parameters that may perturb wound closure and 
lead to the onset. of infections, we have identified as 
• Gdmw, determines the healt.hy EClIvl removed by bacterial "attackll • 
• (JwnJ describes the infiltration of bacteria hence the "seeding" rate into the wound. 
Tables 5.5 and 6.3 provide the standard set of parameters values used to simulate normal 
healing of the extended model. 
Effects of an Initial Bacteria Inoculum 
Figures 6.5-6.8 presents standard simulatiolls under normal healing conditions. \Ve assume 
that there is no loss of healthy EC~\'l post wounding and bacteria cannot infiltrate beyond the 
superficial membrane, hence 0dmw and f3wn are inactive here. The initial conditions are as 
follows and the injured area corresponds to 3.; E (0,32), 
0<x<32: 
32 :s: x :s: 40: 
n = 0, C = 0, f = 1, s = 1, m = 1, d = 0.1, w = 0.1 and 9 = O. 
n = d = c = s = 1,9 = m = w = O. 
\Ve consider small bacterial innoculuIllS of w(x, a} = 0.1 and w(x,O) = 0.5 respectively at the 
initial \vouml site, to assess the healing dynamics. 
In the first case we can observe that healing is successful as bacteria retreats (see left simulation 
of Figure 6.5), where re-epithelisation takes places to prevent further microbial presence, and 
forms a barrier of protection as shown in Figure G.8 (left simulation). 
A higher innoculum of bacteria (w(x,O) = 0.5) begins to proliferate at the wound site, where 
a greater density can be observed (w :::::: 7.5) as seen in Figure 6.5 (right simulation). This 
leads to an increased secretion of signals, and granulation tissue depo~ited and indicates that 
the immune response has been effective in removing a large proportion of the contamination 
present in the wound. \Vound closure to an adequate level is observed for x E (5,32), as 
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Parameters Values Parameters Values 
f3mn 0.004 fJwc 0.2 
f3mg 0.004 f3wm 0.2 
{Jmd 0.004 ,Bwn 0.0 
Odmw 0.0 tJ.iW 0.4 
'Igw 0.004 Jw 0.2 
Ogmw 0.04 oWf 0.2 
ofmw 0.04 Ocmw 0.4 
Table 6.~t Standard set of parameter values for normal healing ldth bacteria. 
keratinocytes (vary in thickness from wound edge to wound cent.re) are unable to migrat.e 
appropriately in the absence of a suitable matrix: hence re-epithclisation is incomplete nea.r 
the wound centre (x < 5). 
A contaminated wound will heal successfully provided the initial innoculum arc at low levels: 
and compares wen with results in Chapter 5 to resemble normal repair. Increase in initial 
w(x, 0), impacts OIl the healing path and can delay or prevent complete wound recovery. 
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Figure 6.5: El'olution of bacteria (w) in steps oft = 6 using values in Table 6.3 wben initial 
w innoculuI1l is (left) w(x, 0) = 0.1 and (rigllt) w(x, 0) = 0.5. 
133 
i 
I ' 
I 
1 , 
! 
• 
, 
• 
-. 
• • • • 
,L-__ ~ __ ~ __ ~ __ ~ __ ~ __ ~~~~ 
• • " • • • • • 
...... 
Figure 6.6: Evolution of signal concentration (s) in steps of t = 6 llsing values in Tab!e 6.3 
wllen initial w innoclIlllIn is (left) w(,:, 0) = 0,1 and (right) ",(x, 0) = 0,5, 
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Figure G.7: Evolution of graIlUlatioll tissue thickness (g) in steps oft = 6 llsing values in Table 
6,3 when initial w innoculuIn is (left) w(x, 0) = 0,1 and (right) w(x, 0) = 0,5, 
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Figure 6.8: Evolution of keratinocytes thickness (n) ill steps oft = 6 using values in Table 6.:3 
when initial w innoclllllm is (left) w(x, 0) = 0.1 and (right) w(x, 0) = 0.5. 
Effects of Bacterial Seeding- /3wn > 0 
Pertllrbations in the healing process are likely to occur the longer a wound remains open, 
posing a greater risk of bacterial colonisation as they invade the skin and penetrate further 
into the dermis leading to long term infections. Here the same parameters apply as in Tables 
5.5 and 6.~~, except for the ::seeding" of bacteria into the wound modelled when f3wn > 0, 
where infiltration occurs when n < n. 
Figures 6.9-6.1~! compares the wound activities for three different ::seeding rates': of f3wn = 
0.001, f3wn = 0.01 and (3wn = 0.1 respectively, to show the transition from a normal healing 
to an infected/non-healing wound as seeding increases. 
From t.he simulations we can observe normal healing when !3wn = 0.001 (left simulations of 
Figures 6.9-6.13) as the contaminated wound heals successfully. Although there are dramatic 
difference in healing profiles when infiltration reaches deep tissue between !3wn = 0.01 to !3wn = 
0.1, where bacterial density increases rapidly (Figure 6.9) at the wound site for x E (0,20) in 
the extreme case, using the damaged dermis as a br(-'(.'<iing domain (Figure 6.12). This could 
potentially inhibit the actions of signals, preventing perfusion and the immune response (see 
middle and right simulations of Figures 6.10). 
The immune response is triggered to combat microbial invasion, and recruits the repair cells 
which peaks at the wound edge (right simulation of Figure 6.10). Although activity is sup-
pressed with the growing number of wound pathogens between f3wn = 0.01 and !3wn = 0.1 (see 
left and right hand simulations of Figures 6.10), and f allocation is unable to cover the entire 
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wound area or prevent the spread of infection in the damaged region. 
Eshcar/dead material m (see right simulation of Figure 6.12) cannot withdraw from the wound 
domain as bacterial invasion becomes more prominent in the dermal and epidermal tissue, due 
to lack of satisfactory signals, nutrients and the immune response (right simulations of Figure 
6.10). The dead material in the case of f3wn = 0.1~ has somewhat elevated values which in 
reality will be sloughed off or leaked away. Note the corresponding parameter Srn = 0 is used 
for comparison with previous simulations, having Srn > ° would resolve this issue. 
For f3wn = 0.01, granulation tissue deposition is relative covering large proportion of the wound 
domain~ although reaches its steady state before t.he wound centre (see right simulation of 
Figure 6.13). The knock on effect. of inadequate fibroblast.s/immune cell distribution can be 
observed in Figure 6.11 (right simulation), where new tissue growth is severely obstructed and 
struggles under the hostile conditions, disrupting vasculature and the perfused environment 
which become limited and unable to .fulfil t.heir obligations for normal developments which 
can be seen from the unhealed damaged domain (see Figure 6.12). The low quantities enable 
inconsequential repair at the wound edge. 
When f3wn = 0.1, wound closure is unlikely considering the activities of the dermal components 
seen in Figures 6.9-6.12, as this region becomes greatly disturbed by microbial activit.y. Note 
that we have increased the domain size for the ca.'ic of f3wn = 0.01 from (x E (0,40) to 
x E (0,50)) to emphasise the non-healing profile (see middle simulation of Figure 6.13). Re-
epithelisation is subdued as there is a :'weak" scaffold for migration t.o take place, as 9 is 
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Figure 6.9: Evolution of bacteria deIL.;;ity (w) in steps t = 6 using values in Table 6.3, except 
for (3wn where we consider (left) (3wn ~ 0.001, (middle) (3wn ~ 0.01 and (right) (3wn = 0.1 
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Figure G.lO: Evolution of fibroblasts/immune cell density (J) ill steps t = 6 using values in 
Table 6 .. 1, except for (3wn wlJere we consider (left) (3wn = 0.001, (middle) (3wn = 0.01 and 
(right) (3wn = 0.1. 
• • 
• • 
/ • 
• • J 
! 11 I • " . I 
i 1 1 I. • I • , . 
III 
! ! 
: 11 
I 
i 1 I • 
i • I • i ; I I • 
• • 
0 
.1), 
0 
.... .... .... 
Figure 6.11: Evolution of granula.tion tissue thickness (9) ill steps t = 6 using values in Table 
6.3, except for (3wn where we consider (left) (3wn = 0.001, (middle) (3wn = 0.01 and (right) 
(3wn = 0.1. 
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Figure 6.12: Evolution of damaged dermis thicknes5 (m) in steps t = 6 using values in Table 
6.3, except for (Jwn where we consider (left) (Jwn = 0.001, (middle) (Jwn = 0.01 and (right) 
(3wn = 0.1. 
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Figure 6.13: Evolution of kcratinocyte thickness (n) in steps t = 6 using values in Table 
6.3, except [or (Jwn where we cOIL,ider (left) (Jwn = 0.001, (middle) (Jwn = 0.01 and (right) 
(Jwn = 0.1, 
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localised to the wound edge at low levels (see Figure 6.13). 
The simulations presented demonstrate that the model call predict healing, partial healing 
and chronic wound scenarios depending on bacteria levels. As infiltration of w increases, 
accessing dermal tissue the healing pat.h is greatly disrupted, and will begin to ;'attack" 
other surrounding healthy tissue if left unmanaged. The observations suggest that we can 
ident.ify three clinical classifications [56] of behaviour, namely cont.amination (e.g the case 
with f3wn = 0.001), colonisation (e.g the case with f3wn = 0.01) and infection (e.g. when 
[3wn = 0.1). 
Bolus Nutrient Treatment 
We can attempt to restore healing in an infected wound as shown in Figures 6.9-6.13 by 
incorporating an initial bolus of nutrients at c(x,O) = 0.01 for f3wn = 0.01 and {3wn = 0.1 
scenarios, similar to Chapter 5 . \\le focus on t.he behaviour of bacteria, fibrobla.st.sjimmunc 
cells and keratinocytes to diffcrentiate between the healing states and determine the likelihood 
of repair. The simulations are presented in Figures 6.14-6.16 for the two non-healing cases of 
f3wn (sce middle and right siwuiations of Figures 6.9-6.1:3 to compare). 
u 
.. 
~ 
r 
l:, , 
\\\ j , 
.. 
i , I \ \'\ 
, I 
! 
l , i .. 
I I 
u I I \ 
I \ I 
I \ \ 
, I 
,\\\\ 11 }}~~H~ \J 
, 
D 
1-------... :~~~L-~~ 
• • • • • • • • • • • • 
-. -. 
Figure 6.14: Evolution of bacteria density (w) in steps of t = 3 after bolus of c(x. 0) = om 
is applied, using values in Table 6.3, except for f3wn where we consider (left) f3wn = 0.01 and 
(right) [3wn = 0.1 
From t.he simulations we call observe that normal healing resumes for t.he first case when f3wn = 
0.01, enabling complete wound recovery although there is slight delay in re-epit.helisation and 
is refi(.'Cted by the the increase in bacteria concentrations to w :::::;: 0.7 (see Figures 6.14 and 
6.16). However it has a contradictory effect when the infect.ion is more widespread for a greater 
139 
" .~~I~ s • f u ! I 
i i ' 
. I ! ' I 1\ 1111111 ! 
: " I I I~ \)\1\ \l , , 
, 
~_)J)))J 
• 
, 
• • • • • • 
, 
• • • • • 
-. -. 
Figure 6.15: Evolution of fibroblastjimmune cell density (f) in steps oft =:i after bolus of 
c(x.O) = 0.01 is applied, using values in Table 6.3, ·except for f3wn where we consider (left) 
(3wn = 0.01 and (right) (3",,, = 0.1. 
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Figure 6.16: Evolution of keratinocyte thickness (n) in steps of t = 3 after bolus of c(x, 0) = 
0.01 is applied, using values in Table 6.3, except for f3wn wlIere we consider (left) f3wn = 0.01 
and (right) (3wn = 0.1. 
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Figure 6.17: Evolution of bacteria density (w) in steps t = 6 using parameters given in 
Table 6.3 except for f3wn = 0.001 when considering (left) D:dmw = (}gmw = 20 (middle) 
Q'dmw = O'gmw = 100 and (right) O'dmw = Q'gmw = fIOO. 
infiltration rate, as seen in the right simulations of Figures 6.14-6.16; where t.he Rmallllutrient 
concentration initiates the activity of fibroblasts, (see Figures 6.15) penetrating further into 
the wound domain, although insufficient to cover the whole injury. Consequently the bacteria 
benefit (sce right of Figure 6.14) from the treatment as their density increases dramatically 
reaching w :::::: 450 by t = 20, seemiugly well beyond the levels that can be managed by the 
immune system. 
It appears in this simulation that a bolus of nutrient in a severely infected wound. would 
provide a stimulus for both bacteria and healing components; however wound healing could 
fail if the bacterial density becomes llrunanageable allowing infections to persist. This suggests 
that the ::golden bullet" of adding nutrient could have detrimental effects by benefiting the 
bacteria more than the host tissue. 
Loss of Healthy ECM -C\:'dmw > 0 
So far we have considered bacterial invasion in the wound domain for selected infiltration rates. 
In this section we invest.igate bacteria ::attacking" healthy ECM (dermal) that remains intact 
pm;t injury, which can re~iUlt as iufL"Ctiolls persist. The parameters for I,he above simulations 
(Figures 6.9-6.13) apply here for a small infiltration rate of fJwn = 0.001, except we consider 
the cases where O'dmw > O. 
'Ve can observe from the simulations that w consumption of the dermis has a significant impact 
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on the healing processes, where small loss allows complete repair (see left simulation of Figures 
6.19) and wound closure (see left simulations of Figures 6.17-6.21). Complete dermal removal 
occurs when bacterial movement in deep tissue intensifies and this impairs recovery (when 
Odmw = 100) by producing nOIl-healing profiles. This interferes with adequate granulation 
tissue deposition which supports the wound matrix and an inconsequential quantity is present 
at the wound edge. This reflects the fibroblastsjimmune cell density that is less sufficient 
(J ~ 2.5-compaxe left and middle simulations of Figure (i.20) in this case and cannot penetrate 
into the entire wound domain, hence wound closure fails (see middle simulation of Figure 
6.21). \Ve should note that the small infiltration of bacteria introduced does not grow rapidly 
(sce Figure 6.17), and could iudicate that presence a.t the wound bed may be problemat.ic, 
irrespective of the original population. 
[n the worse case, we observe some regressive behaviour in fibroblasts/immunc cells (further 
reduction in density at the wound edge f ~ 2 here) and keratinocyt.es (sce right simulations 
of Figures 6.20 and 6.21), even though bacteria density does not exceed w :::::.:: 0.25 (they arc at 
low levels). The surrounding healthy tissue in consumed in addition to dermal tissue present 
in the damaged region (sce right simulation of Figure 6.19) leading to an expanding wound 
domain. Tllis stalls the re-cpithelL<>atioll process (see Figure 6.21), as the immune response is 
perturbed calL<;ing insignificant contribution to grauulation tissue formation (see Figures 6.18 
and 6.20) 
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Figure 6.18: Evolution of granulation tissue thickness (g) in steps of t = 6 using parameters 
given in Table 6.3 except for {Jwn = 0.001 when considering (left) Qdmw = Q gmw = 20 (middle) 
O'dmw = O"gmw = 100 and (right) (l'dTnW = ngmw = 500. 
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Figure 6.19: Evolution of normal dermis thickness (d) in steps of t = 6 using pararueters givel] 
in Table 6.3 except for [3wn = 0.001 when considering (left) O'dmw = Q gmw = 20 (middle) 
Ctdmw = Q gmw = 100 aIul (right) O'dmw = Q gmw = 500. 
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Figure 6.20: Evolution oiflbroblasts/iIllIIlUn€ cell density (f) in steps oft = 6 using parameters 
gh'en in Table 6.3 except for (Jwn = 0.001 when cOIlSidcring (left) C>dmw = C>gmw = 20 (middle) 
Odmw = Q gmw = 100 and (rigllt) Q'dTTlw = Q gmw = 500. 
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Figure 6.21: Evolution of keratinocyte thickness (n) in steps oft = 6 using parameters giyen 
in Table 6,3 except for f3wn = 0,001 when considering (Ieft) "dmw = <>gmw = 20 (middle) 
O'rlmw = Ctgmw = 100 and (right) O'dmw = ('tymw = 500. 
From the simulations in thL" section, wc can conclude that bacterial iufections that reach the 
dermis and completely remove the remaining tissue aft.er wounding, severely suspends the heal-
ing course, preventing recovery and wound closure. They ::at.tack" surrounding healthy skin 
if invasion persists determined by consumption rate of bacteria into a weak superficial mem-
brane, resulting in an enlarging wound area. The characteristics exhibited by the infections of 
the deep damaged tissue in this section are common ill chronic wounds) as granulation tissue 
is almost absent. due to incomplcte wound bed preparation and rc-epithelisation is delayed as 
a result [:12, 71, 1291. 
Varying Wound Geometry 
It. was found in Chapter 5 (see Figures 5,35-5,36) that altering the wound shape had a sig-
nificant impact on healing: whereby wOW1d closure could occur in a sloping wound when 
vasculature was considered poor: using "tb = 0.85. In this section we will consider the ex-
panding wound case as presented in Figure 5.31 (sec left simulations of Figures 6.17-6.21): to 
invest.igate whether the domain shape has any significance in a poorly vascularised wound and 
modestly contaminated with bacteria: hence (3wn = 0.001 and fidmw = 20. d(x) O} function 
rcmains unchanged from that seen in Chapter 5) and we also use the exponent <; = 1. The 
simulatioIls arc given in Figure 6.22-6.23. 
The results suggest. that although signal concentrat.ions (sce Figure 6.2:i) arc adequate and 
consistent throughout. the wound domain: the small infiltration of bacteria have the ability 
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Fignre 6.22: Evolution in steps oft = 6 for (left) granulation tissue thickness (g) and (right) 
bacteria. density w using the parameter values in Table 6.3 except for Gdm.w = 20, /3wn = 0.001 
and " = 0.85. 
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Fignre 6.23: Evolution in steps of t = 6 for (left) signal concentration (8) and (right) ker-
l-ttinocyte thickness (n), when c; = 1 using the parameter values in Table 6.3 except for, 
O'dmw = 20, f3wn = 0.001 and Ib = 0.85. 
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to ::attack:: tissue surrounding the wound, disrupting granulation t.is."me deposit.ions near the 
wound centre (see left simulation of Figure 6.22), \ ... hich prevents complete wound healing 
as re-epithelisation is impaired (see Figure 6.23). Note: if fidmw = 0 i.e no dermal damage 
by bacteria: the wound will heal normally. The simulations demonstrates that in a poorly 
vascularised wound: a low level presence of bacteria can contribute to significantly impairing 
the healing process. 
Topical Application of GFs 
In this section wc will consider the topical application of GFs seen in chapter 5, to observe 
whether this would retrieve the normal healing path for f3wn = 0.001 (vascularised wound 
where ')'b = 0.6), in the cases when Odmw = 100 ami O'dmw = 500 seen in Figures 6.17-6.21 
(middle and right simulations). Debridement of necrotic tissue is key to reducing the risks of 
worsening infectioIl where m(x, 0) = O·and fJsm = 0 are consequently removed. As a reminder 
the treatment is given by 
(3,H(ii - n), (6.19) 
and the s equation becomes 
8s 83 
at =D, 8x + (n({3,n + (3"n s) + /({3'1 + {3"13))(1 + (3"H(c - c)) 
{3,mm + (3,w/w - 3(0, + o,nn + 0'1 f) + (3,H(ii - n). 
Using f3s = 4 and n = 0.3, the simulations for bacteria, signals, granulation tissue, fibroblasts 
and keratinocytes are presented in Figures 6.26-6.28. 
From t.he results we can observe wound closure is !·H1c:ce.'JRflll when topical application of sig-
nals are administrated, for the first non-healing case as re-epithelisation takes place, after 
adeqnate Signals, fibroblastjimnmne cells and granulation tissue (St'C Figures 6.26, 6.25 and 
6.27) arc available in the wound domain. \Ve expeet travelling waves solutions, guarantee-
ing eventual wound closure! from Figures 6.27 (left Simulation), as the wavefront appears 
flat which is clearly not. the case without treatmeut. (see Figure 6.7 to make comparisons). 
Bacteria behaviour appeani insubst.antial (sce Figure 6.24), when comparing t.he two cases 
after debridement and signals have been topically applied; densities may have become more 
manageable with treatment and less able to reach dC(!p tissue. 
However: this treatment is unable to fully revive the abnormal behaviour for the expand-
ing wound case (Odmw = 500). The signals secreted ::leak" into to t.he wound and provide 
the stimulus, allowing sufficient granulation tissue deposit.ion (g :::::; 2.5 hereL although ker-
atinocyte migration is severely inhibited; it may need further intervention of a combination of 
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Figure 6.24: Evolution of ba,cteria density (w) in steps of t = 6 using parameter values in 
Table 6.:!, except for (3wn = 0.001, (3, = 4 when considering (left) "dmw = lOO and (right) 
Odmw = 500. 
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Figure 6.25: Evolution offibroblasts/immune cell density (f) in steps oft = 6 using parameter 
values in Table 6.3, except for f3wn = 0.001, f3s = 4 when considering (left) Odmw = 100 and 
(right) "dmw = 500. 
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Figure 6.26: Evolution of signal concentration (8) in steps oft = 6 using parameter values in 
Table 6.8. except for fJwn = 0.001, fJs = 4 when considering (left) admw = 100 and (right) 
Ctdmw = 500. 
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Figure 6.27: Evolution of granulation tissue thickness (9) in steps oft = 6 using parameter 
values in Table 0.3, except for fJWtl = 0.001, f3s = 4 {lrhen considering (left) Qdmw = 100 and 
(right) Qdmw = 500. 
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Figure 6.28: Evolution of keratinocyte thickness (n) in steps oft = 6 ll,)jng parameter valllcs 
in Table 6.3, except for {Jwn = 0.001, {J, = 4 when considering (left) Qdmw = 100 and (right) 
Q'dmw = 500. 
treatments. It. also suggests that there Illay be a rela.tionship as large deposits of granulation 
tissue exceeding the skin's surface known as hypergranulation, could be responsible for stalling 
the re-epithelisation process; preventing wound contraction and are common characteristics 
described in chronic WOllllds [11, 31, 56, 65]. This can lead to tissue ::rolling" over the woun~ 
edges (also known as epibolyl) [65] and excess tissue deposits with unequal distribution in the 
region x E (30,35) as keratinocytes retreat (see Figure 6.27). The process of hypcrgranulation 
is likely to involve a number of processes outside the scope of the current modelling; however) 
the results here may provide an indication to its initiation. This type of application may 
have encouraged immature angiogenesis and cause the wonnd area to become swollen due to 
uurelieved pressure [65]. 
\Ve can conclude that topical application of signals could be effective and this treatmcnt 
succecds in enabling the laying down of the ECM bed, but is unable to be effective against 
epidermal vulnerability against bacteria, Although fibroblast/immune cells and granulation 
tissue levels seem appropriate, it is unfavourable for re-epithelisatioll to take place. F\uther 
intervention methods are likely to be needed to prevent progressive bacterial invasion and 
allow recruitment of repair cells able to cover the entire domain. 
I Rapid cell dh:ision in the vicinity of slow dividing cell groups 
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Topical Application of Fibroblasts 
The expanding wound domain requires intervention in aUempts to restore tissue lost via 
infections, as application of signals is unsuccessful for Udmw = 500 case. In this section we 
will consider the application of fibroblasts, which could describe the skin substitutes such as 
Dermagraft. Again, we will ~ume that debridement has taken place m(x, 0) = 0 and signals 
are lost as a result hence f3sm = O .. Although f activity subsides in the delayed/non-healing 
wound: we assume t.hey become inactive and are not lost t.hrough intervent.ion methods. 
Topical application of fibroblasts should essent.ially stimulate wound fibroblasts/imffiune cells, 
granulation tissue production and prevent. further invasion which are inhibited in chronic 
wounds, and works symbiotically wit.h t.he other dermal components. An additional birth rate 
term will be applied to the fibroblast equation given by 
flJwH(fi - n), (6.20) 
so that the f equation becomes, 
where (3fw describes the fibrobla.c;;ts/immune cell int.roduction in a hypoxic wound bed to 
combat b~terial inva.<;ion, hence n < n 
{
I if n < fi (Treatment required) 
H(fi-n) = 
o if n ~ fl (Treat.ment not necessary). 
\Ve use the parameter values of f3fw = 0.3 and fl = O.:~ and the corresponding simulations are 
presented in Figures 6.29-6.30. 
From the results we can observe t.hat healing is restored in t.he expanding wound domain, as 
signal levels increase, further recruiting morc fibroblasts to the damaged region, where normal 
levels of granulation tissue formation occurs and peaks at the wound edge (sce Figures 6.29, 
6.30). 
It appears that topical application of fibroblasts is an effective strategy, t.hat can retrieve 
llormal healing patterns in a severely infected woulld characterised by surrounding t.issue 
damage. This treatment prevents furt.her bacterial invasion entering the wound and is able to 
st.imulat.e t.he healing components such os granulation tissue growth, at appropriate levels to 
allow wound repair to take place. This simulation gives results t.hat qualitatively agree with 
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Figure 6.29: Evolution of (left) signal concentration (5) and (right) fibroblast/imIllune cell 
dCll .. ,ity (f) in step ... " of t = 6 using parameters in Table 6.3, except for {3w-n = 0.001 O'mdw = 500 
and (3fw = O.:!. 
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Figure 6.30: Evolution of (left) granulation tissue thickness (g) and (right) keratinocyte thick-
ness (n) in steps oft = 6except for (3wn = 0.001 Ilmdw = 500 and (3fw = 0.3. 
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the frequently successful application of skin substitutes, such as Dermagraft, on advancing the 
healing process when infection is problcmatic [44, 63,90, lOO, 136]. 
6.4 Summary 
This chapter explores the healing behaviour of deep tissue wounds exhibiting microbial activity 
COlllmon in chronic woundsi to resemble a more realistic wound scenario. The severity of 
bacterial activity defined by the three states contamination, colonisation and infection can 
severely impair the norlllal healing path and provide a retarded wound that may require clinical 
intervention. A simple model was proposed, which extended ideas presented in Chapter 5; 
exploiting the proliferation process and investigating the two key parameters 
• !3wn which is responsible for bacterial infiltration into the wound domain, 
• O'd1l1w which represents the loss of healthy ECrvl as bacterial infections call expand and 
attack surrounding healthy tissue, 
to highlight normal (refer to Figures 6.5-6.8) and abnormal (refer to Figures 6.9-6.1:~ and 
6.17-6.21) healing scenarios as they impact greatly to the wound environment, and contribute 
to invasion of bacteria in deep tissue wounds. 
It is evident from the simulations that bacterial growth and contamination are key factors 
that govcrn healing profilesi although low level contamination can be detrimental to a poorly 
vascularised \,,"ound (refer to Figures 6.5-6.8). In severe cases especially when (kd1l1w > 0 (refer 
to Figures 6.17-6.21)' reflecting cases of very poor wound management, infection can impact on 
the healthy tissue bordering the wound causing spread of the damage and increasing the initial 
wound domain. It is interesting to note that whilst enhancing the nutrient supply can be very 
effective in retrieving normal healing in contaminated wounds (refer to Figure 6.14-6.16 left 
simulations)i this lllay benefit the bacteria more in the other two cases of infections (colonised 
and infected) causing greater complications and wound recovery is prevented (refer to Figures 
6.14-6.16 middle and right simulations). In such circumstances, the results suggest that an 
additional supply of growth factors and fibroblasts will provide a. better outcome. Although 
topical application of growth factors leads to hypergranulation and stalls the re-epithelisation 
in the infected (extreme) wound case (refer to Figures 6.24-6.28) and full recovery is only 
possible when fibroblasts are applied (refer to Figures 6.29-6.30). This implies that fibroblast 
substitutes such as dennagraft are less sensitive to the severity of infections when compared 
to growth factor treatment. 
The standard practice of wound debridement and replacement of fresh dressings to remove 
and restrict infection is very important as the simulations demonstrate that bacteria presence, 
even in small amounts, can prevent complete healing leading to chronic wounds. 
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i<or purposes of modelling many factors were ignored as listed below 
• Delivery of antibiotic treatments. 
• Individual bacteria species. 
• Polymicrobial infections. 
• Differentiating between anaerobic and aerobic bacteria 
• Anatomical location of wounds which Illay affect healing rates and spread of infections. 
and could be the focus of further investigation in this area.. 
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Chapter 7 
Concluding Remarks & Future 
Work 
7.1 Key Findings 
The thesis incorporates many biological activities and functions) important to dermatological 
disease and recovery which are described by the Ilew mathematical PDE models given in 
Chapters 3-6. They provide a realistic account of skin activity after damage or disease and 
the nonlinear systems were solved using analytical and numerical methods. There are two 
broad areas 
1. EpidermaJ groWUl and recovery investigated in Chapters 3 and 4 
2. Dermal and epidermal IlCRling between the proliferative and repaired stages of healing 
investigated in Chapters 5 and 6 
where wound healing was the main research area in both superficial and partial/full thickness 
wounds. One of the fundamental aims of the research was to obtain a greater understanding 
behind the wound healing phenomenon in normal and abnormal cases, which was obtained 
by manipulating key parameters and extending model concepts. Details of individual models 
will be discussed below accompanied by the key findings. 
7.1.1 Models 
The self-renewal property of the epidermal membrane is governed by the keratinisation process 
where fundamental epidermal cells namely keratinocytes undergo a maturation process and 
slough at the skin's surface. \Vhen considering the superficial wounds in Chapter 3, the 
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keratinisation process was key to demonstrate the re-epithelisation process and the model 
devised of cell binding, signal distribution, cell velocity and cell growth. The model was able 
to reproduce the re-epithelisation process where the live and dead cell states were highlighted. 
The key findings predicted by our model are as follows 
• During the re-epithelisation process signals (GFs) dominate the reformation of the live 
cell region and once completed the keratinisation develops. 
• \Ve can quantitatively describe epithelial recovery and development within a reasonable 
time scale that agrees with literature and is confirmed by medical observations. 
• \Ve can assess in terms of individual model parameters (such as A) epithelial thickness, 
thickness of live and dead cells and tilllcscale for growth. 
• The signal molecules obtained frolll the dermis and binding protein production are suf-
ficient to regulate the thickness and structure of the epidermis. 
• The effect of growth factors on recovery rate and skin structure provides scope to look 
more closely at impaired epithelial healing. It was found that increasing A, would restrict 
growth factor delivery causing premature cell death and result in a thinner live cell 
region. 
• Elevated signal (Cl") levels in the skin may occur due to a reduced domain obtained from 
superficial injury, where signal levels in healthy skin will be more evenly distributed. 
The model was extended and applied to the skin disease psoriasis presented in Chapter 4, 
which is an incurable condition that exhibits hyperproliferation and parakeratosis (live and 
dead cells coexist). The symptoms occur in the form of psoriatic plaques (resulting from the 
inflammatory response), which are most visible at the skin's surface and explains why the 
epidermal membrane was considered. \Ve introduced immune cells) IGFBP-3 and IGF-l to 
accommodate for the onset of abnormal keratinocyte cell behaviour and investigate the normal 
and abnormal cases. The key findings predicted by our model are as follows 
• The normal re-epithelisation process can be reproduced with the introduction of the 
new components, provided the promoter and, inhibitor relationship between IGF-l and 
IGFBP-3 are balanced. 
• Psoriatic behaviour results from overabundant IGF-l and low levels of IGFBP-3 initi-
ating the inflammatory response, as immune cell production increases and penetrates 
further into the upper epidermal layers (which would not normally exist). 
• Skin thickness exceeds the surface of normal unaffected areas, and cell death rate is 
impeded allowing live and dead cells to coexist at the surface resembling psoriatic be-
haviour. 
• Topical application of IGFBP-3 applied as a dressing can regulate excess IGF-l levels, 
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by inhibiting the proliferative activity and reduce the skin domain although SOllle live 
cells still appear at the surface and requires further investigation. 
• Overabundant IGFBP-3 severely inhibits the the proliferative activity resulting in a 
thinner epidermal membrane. 
Deep tissue wounds affecting the dermal and epidermal membranes are problematic when 
they become chronic, compromising and delaying the healing process. Many components are 
involved in the general wound healing process, although surprisingly the entire process has 
not been modelled before due to the complexity, which results in the generation of numerous 
variables. In Chapter 5 a dermal wound healing model is presented, which comprise of key 
variables (flbroblasts, keratinocytes, GFs, healthy dermis, damaged dermis, granulation tissue 
and nutrients) selected after reviewing many sources of literature, where vasculature and blood 
clotting ability were important measures to determine the healing progress. l'vlany scenarios 
were investigated to highlight the change in wound recovery and most important parameters 
contributing to impaired healing. Bolus and topical applications were reviewed to observe 
their ability to retrieve a delayed/arrested wound. The key findings predicted by our model 
are as follows 
• Expected normal dermal healing profiles are achieved by cell and signal interaction in 
the form of travelling wave solutions and wound recovery is observed. 
• Lowering the vasculature parameter rb and clotting ability f3sm results in a poorly vas-
cularised wound with an inefficient clotting matrix, resulting in healing arrest and re-
sembling poor circulation common in diabetes. Both cases illustrate lack of adequate 
nutrients to the entire wound domain, which prevents signal distribution, cell migration, 
tissue formation and wound closure. Bolus nutrients was the most effective in retrieving 
the normal wound healing in such both cases. 
• Topical application of GFs is enough to retriev.e the severely retarded wounds by allowing 
signal infusion allowing cell migration, tissue growth and wound coverage. 
• Varying the wound geometry from rectangular to a semicircle shape, allows healthy 
tissue to be retained underneath the damaged area. The effects of poor vascularisation 
are less dramatic, as wound coverage is greater than the rectangular wounds, although 
complete wound recovery still fails. 
A common problem in chronic wounds are recurrent bacterial infections resulting from the 
hostile necrotic wound environment, inhibiting normal growth and development. We intro-
duced bacteria and extended the model in Chapter 5, to investigate the impact on the healing 
process in terms of bacterial seeding rate f3wn and loss of healthy ECM O'dmw as presented in 
Chapter 6. The key findings predicted by our model are as follows 
• Small inoculum of bacteria resembles a contaminated wound that can impair complete 
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wound healing however one that can be retrieved quite easily. 
• Contamination, colonisation and infection can be illustrated by different seeding rates 
as bacteria penetrates further into the dermal tissue, severely perturbing the healing 
ability. In the severe case, the widespread bacterial activity obstructs new tissue growth, 
vasculature, perfusion and re-epithelisation of the wound area. 
• Bolus nutrients are only effective for the colonised wound as bacteria can be removed 
to restore normal repair. However there is a contradictory effect in the severely infected 
wound scenario as a greater infiltration rate results in bacteria competing for nutrients, 
and we see a dramatic increase in bacterial density which exceeds the realm of the 
immune system. This implies that nutrient applied can benefit the bacteria more than 
the host tissue. 
• Unmanageable infections can result in the loss of healthy ECr ... 1 tissue, as they 'at-
tack' surrounding tissue and expand the wound domain. This results in regressive cell 
behaviour which is unable to initiate the immune response .to its full capacity, allow 
adequate signal or nutrient distribution and stalls the re-epithelisation process. 
• Topical application of GFs applied to the expanding case, is only effective when a wound 
is colonised as full wound recovery is observed. However in the severely infected case 
this results in large deposit.ion of granulation tissue known as hypergranulatioll which 
may be responsible for hindering the re-epithelisation activities. 
• Dermal substitutes presented in the form of topical fibroblasts is successful in reinstat-
ing complete wound recovery in the infected case, as fibroblast activities are enhanced 
allowing debridement and sufficient new tissue growth to complete wound healing. 
7.1.2 Thesis Summary 
In this thesis, we focus on dermatological activity with particular interest given to the \vound 
healing phenomenon, defined by mathematical models formulated and simulated using nOI1-
linear PDE systems to describe epidermal and dermal skin growth and recovery. One of t.he 
principal aims of the research was to gain insight into healing behaviour of normal injuries par-
ticularly of deep tissue wounds 1 then translate these findings to delayed/non-healing wounds 
and highlight key parameters involved which refer to biological components or functions. A 
more in depth overview was obtained and the transformation from an acute to chronic wound 
state1 was made clearer once we established the most influential parameters as it was clearer 
to envisage why such behaviour occurred. The investigations of non-healing/delayed scenarios 
which resembles characteristics common to chronic wounds, suggests that abnormality should 
be attended to immediately, to prompt reinstatement of healing the components. Conven-
tional therapies are important, however our results imply that management of nutrients, GFs 
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and fibroblasts and prevention of infection all enhance the healing process by reducing the 
chance of the wound becoming chronic. lIv1any of the management strategies are now possible 
and the current modelling framework enables a theoretical analysis to investigate and optil11ise 
these treatments. 
7.2 Future Work 
The thesis investigated many interesting scenarios that demonstrate dermatological growth 
and repair of chronic conditions, which includes deep tissue wounds and the skin disease 
psoriasis. From the superficial healing aspect we can make further investigations into the 
following areas 
• ~.'lany growth factors aid the epidermal healing process such as EGF, FGF and TGF~ 
{3; further investigation could study the role of specific GFs in the wound and the 
characteristics they exhibit to ensure repair and re~epithelisation. 
• Psoriatic model provides a foundation for skin diseases that exceed the wound mar-
gins. This concept and modelling can be improved and applied to the study of keloids 
and hypertrophic scars for insight into their behaviour, to determine whether there are 
perturb at ions in the keratinisation process. This would require a more in dept.h llnder~ 
standing of the conditions. 
• The role of calcium signalling on the regulation of the keratinisation process. 
• Examine the similarities of skin diseases mentioned to see if a generic model can be 
imposed, which will deduce the effectiveness of modern treatment and their effects on 
managing the signs and symptoms. 
The dermal model which was key to the research in the report has Illany areas that can be 
investigated further, some of which are mentioned below 
• The model has considered simple wound shapes so far in ID and future work can investi-
gate radially symmetric wounds, which will offer more details regarding healing profiles 
and the problems faced by chronicity. 
• Nutrients were considered as a generic variable, and further studies could look more 
closely at specific types such as glucose and/or oxygen to obtain information on concen-
trations in healthy and unhealthy skin. 
• Platelet· disorders such as von "'illebrand disease could be investigated by extending 
the model and looking closely at the clotting mechanism, which could provide greater 
insight into healing defects and possible intervention methods. 
158 
• Literature suggests presence of t\ .... o specific GFs, namely TGF-,t3 and PDCF that influ-
ence wound repair by exhibiting positive and negative characteristics. The way in which 
these interact in a wound environment from the beginning to the final stages, could be 
insightful when considering topical applications. 
• \Vound closure was modelled between the proliferative and repair stages of healing, 
this can be extended to account for wound contraction and maturation to highlight 
transitional period from granulation tissue growth to scar formation. 
• Hypergranulation observed after topical application of signals in an infected wound can 
be investigated further. Excess tissue in wounds can make them more prone to blceding 
as the presence of illlmature capillaries cause swelling of the wound, and special dressings 
could absorb moisture stimulating re-epithelisation. Research is limited ill this area and 
could contribute greatly, to understanding chronic wounds further. 
• It is COlllmon to find low quantities of granulation tissue in chronic wounds when vas-
culature is inadequate, it would be interesting to find a cOlllmon element responsible 
for the under or over- abundant deposition at the wound. There may exist a fibroblast 
threshold and variation in granulation tissue behaviour as a response. 
• \Ve considered chronic wounds, and further work could extend the model in Chapter 6 
and look more closely at certain wound type e.g foot ulcers and try to compare healing 
pathology. 
• Loss of the hypodermis from deep injury could also be another avenue for research, as 
it seems such wounds heal even slower and are prone to infections. Research into this 
area may need to consider interaction between bacteria and adipose tissuc) and other 
appendages that are found in the membrane. 
• A more in depth investigation of wound healing processes in circulatory problems e.g. 
diabetes would benefit advancing treatments available and may prevent severe strategies 
such as amputations. 
• l3ifurcation analysis beh .... een healing and non-healing domains and parameter sensitivity 
analysis will provide details regarding the models introduced to the thesis. Travelling 
wave analysis will also benefit further understanding of the models. 
i\.oIany of the suggested investigations should only require small modifications and/or extensions 
to the models studied in this thesis. It is hoped that the work described in this thesis has 
offered many insights into key processes of normal and impaired wound healing, and forms a 
basis for advanced studies and perhaps development of new and effective treatments. 
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Appendix A 
Finite Difference Schemes 
The mathematical modelling of the wound healing of epidermal and dermal membranes and 
skin conditions, involves coupled nonlineaI system of firRt order and second order PDE systems. 
Finite difference schemes are used to produce numerical results [118]. In this appendix wc 
will summaris~ the schemes that will be applied to Chapters :!, 4, 5 and 6. \Ve want to find 
solutions of the PDEs at the mesh points (x, t) = (iLJ.x, jLJ.t) for i E (O,!) and j E (0, K). The 
general form of the PDEs are 8..'J follows 
where J is the flux 
1. In Chapters 3 and 4 we have J = vu. Defined! = f - u ~~ the problem of the form 
, , 
, £ix , 
, - _. 
£it 
u'l 
- _. 
r' 
• 
Figure A.I: AJesh grid {or finite schemes highlighting tIle initjal point Ui,j, where i is the 
spatial and j the temporal index of the mesh point IllS}. 
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was described using an explicit Euler time step and upwinding for space so that 
Vi,j < 0 
Vi,j > 0 
and 1 was approximate by li.j. This is O(~x) and O(~t) accurate in 
I
vtJ.tl ~ <1 ~x -) 
which is the so called Courant-Friedrichs and Levy (CFL) condition. 
2. Diffusion. terms J = -D~~ in Chapter 5 and 6 were solved using the standard central 
difference schemes, namely 
UH1,j - 2Ui,j + Ui-l,j 
6.x 2 
and Bu/Ut as above. This is O(6.x2 ) and O(~t) accurate and numerically stable if 
I 
DtJ.tl <~. 
6.x2 - 2 (A.l ) 
3. Chemotactic coefficients used in Chapter 5 and 6 given by J = X(ll) g;, are solved using 
the central difference in the following manlier 
(A.2) 
and Bu/Bx as above. This is O(~X2) approximation of t.he chemotactic terms, with 
more complicated stability criteria requiring a contribution from the diffusion term. \Ve 
found in our simulation that (A.I) was generally sufficient. 
The quasi-steady equations are of the form 
and 
av = j 
ax ' 
a2 e 
ax2 = J. 
161 
(A.3) 
(AA) 
The first of these was solved using the trapezium method, namely 
\\o'hich is O(.6.x2) accurate. 
\'i+l,j - Vi.j 
L'>x' 
1i+1 +/; ==> 
2 
L'>x V . =V . + - (1/+1 - f·) t,) I.) 2 t , 
(A.5) 
(A.6) 
The non-linear 2nd order quasi-steady equation is solved using the Numerical Algorithm Group 
(NAG) boundary value solver D03RAF. 
For the co-ordinate of the moving boundary, H(t) in Chapters 3 and 4, the simple Euler 
method is used, hence 
dH (3 
-=v--
dt b 
is rewritten as 
(A.7) 
(A.8) 
A.1 Numerical Schemes: Chapter 3 
\Ve solve the resealed system given in Chapter 3 using FDr.'I, and compute in Fortran. The 
NAG routine D03RAF solves the c(x,t) and its corresponding boundary condition. (3.71) is 
discretised on 
N. =N .-6T(N '{(1- ucZi ) _ V,.i-V,-I';}+ (V,.i- ZHi)6N) 
1.)+1 1,) 1,) 11 + 'I H. AZ H. ' 
Cc Ci.j)Ll ) 
(A.9) 
(3.73) is discretised on 
B· ;, B + 6T (N. _ B· . {6 _ (V,.i - V,-I.i)} + (V,.i - ZIji) 68) 
1.)+1 1,) , 1,) I,) H .6.Z H. ' , , 
(A.1O) 
and (3.72) becomes 
V '+1 = N ·H6Z 1- '" -- - -- + V'. ( UC".) (if> 1) 1,) 1,)) 'I + 1/ 1,) Cc Ci .j Trlmax n max (A.11) 
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A.2 Numerical Schemes: Chapter 4 
The rescaled system from Chapter 4, also solved in Fortran where the NAG routine D03RAF 
is applied to A(x, t), B(x, t) and c(x, t) and the corresponding boundary conditions. As seen 
in Appendix A.I, the modified equations for n, b and v become 
N',j+) =N',j + t.T (N"j {kd(C"j) + 8 (Ci.i> A',j) (1 + n~aJ } -V;'~;t.Ztj t.N) , 
(A.12) 
B. =B, t.T { ILN,,j _ oB.. k (CN. ) _ 8(C',j, A',j)N',j _ V;,j - zJij t.B} 
1,)+1 t.) + 1+ 8(C .. A . . ) t,} +.d t,) I.J1 HAZ' 
, t.) 1 t,) nmax)t..:l. 
(A,la) 
v, -V, Hjt.Z (k (C) 8(C' ) N',j . () ( ) N,_1. j ) 1,j+l - i-l,j + -2- d i,j Ni,) + i,j, Ai,) -,,- - kd Ci-I,j N i _ 1,j + e ei-I,j, Ai_l,j -,,-- , 
~max °max 
(A,14) 
The analytical solution for imlllune cells can be written as 
( ,;pH' ) cosh ~
U',j+) = cosh( /PH2) , (A,15) 
A.3 Numerical Schemes: Chapter 5 
If e(a) = 1?1+1.~+'hd and w(b)::; ;::;:>l±ld~wi.t where a = n,i,d,g and b::; n,j,c,s then using 
central differencing, "Euler" and forward schemes the system becomes 
N. =N' .. + t.t (w(n) - g(n)(Xn(g(d) + ung(g)))w(s) + N',jC,,j (1 _ N"j) _ O,nN"j ) 
',,+) '" A 1 S / 1 C' / uX + i,j fncs "'n + i,j I'ne 
(A,16) 
F.-. =F.-. + t.t (W(f) - g(f)(Xn(g(d) +ufO(9)))w(s) +f3 k (D . G .) + PC"f3 H(S· - S)) ~,}+ 1 1,} D..x fb b 1,}, I.} I.) I,) jcs t,) 
(A,17) 
(A,18) 
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+ t:.t ({3,mM,,; - 5,,;(6, + 6,"N,,; + 6,/ F,,;)) 
M',j+1 =M,,; - t:.t (M,,; F;,; (6ml + 6m ,5,,;) + 6mM,,;) (A,20) 
G',j+1 =G,,; + t:.t (C,,;J~,;({3g'l + (3g,5,,;)H(5,,; - s)H(c - C,,;) - 1 +G(::'~/~g/) (A,2I) 
A.4 Numerical Schemes: Chapter 6 
The additional components have been imposed to give 
N"j+1 =N,,; + t:.t (<p(n) - g(n)(x"(g(d) + ""g(g)))<p(s) + N,,;C',j (1 _ N;,;)) 
~x 1 + Si,j/"fncs /'\.11 
(A,22) 
( 6," ) - t:.tN,,; C' '/ + w,,] , 1 + I,J 1nc 
F, =V + t:.t (<p(f) - g(f)(x,,(g(d) + "Ie(g)))<p(s) + ~ k (D ' c ,) + F ,C'~ H(5' _ -)) 
l.}+l I.J .6..x /JIb b 1,1' 'I,) 1.) I,)I-'jcs I,J S 
(A,23) 
+t:.tP,,; (C,,;{3I' (1- P,,;) - 1+(0. ,+6/ S. ,)/ -a/mwll'"j) 
/'i,f t.) PI I,) lies 
C"j+1 =C;,; + t:.t (~~ + (3,bkb(D,,;, G,,;) - C,,;(6,"N,,; + 6'1 F;,; + Q=w W,,;)) (A,24) 
5"j+1 =5,,; + t:.t (~; + (N,,;({3," + (3,,"5;,;) + P',j({3'1 + {3"15,,;))(1 + (3,eH(c - C"j))) 
(A.25) 
+ .6.t ({3sml\1i ,j + f3swFi,j H/i,j - Si,j(Os + OsnNi,j + Os! ~,j)) 
1\hi+1 =1Hi ,] +.ut (H'i,j(r;&Ni .j + D.gmwGi.j + QdmwDi,j) - Ali ,j Fi.j (Omf + b1T,,;Si,j) + oml\l j ,j) 
(A,26) 
(A,27) 
ClgmwGi,j lVi,j) 
(A,2S) 
W"j+1 =II'"j - t:.t(W,,;({3w,Ci,j + (3wmMi,;) + (3w"H(n - Ni,;) - Wi,;(6w + 6wl F';,;)) 
(A,29) 
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Appendix B 
N ondimensionalisation 
B.l Re-epithelisation Model 
\Ve int.roduce the nondilllensional quantit.ies t "= tot, x = xnx, H = xoH, v = vov, b = bob, 
c = coe and Vw = vov;". We note that V(t} = v(1 - w} + vww so that V(t} = Vu V(t} and n 
and m are dimensionless. On substitution the system given in Chapter 3, 
~-+-- vn =-~, 1- n 1 an Vo a (') ~ ( ,,(coe)") 
to ai Xo ax c~ + (coe)'} 1 
Vo av =Il (1 _ "(c,,e)" ) n (_1> ___ 1_) 
Xo ox c~ + {COC)11 mmax n max ' 
bo ah vobo a " , -~ + ----;c(vb} =1''' - Jbob, 
tu at Xo D.L 
~ ac voV(t}co ae _ D,c" a'e _, ( ,,(cue)" ) 
a, + a' - 'a" ~n " (') , to t Xu :t: Xo x Cc + COC 1/ 
and the initial and boundary conditions become 
b b _'tnmax 
o --J-
Xu aH , Fu 
-- =vov--, 
tu at b"b 
O ' (xo dfl V( }) D,eu ae =coc -- - 1'0 t + -----;c. 
to dt Xo ax 
"Ve can multiply the system by tu, e, {! and ~ respectively and this gives 
an v"to a (') ~ (1 ,,(eoe)") ~+--;::- vn =-ldu - 1] A n at "'0 ax c, + (coc)" 
ail Ilxo ( O"(eoe}") (1) 1) 
ex =~ 1 - c~ + (COC)11 n mmax - n max 
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(RI) 
(B.2) 
(B.3) 
(B.4) 
(B.5) 
(B.6) 
(B.7) 
(B.8) 
(B.9) 
a~ + voto ~(vb) =Itt"n _ Jtob 
at Xo Dx bo 
(B.IO) 
iJc + V(t)votu ac = Dctu a'c _ Ato n ( u(coc)O ) 
at Xo 8i x~ [)5;2 Co c~ + (Coc)'l (B.11 ) 
and JIlultiply the initial and boundary conditions bv ~, lit. and DXQ so the initial and bound-
• ¥vuXo "co 
ary conditions become 
b =Jlnmax 
J (B.12) 
8H vnto A Foto 
-=-v---_ 
at Xo xobob 
(B.13) 
a~ = X5 c (voto V(t) _ dH) . 
ex loDe Xo dt (B.14) 
Using the rescalings to = fi I Xo = Tt, bo = IT, J = A, (c = ~, ~ = M; and IJ = ~C~~ and 
dropping the hats we can derive the full nondimensionaliscd system and corresponding initial 
and boundary conditions, presented in Chapter 3. 
B.2 Psoriatic Model 
\\le introduce the nondimensional quantities b = bob, t = toi, x = xox, c::::: coe, VU) = Vn V(t), 
H = xn!l, v = voit, Vw = v()v~ A = AoA, B = BoB and I = fot On substitution 
~ an VD ~(', ) _ (Coc)"' (AoA)O' 
to ai + Xo Dx vn -0 (coc):!' + (Coc)"' (AoA):!' + (AoA)"' n (B.15) 
_ 0 (I _ u(coc)" ) 
(coc):! + (coc)" n (B.16) 
Vo iJv =0 (I _ u(coc)" ) n (_1> ___ 1_) 
Xu 8x (coc)i + (coe)'] ffimax nmax (B.17) 
(coc)"' (AoA)" n 
+ 0 ( _)"' (_) _ _ 
CoC c + CoC 111 (AoA):Jl + (AoA)1I2 nmax 
Jln A -------.!:.~--_-- - 6bob I + (CQc)'l1 (AoA)'ll 
,a (CQC)~I +(COC)'l1 (AoA)~2 +(AoA)'l2 
00 D~ + voba ~(i)b) 
to at Xo 8x (B.18) 
Co iJt voV(t)co ac _ Dcc" a'c _ A ( u(coc)O ) 
t iJ - + a - - , a -2 n ( -)" ( -) o t Xo x Xo x . c"c c + coc" (B.19) 
A"iJA vuV(t)A"aA_DMI"a'A AA-BB' AA--
-t -a- + a ---,- D-' -(1 0 " + (, 0 IoI 
o t Xo x Xo X 
(B.20) 
A A. 2 A 
Ba DB + voV(t)BoiJB _D8 BoD B +" n <" A A-B B- <" B B-1 1-
-t -a- a- ---,- aA2 "·1 - "·2 0 0 - '''3 0 0 
o t Xo x Xo x 
(B.21) 
10 Dj voV(t)Io aj DJ 10 a'j -
-t a-+ -a-=-'-a-,-pIoI 
o t Xo x Xo x 
(B.22) 
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subject to the initial and boundary conditions 
b b _ J.Lnmax 
o - J{l + ,il{e, A))' 
Xn ail ~ Fo 
--~ =vov--" 
to 8t bub 
0 _" (xo dH I'{)) D,eo 8c -eco ---,t +---
to dt Xo ex' 
0 - A"A (xo dl1 V{)) DAAo 8A - () ---Vo t +---
to dt Xn 8x' 
0 - B"B (xo d/J . V{)) DBBO 8B - 0 ---vu t +---
to dt Xo ax' 
O-f"f (xodH V{)) D/f0 8i - 0 ---1.'0 t +---. 
to dt Xn 8x 
\Ve can multiply by to Bl. .!.l!. .!.l!. .!u... .i!L .!.l!. respectively. 
, vo' bll' co' Ao' Bn' 10 
8b votu 8 ("b") ~+---;cv 
8t Xo 8x 
Jlt()n. £ b" 
_ - uto 
b (1 (Oocl" (A,AI") 
o +),0: (coc)2+(coc)'1 (AoA)~+(AoA)'1 
8c V{t)voto 8c = D,to 8'c _ Aton ( a{eoc)" ) 
8t + Xo 8x x5 ax2 Co (eoc)~ + (COC)l1 
8A I'{t)vuto 8A DAtO 8'A "" "" 
-8" + 8 =-,- 8"' - (1 toABoB + (2 toAfof 
t Xo x Xo x 
~ - 2 -
8B V{t)voto 8B _ DB to 8 B "1 ntO _ A A B" _". " " 
8 " + 8" - , 8"' + B "2 0 to ".Ito
Bfof t Xo x Xo x 0 
~ - 2 -8: + V{t)voto 8B = D/to ~ _ ptoi 
at Xo 8x Xo 0£2 
(8.23) 
(8.24) 
(8.25) 
(B.20) 
(8.27) 
(8.28) 
(8.29) 
(8.32) 
(8.33) 
(8.34) 
(8.35) 
and multiply the initial and boundary conditions using fo, ~, 
--"'-
D~~o' D~oBo and 
D[lo 
b _ P.Hmax 
- Jbo{l + ,il{e, A)' 
oli voto ft Fotu 
-" =-v---", 
at Xo xobob 
8c = X5 c (uoto V{t) _ d/J) 
Dx toDf; Xo dt' 
- 2 ft 2 
8A = ~A (votoV{t) _ dl1) 8B = ~B (votOI'{t) _ dH) 
ox toDA Xn ' dt 'ox toDB Xo dt' 
8~ = X5 i (vutoV{t) _ dH). 
ox toDI Xt) dt 
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The additional rescalings to are fA = ~, (1 = (l~f~A, (2 = (2In~A, EB = -1#f, [;,1 = ?l~~I, 
K2 = KV:r fl , 1\,:\ = K'!~u!, El = =J¥ and p = E[f. The nondimensionalised system is given in 
Chapter 4. 
B.2.1 Zero Flux Boundary Condition 
\Ve are aware of the moving boundary and to overcome this issue, a conservation argument is 
used to obtain the correct boundary condition. The zero flux condition for the growth factor 
concentration at x = H(t) will be deduced here and applies to Chapter 3 and 4. The total 
amount of c in the spatial domain (x E (0,11)) is given by (using conservation law) 
~ rH cdx = Jc(O, t) _.\ rH -,/'-ndx, 
ut la , la Cc + C11 
consumed by cells 
equivalent to 
{) i H i3c i H cry 
" cdx = -Dc,,(O,t) + V(t)c(O,t) -.\ -ry--ndx, 
ut 0 uX a Cc + C11 
as DX ---> O. Recalling the growth factor concentration equation 
8c 8 2c ac c11 
" = Dc", - V(t)" - .\n-ry--, 
ut uX uX Cc +C11 
and integrating between the spatial domain gives 
iH {)c iH ({)'C i3c cry) ~ dx = Dc-, - V(t)- - .\n-ry--oat 0 8x 8x cc+c11 dx. 
Reversing the normal differentiation process inside the integral argument we obtain 
{) i H {)H i H ({)'C {)c Cry) 
" cdx = c(H, t)" + Dc", - V(t)" - .\n-ry-- dx, 
ut 0 ut 0 uX ut cc+c11 
and integration yields 
a rH {)H [ i3c] H 
at io cdx = c(H, t)at: + Dc {)x () 
Subtracting (B.37) from (B.40) 
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(B.36) 
(B.37) 
(B.38) 
(B.39) 
(B.40) 
simplifying to 
aH Bc 
c(H, t)7it + Dc at (H, t) - V(t)c(H, t) = 0 (B.42) 
and substituting (3.18) gives the zero flux condition for c. Similarly we can derive the zero 
flux conditions for A, B and I for the extended model in Chapter 4. 
B.3 Dermal Model 
Substituting the rescalings x = xox, t = toi, n = noil, m = dum, d = dud, 9 = dng, f = in], 
C = CoG apd 8 = SOS, the dermal system in Chapter 5 becomes 
noaTi _Dnnoa'fl_ sonol!-. (" . (d d" d ")as) 
t a ' - , a' 2 a nXn 0 + an 09 a" o t Xo x Xo x x 
+ 1 - - - :--:-=--;:,-i3"noF!cco ( nOil) OncnO f! 
1 + 80S/,nes fi-n 1 + COC/,nc 
moaT;' f, "f"(' , ")' " 
- -~ = - mo om Umf + UmsSOS - um1Hom 
to at 
do a~ =0 
to at 
do a[} "f, f"(fJ fJ ")ll(" -)1-1(- ') dogJge 
----;:;: =C()C 0 gsf + gfSOS SOS - S C - C(JC - ~/ 
to at 1 + CoC 'YgI 
foai _DJioa'i _ sofol!-. (f"' (d d d ")88) 
t a" - 'a"' 'a' XI 0 + al 09 a' ot xox XoX x 
+ fJlbk,(d, g) + foi coi' (fJle (1 -~n + fJle,H(sos - s)) 
Jlfoi 
1 + (coi' + PIsos)hle, 
Co ac Deco a'i' )"(' ") 
-a" =-'-a" +fJcbkb(d,g -C;)C JennOn + Jeffof 
tot X(j x 
(B.43) 
(B.44) 
(B.45) 
(B.4G) 
(B.47) 
(B.48) 
So as D,so a's ("(fJ fJ ") r f'(fJ fJ '))(1 fJ -H(- ")) 
----;:;: =-,- a~2 + non sn + ssnSO s + JO sf + ssfsos + se C - COC 
to at Xo x . 
(B.49) 
(B.50) 
Multiplying the system by to/no, to/mo, to/do, to/do, to/lo, to/C;) and to/so respectively to 
give 
(B.51) 
(B.52) 
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a~ =0 
at 
ay to - f f-((3 (3 -)fl( - -)fl(- -) gJgctO 
----;::: =-d COCJO gsl + gf 8 0S SOS - S C - Coc - ~/ at 0 1 + CoC "'tg! 
aj Dltoa'j s"tna(- - ,as) 
-a' =-'-a-' - -, -a- fx/(d"d + (JA,g)a' t Xu x Xo x x 
(3lb tokb(d,g) - _ ( (Joi ' _)) + f" + feoet" (3lc 1 - "I + (3lc,H(sos - s) 
811."j 
(B.53) 
(B.54) 
(B.55) 
(B.56) 
(B.57) 
The system can be simplified further by applying appropriate nondimcnsionai quantities 
which are presented in Section 5.3.5 as well as the full nondimcnsionalised system. 
B.4 Bacteria Model 
Substituting the rescalings x ::;:: XOX, t ::;:: tot, n ::;:: non, m ::;:: dam, d ::;:: dud, 9 ::;:: dog, f = foj, 
c::;:: CoG, 11) ::;:: WOW ancl s ::;:: sas, the dermal system in Chapter 6 becomes' 
do ad , ' 
-----;::: ::;:: - O::dmwwowdod 
t" at 
do ay 
to al 
eocfoj((3g'l (3 ')fl(' -)H(- ') ( doy8gc ,) 
, / + gsSOS SOS - S C - coe - ~/ + QgmwWOW 
1 + WOW 19w 1 + COC "/9f 
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(B.5S) 
(B.59) 
(B.60) 
(B.61) 
(B.62) 
Co Dc D,co a'c {3 k (d) '(' ' , r f' ') 
-----::;: =-'--a~2 + cb"b ,9 ~ coe Ucn1l0n + Vc!JO + QcmwWOW 
to at Xo x 
Wo a~ =WoW(!3wcc + f3wm Tnom) + f3wn H(il - non) ~ w()w(Ow + Owl foj) 
to at 
StD aa~ = D,;o aa~~ + (noi\({3m + {3"nSOS) + foj({3'f + {3"fSos))(1 + {3"H(e - coe)) () t Xo x 
+ Bp{3smdol'h - sns(Os + t5snn oft + Os! i(d) 
(13.63) 
(13.64) 
(13.65) 
(13.66) 
:rvIultiplying the system by to/no, to/mOl to/dol to/dol to/ /01 to/COl to/wo and to/so respec-
tively to give 
(13.67) 
(13.68) 
(13.69) 
cocfojtO({39'f + {39'SOS) H( '-)H(- ') to ( g69, + ') 
d (I '/) 80 S - s C - CoC - -d '/ CtgmwWOW o + WOW "(gw 0 1 + CoG 'Ygf 
(13.70) 
(13.71) 
(13.72) 
(13.73) 
(13.74) 
(13.75) 
The rescalings and full nondimensionalised system can be found in Section 6.2.4. 
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